<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:b667ec8b-a5a2-4565-a4d9-dde39ace17d0,g:ab623129-dd8d-41bb-a89d-0d0241232c84,d:c108ce1ac62e43b3b0fd6869b9627b1f--><html xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:vrtx="http://www.vrtx.com/20230331" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vrtx-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80L2ZyYWc6OWZjZTg2NDZkODE0NGI1ZTg5NTAwMTFhZjUyYmIxZmIvdGFibGU6ZGM4N2VmNWQ3NzAzNGJhMWE2ZDQyOTA1YmE4NjBkYWMvdGFibGVyYW5nZTpkYzg3ZWY1ZDc3MDM0YmExYTZkNDI5MDViYTg2MGRhY18xLTEtMS0xLTE1NDQ2NQ_35a397c6-42f7-4d01-a4e4-98ee0fcf15e9">VERTEX PHARMACEUTICALS INC / MA</ix:nonNumeric><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80L2ZyYWc6OWZjZTg2NDZkODE0NGI1ZTg5NTAwMTFhZjUyYmIxZmIvdGFibGU6ZGM4N2VmNWQ3NzAzNGJhMWE2ZDQyOTA1YmE4NjBkYWMvdGFibGVyYW5nZTpkYzg3ZWY1ZDc3MDM0YmExYTZkNDI5MDViYTg2MGRhY18yLTEtMS0xLTE1NDQ2NQ_c03b7864-d528-4f32-a842-0a3ec92d5693">0000875320</ix:nonNumeric><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80L2ZyYWc6OWZjZTg2NDZkODE0NGI1ZTg5NTAwMTFhZjUyYmIxZmIvdGFibGU6ZGM4N2VmNWQ3NzAzNGJhMWE2ZDQyOTA1YmE4NjBkYWMvdGFibGVyYW5nZTpkYzg3ZWY1ZDc3MDM0YmExYTZkNDI5MDViYTg2MGRhY18zLTEtMS0xLTE1NDQ2NQ_5c8a3bf2-981b-469c-bcaa-4535fc48ea87">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80L2ZyYWc6OWZjZTg2NDZkODE0NGI1ZTg5NTAwMTFhZjUyYmIxZmIvdGFibGU6ZGM4N2VmNWQ3NzAzNGJhMWE2ZDQyOTA1YmE4NjBkYWMvdGFibGVyYW5nZTpkYzg3ZWY1ZDc3MDM0YmExYTZkNDI5MDViYTg2MGRhY180LTEtMS0xLTE1NDQ2NQ_766d9527-fdf9-49fb-ac76-25c2f7d171fc">2023</ix:nonNumeric><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80L2ZyYWc6OWZjZTg2NDZkODE0NGI1ZTg5NTAwMTFhZjUyYmIxZmIvdGFibGU6ZGM4N2VmNWQ3NzAzNGJhMWE2ZDQyOTA1YmE4NjBkYWMvdGFibGVyYW5nZTpkYzg3ZWY1ZDc3MDM0YmExYTZkNDI5MDViYTg2MGRhY181LTEtMS0xLTE1NDQ2NQ_5b9cba4d-3604-4799-802b-6559b7ebff80">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80L2ZyYWc6OWZjZTg2NDZkODE0NGI1ZTg5NTAwMTFhZjUyYmIxZmIvdGFibGU6ZGM4N2VmNWQ3NzAzNGJhMWE2ZDQyOTA1YmE4NjBkYWMvdGFibGVyYW5nZTpkYzg3ZWY1ZDc3MDM0YmExYTZkNDI5MDViYTg2MGRhY182LTEtMS0xLTE1NDQ2NQ_a5ee2b24-5f43-4cf7-8ffa-980149512efa">false</ix:nonNumeric><ix:nonNumeric contextRef="i32f7b7c8737742258ed109e5d83fb764_D20230101-20230331" name="us-gaap:DerivativeTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfNDE4_d1c0c737-93ce-41cb-b05c-df6e20f05e94">P1M</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vrtx-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i797275cda4d74310a9cdaf8c86828d19_I20230425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i184cf5afd6cd4fa685060fb920896ba9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i108d7bd86abe4e58838391cedbbc7af4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9644a4268654e9c8ac1040d8f7e79c9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if11c93d7fb4c4f3c9c6178a17f8464bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78dd0b0a3c85467781f9ab6e34e27864_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e315428b573487aa6dbd1c0da1aa056_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94ed48e03e6e4037bf3e89fb85ccd323_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7612c85cc2ee463982591ad6233a366a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96d5c66c307b4ddbadb7f8693a79b13a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89fc085156c84c1584294f205d4d7704_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9750561a4f8147f4bc490e7a5f0c4719_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00983d2d8e084d6ea561084fa99ed99f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5dc994fb57941a6994b020468c9c7fb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i914f1759975744f481aba609735018e0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i965b485f68b84496a4a73dfb194953aa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1af14e7def84e3590f8cdcf9d63aa32_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0be4937c73843eca3d724ac6fb90e1a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib977b600bd39401f8c9230b2429ba0e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8554735455834204b136bf02ee206adf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0db3c1abefb42109af3bd73e1178ec6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03910580239e48388fdcc461d33f0896_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86a7f4d7e65b4ad8a58d97f90dd851a0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cee9dd573ad45809f92b1f95bf98b88_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9ec51fa63f1409ebacc82d94d16c23d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e809bf63b404ae482a643c548a33cb9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2025e93e9b9547aabc13afcfb311526b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92ee2dbb965f48489dd427b879f349f8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib74fd5062b9c4340bb2c4c5fadcf6657_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>vrtx:segment</xbrli:measure></xbrli:unit><xbrli:context id="icd4f77cc41374bc7a80cdb0fc196c854_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrtx:TRIKAFTAKAFTRIOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f36e45386274e77ad47eb2848f0c317_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrtx:TRIKAFTAKAFTRIOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d5cdadcb40c4a7b9d5fc4a892524206_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrtx:KalydecoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccac4c61256546d58cc69acb9e2ba857_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrtx:KalydecoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91dc78cd89b2461d83edb8473d0d8a8b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrtx:ORKAMBIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bd1bdf70f064b299ffacaeb642c9355_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrtx:ORKAMBIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i465ccbd266d140cb8265be3e1437dfe1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrtx:SYMDEKOSYMKEVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aacc5540aee4a7f92575c5b335f46e9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vrtx:SYMDEKOSYMKEVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42ba7520aa3742e08869dd02bc97113c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65992ec525c0440fb4006df41bf023cf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12def64051c340048a7d28c296ea29ae_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6524abece9604a65b92e34f77f73a8a5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i528415acc74b414dbbaec7b7053d8506_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vrtx:OtherNonU.S.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbb63d727fe94cc39e39b4d5eea23488_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vrtx:OtherNonU.S.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0b80a074ccc43f5a47c621d5310c23a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3210a82692ba4c929a81d39788242c43_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id96f32d9bccb4f5ba68093ece409879a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vrtx:CollaborativeArrangementsByAgreementAxis">vrtx:CRISPRTherapeuticsAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="target"><xbrli:measure>vrtx:target</xbrli:measure></xbrli:unit><xbrli:context id="i1ac5aca29e3145cea1ae716e1ace4fcc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vrtx:CollaborativeArrangementsByAgreementAxis">vrtx:CRSIPRJDCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id397992e0b004888b8845d29138cc50c_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vrtx:CollaborativeArrangementsByAgreementAxis">vrtx:CRSIPRJDCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i3037c05af4d7452dba1bbfbd1a6512be_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vrtx:CRISPRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="vrtx:CollaborativeArrangementsByAgreementAxis">vrtx:CRSIPRJDCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dc0c51184ba46bf9d104a0d64b0a205_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vrtx:CollaborativeArrangementsByAgreementAxis">vrtx:CRSIPRJDCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i526aab6a6d8042eaa0634e3b89fca4cd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vrtx:CollaborativeArrangementsByAgreementAxis">vrtx:CRSIPRJDCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i167ddb8e36774d78b74cf96f19056563_D20230301-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vrtx:CollaborativeArrangementsByAgreementAxis">vrtx:CRISPRT1DMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieed5c5b2cca4423798a0da7b3c4ed75d_D20230201-20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vrtx:CollaborativeArrangementsByAgreementAxis">vrtx:EntradaTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c84da8c391241e2910335bfe14620b5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e510f4ce851440bbfd4b3bfdaa33205_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50480a6a862a46a89bf686dd930034e6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44b72b8950a648979b11f67a50f078a7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i308dad806e734f57ae8103ccbe049621_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i496dac79d34b408fb7efb45910444a88_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2777e8e16f2433c947bc7879312f93f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe1679ca0f4743158bdaf62b05b26efc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i951d6dd52836455092fe29cb8e926f82_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e1b5f45469c4b2f9542ef9056135420_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1172b544a5e4dfeaec557b7f54b8c2e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdcf94ce627c4be4a03c2b555eb02850_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19df7d41a2664fb0a6a67b075b15daf4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3a7e4f7cb4e41729070a784a25c8e23_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51b76dd557cc44c5a7683f6822150efc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ed0527849db4ddc810087f8269e6a64_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic343766e206f4789942ef9275cda71a5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i131b6f1d70f94c9f90dfedcdc7a01ff5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99eafb1412f04883bb2ae4db33955742_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c490bcc66894ea98d7429a3117bfa3b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4db63b9d16fd41768755596324d96881_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e7ccae904db4bb594d5120e116b9807_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90aaba6347244ab085a0aa1f4b89a042_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fb1005043c447909f914296771d03db_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c93b1377c664c448dcf6673205406fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5919ceaa00e4362ab8fbb121c59317d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1782d4264f424222af51258f6a4ae9a6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i181055a8f6ac466285fd64c2fef5df1a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bb10fbf88cd4d00b87defa7c623ee5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i015bdda56ff0453f891016f489d1e086_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib66f13223992427f902c8fa1ca24c95c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0e746950de04d5793a708d0939a53f2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460b99888b4f4a44bdc3579e4daa8cb0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i826c05e248484749a5b7f1e659cdf99a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic14a4abd2a6847819be82dc64adca15d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe42df834c8a4f769cf33ae1eab132d7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b5cc7ed365c4cd594b8d5efd9e1b4fb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ab3546549914211ba6c58294b8ef2ba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27cb56654e1c4d8b9e6bfe1ad91ed595_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c1f02e67c014e458edc4f0ecad75d48_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43ae332addf24f6ea1ef3591d8d5ffc1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8142c561d704f2cb44c76e8dc1f64c2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3fe7f7698094ecc904e5bb0b8ed7b86_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2def3af1f037408e85c5c12d51c98a90_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i858376dc0f0c436fbd3f2789d576c706_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9148dcf280149118c7e0db009df819b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i171a9edec9b549f0989290feafdd6ad4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07323877662742d7923c69c73715f083_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a23a85394040289cb08604ba588cd1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f33ba770f9d4332b8449fa051e6f298_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf98e5400e8f4988acb66dd43618d188_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c1c0034f76249d3accf2067044e47e5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic409c3dae38841c4b7b3df9e310a1a62_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i794718dd416648e39771ffbb2f2ad9bd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i743ccaf5675a44b2991a40aa6f855311_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e5c5072ec2243548cbbd937eafa1d4c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdbd1ac532d74157a2c355f92e0ebe09_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4d81680f1fe4c619f9630996ccde6c9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45f2d45f662849808db19555d9490b75_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87d7bf8e231f432895a57c796d5e7dcc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cbdb33ee2764495aa0d5503b0448a57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i601b3ddb8fbf47b4a23246f8836f08db_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc24eb02c014453492edaff2729d75ea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c75ce76e1d844df8f0223492f1dff9e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic839f9440412484a8780bed0df44e3f5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24dc16db341473b9b690dd888d7044a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341cbe1625c7434e845c240c80916396_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia26a2cb8333a43819c70d40501127a7f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a677cbbda2d4e229af873a225992bcb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i731a196828414206b0a07510cafbbff3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f032b45b53947a98d7eab1538fb03ce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i566604ceb3cd40c18cb5699884878aa0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7152b487895c4221adb3eec300a99ea6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i058acce7d553477abe4b88dbdeaed279_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie01b816a88f1486a9d98a071e20c2447_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieba25a1abe7e45c0b2f06fc40962333a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b4493082f544900818b20256cd2ba59_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f6fcb82eb1446b9b8b976728cb94899_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d45e4815ddf48a0a311ecd258a7964b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c2df0bf70c0467987e636b3687fb433_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb59fbd9724a4ceca9f28e9783d88ddd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63f68503c2134982b2667a09e5cb81e6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca37e70e82847a68b12c9859eb40575_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe2eb573b1a64097a177338f5347c5c3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36fd34154c814cd6a86bb6aaa2dbfd49_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i349b5de63331495fa55c332e27a15ad6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6d5c17249984a9cbb2bf43a0c90847a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dbd6f5eca0d4aa2848c9e9ac7b0c90e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64aef10fd68344e1a6be0ffc774989a0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a7cd8e256674846a711534e9b618407_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a91ba5b083946cd879b4f82a5acd934_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie77bd3b24a5d45718fbfd42904d612c8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i148e26f7d2fe46b7bb59dd368e3eae12_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75c22c506edf4ea8b1ba6a5fa91fd631_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f2005ea5d94ee7bbb58bf806bcee1e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i182b3503a8864d01b321392ea01ed794_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a6938f8447e4f23af33ae0f174a67d9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i605e263269d24c96978db991134781c2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief8259f1f6ca4894bbf96d2eb350c313_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadcb4043793c416ca9f8733dfb8ea957_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd741e8c3b8145bcb180c65bbd50f481_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i484a922f34254d179c7b9454d5ddc8cd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i415cea4547f4489d8e4c2f211e8dadb4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cead76d8658403490c6650e993fdb09_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ed3df94f04c4269afb2d20a9b77f1dc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia70b63a884f94134a4a548039da0324b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bb32021800c4e4fa52f9b6e0801f59a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibffdbad2314543c4b842e0519cea4c96_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72c53293cfe9440db0139788931e7042_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5e1168452db44dbaccf71b9f4935933_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib69a994adbdc483cbed6810d023feb05_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vrtx:MarketableSecuritiesAndOtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5db26a92f6514cd88c8471039b7932aa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vrtx:MarketableSecuritiesAndOtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i791a7bbbc18d48e5b2b196484732a23b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f3f564c5871417a8ad1a1335612f366_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbd27dba152a49de9cf1dd071b4c6c4e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vrtx:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i482139101e6848e6aa8d56b9a8e9b92e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vrtx:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8887406a8084124983bf6fd7e465db0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vrtx:MarketableSecuritiesNoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44aaabd69e6e4cbfbe1300dca8ecba7a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vrtx:MarketableSecuritiesNoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b71db6377cd4cdab4cdfbdc6c2d519e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6373ebcbf5f48f494faefeab52b0a31_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic875365bdccf4fdfadcacda1068e90b0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia097b2ea579e471cbb8389aeb6857267_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id69e25ace2084e9faf9daa19d31da608_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4450dd2feca843868a5df5bdae53a781_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64d6acf971364adf93cbee5ddda04052_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7b3fc1cef494189960db6785b28d54f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b38015e7d9842408c2f21c66edea33c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i362c0db1e14d479eb5d71580ef8d640c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if40387e6a37d4de5bc0d23ac3a122239_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia11b3ad2463c4525b2c6a2b8c38a65b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic62ad0a2c3d44d0a810b4a9b0c542cea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4003919acf2e41de909e937dc581073f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i969eeb4d24704dceb2c378052f60b3f9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7425ec7db87d45dd89f2916c71d3b693_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1879c547204409c8d3f60d01810144c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407c5c8db382405ab870dfbad9a9ac17_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i577c589d96dc40628404d8e5c67a33b0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32f7b7c8737742258ed109e5d83fb764_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99106f8f60db40709282c8dddc2f957b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ac87b05cc0141978ceb195b2fdce104_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddfb6891c7c24c079494516ee3b71857_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a57f43f5e384e97927f460413351772_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef3a7c3851a4758a7ac884cf237c64c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i791e9aff90374493ad38f58b1f0c2800_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f78c4320d340889a50077eaeb2f6bd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c65bbde98f643c382b0467b736c9aff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb98e3e6592b4728a7b017926d2963df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd55ca1ba3204fc4843341c209d0c58b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1633a9f256fd47c7ae8f5503a46e98f3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23fe0afde1cd458bb33f64f4dd947b25_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia45a80fbfa8b413799aab519c086a013_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac4a35b6dee84645b2e1cba9306d6c09_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc8da2164469417381f3fbab7a1fcaa6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i137713e1e1434b0c88d15339138d9e89_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i498f13f4b18f4dcd992573844c575682_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45dea239c6874c28ae70eafc6d0b2044_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32fdedd938524ba18a3a76ff8d21eaa3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21aabf003faf4de0853a5a437028da46_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b323f0f34054e90b07db59a177754d8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1b3c9fbffa344dfb792a557883ca887_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i003858b3945e4cdc80aa86397d139171_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c42dff4082943b9b2f971a97f36270a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88be060b3a3e4813959cd282733b2a01_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36591897228a412aacb120f083844e93_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if17adf051053446b88959a159709af08_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i656bb92a0277415cb8bbe0b9e56f15a2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic47188c6696d43f783a095257f822fa0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83507af2ac3a4a3fb6e00e4c990a3bd5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4481d52a03e244f7af2ed89bfbea4ec5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe64753d4f0d46208f21adb58f70f790_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6357aba6e8814ca3b607e5e909aea6b2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f75883c03934f8b9f0845d4876ded39_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4165b4e35c744a5ead585d77ab64ec81_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31e9bb0a22cd4e68b09b3fbafbd81752_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dd8aa202cc44acba501ace4f542abbe_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i449ced1d194f43f2af675a42b7885c1e_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31bb714a138e462eba7e3bb4db8bd563_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43c2fa6156f84d49b34f2bb5ed60c77c_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eba170c9dc9498eaead0dc958583ae7_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb3213a8e90a40d188b46faeb6d69bea_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if290886dd10b49529443a59282d6069d_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000875320</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_1"></div><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">________________________________________________________</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8xNDE_1498632a-4b8e-484d-9b8d-389bf544ccfc">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjE3_8f5f14db-c78a-472a-9c0d-c8da882d137f">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE QUARTERLY PERIOD ENDED <ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjc_27e5e70f-b3a0-4914-96bd-837f4b24ede2">MARCH 31, 2023</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjI5_1a58310f-9cf0-4c3f-9953-c62592e77537">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">   TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></div><div style="margin-bottom:3pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE TRANSITION PERIOD FROM&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">           &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> TO&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">           &#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number&#160;<ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjI0_05aec2cb-6fd1-47d4-9a59-931dcf2a3d4f">000-19319</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">____________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Vertex Pharmaceuticals Incorporated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.428%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjI1_ec548304-4fcc-4fdb-bfa0-b1dd9f040e8c">Massachusetts</ix:nonNumeric> </span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation or organization)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjE4_e785a510-56f1-4474-a9f1-ab9d9070ca29">50 Northern Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjI2_49a5c6f1-298b-472f-835e-71ac1bff5981">Boston</ix:nonNumeric>, <ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjI3_1a58a723-5616-4842-b756-79ce663ed873">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div></div><div style="display:inline-block;max-width:7.142%;min-width:6.142%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.430%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjE5_2e48f587-2d2e-43ae-8f06-a17ad1dd93f6">04-3039129</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification No.)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjIw_a50054a8-27e0-4a65-b9aa-d13f5c3bd0da">02210</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(Zip Code)</span></div></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjMy_39552503-b41d-4009-8318-eac5510e3120">617</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjI4_e28f24b4-bc69-4d2b-82f2-420c4c3b4380">341-6100</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________________________</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:29.25pt;padding-right:29.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trading Symbol</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGFibGU6NGI0ZDA3OWUyNDVlNDEzNmIxYzNiMWFiNzE0MGRmOWEvdGFibGVyYW5nZTo0YjRkMDc5ZTI0NWU0MTM2YjFjM2IxYWI3MTQwZGY5YV8yLTAtMS0xLTE1NDQ2NQ_8d71fb70-ddcd-4b23-b09d-3f1924047d5a">Common Stock, $0.01 Par Value Per Share</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGFibGU6NGI0ZDA3OWUyNDVlNDEzNmIxYzNiMWFiNzE0MGRmOWEvdGFibGVyYW5nZTo0YjRkMDc5ZTI0NWU0MTM2YjFjM2IxYWI3MTQwZGY5YV8yLTItMS0xLTE1NDQ2NQ_a7119b3b-d20c-44a1-8108-90f637d0b0b3">VRTX</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGFibGU6NGI0ZDA3OWUyNDVlNDEzNmIxYzNiMWFiNzE0MGRmOWEvdGFibGVyYW5nZTo0YjRkMDc5ZTI0NWU0MTM2YjFjM2IxYWI3MTQwZGY5YV8yLTQtMS0xLTE1NDQ2NQ_be5c3877-9502-4823-90f4-f2070b1182fd">The Nasdaq Global Select Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. &#160;<ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjIx_42611369-384c-450e-8ff1-172a646b11b7">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160; <ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjIy_36ab3627-1189-4d56-b5a4-c85c3a88f727">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjMz_23639ca0-c503-4ab6-b5eb-b0e1e70ba95b">Large accelerated filer</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   Accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   Non-accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   Smaller reporting company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjMx_945b101b-bdc1-4888-b767-d737b1401295">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjIz_e4e80ffd-37f8-43b7-aadf-850e1d92b26a">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).  Yes&#160;<ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGV4dHJlZ2lvbjo1YTMwOWU1MzgzY2Q0MWI0YmRkNTJiOThmY2Y4YTY2Zl8yNjM1_10339e03-08b5-496a-b546-572907e607aa">&#9744;</ix:nonNumeric>  No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.797%"><tr><td style="width:1.0%"></td><td style="width:40.933%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common Stock, par value $0.01 per share</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i797275cda4d74310a9cdaf8c86828d19_I20230425" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xL2ZyYWc6NWEzMDllNTM4M2NkNDFiNGJkZDUyYjk4ZmNmOGE2NmYvdGFibGU6NjMyNzk2YTFhZTVlNDFkZTg4ODU0OWMwNDkxZDg2ZjkvdGFibGVyYW5nZTo2MzI3OTZhMWFlNWU0MWRlODg4NTQ5YzA0OTFkODZmOV8wLTEtMS0xLTE1NDQ2NQ_c2e7b210-6dcc-4ffc-842e-cb950d7c01ab">257,551,600</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding at April 25, 2023</span></div></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_7"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE QUARTER ENDED MARCH 31, 2023 </span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.423%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Page</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_10">Part I. Financial Information</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_13">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_16">Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_16">Condensed Consolidated Statements of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_16">Income</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_16"> -</a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_16"> </a>Three Months Ended March 31, 2023 and 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_19">Condensed Consolidated Statements of Comprehensive Income - </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended March 31, 2023 and 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_22">Condensed Consolidated Balance Sheets -</a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_22"> </a>March 31, 2023 and December&#160;31, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_25">Condensed Consolidated Statements of Shareholders' Equity - </a>Three Months Ended March 31, 2023 and 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_28">Condensed Consolidated Statements of Cash Flows -</a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> Three Months Ended March 31, 2023 and 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_76">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_76">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_76">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_91">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_91">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_91">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_94">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_94">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_94">33</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_97">Part II. Other Information</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_100">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_100">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_100">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item 1A.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_103">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_103">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_106">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_106">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_106">35</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_115">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_115">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_115">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_118">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_118">37</a></span></div></td></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Vertex,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; as used in this Quarterly Report on Form 10-Q refer to Vertex Pharmaceuticals Incorporated, a Massachusetts corporation, and its subsidiaries.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Vertex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;KALYDECO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;ORKAMBI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;SYMDEKO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;SYMKEVI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;TRIKAFTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;KAFTRIO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are registered trademarks of Vertex. Other brands, names and trademarks contained in this Quarterly Report on Form 10-Q are the property of their respective owners.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the brand name for our products when we refer to the product that has been approved and with respect to the indications on the approved label. Otherwise, including in discussions of our development programs, we refer to our compounds by their scientific (or generic) name or VX developmental designation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_10"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part&#160;I. Financial Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_13"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;Financial Statements</span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Income</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share amounts)(unaudited)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.054%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenues, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMy01LTEtMS0xNTQ0NjU_e30e170d-434c-4624-8bf2-f92ccd70287d">2,374.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMy03LTEtMS0xNTQ0NjU_f7012786-1cdd-4538-8d62-0fdad3116d6d">2,097.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfNy01LTEtMS0xNTQ0NjU_5301ee99-3a4a-4758-92af-2a9ecf7b9fa2">266.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfNy03LTEtMS0xNTQ0NjU_9c36739c-9a0d-4e00-b8b5-58228f2119f6">245.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfOC01LTEtMS0xNTQ0NjU_89c102fa-c386-44ff-a505-b9a7227c5d4c">742.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfOC03LTEtMS0xNTQ0NjU_6cbb9909-2e18-441c-accb-7a87c7d8ede3">601.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfOS01LTEtMS0xNTQ0NjU_235651b4-6c30-4bb8-8ff8-76c674b7829a">347.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfOS03LTEtMS0xNTQ0NjU_60c5c646-172f-4aac-8d1a-c5b835975510">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTAtNS0xLTEtMTU0NDY1_412fc37a-fd28-4b08-ae38-9c2debfdc129">241.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTAtNy0xLTEtMTU0NDY1_5f650657-11c6-4508-9874-28dc27c940ab">215.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTEtNS0xLTEtMTU0NDY1_f13b718a-fa40-4ea9-ac8c-9625b3cb0bb9">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTEtNy0xLTEtMTU0NDY1_d79d7ea8-52b9-472f-abb9-60e98b6ad151">7.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTItNS0xLTEtMTU0NDY1_9862c4ca-4fdc-402f-8882-e14e6dd17510">1,595.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTItNy0xLTEtMTU0NDY1_bf9bc399-c494-4f39-980c-7e606c31befa">1,056.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTMtNS0xLTEtMTU0NDY1_a1f353a9-9650-4118-939b-4c951e8f6428">779.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTMtNy0xLTEtMTU0NDY1_8779f675-99b8-42ed-8ae3-6b551155a3fc">1,040.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTQtNS0xLTEtMTU0NDY1_e4163047-d3b1-4c90-bf3b-094f67573aca">122.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTQtNy0xLTEtMTU0NDY1_32ccdfc7-8b19-4819-bbdd-896cc51881a3">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTUtNS0xLTEtMTU0NDY1_c78730b3-9428-42ba-b646-9b44794657ed">11.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTUtNy0xLTEtMTU0NDY1_eb865bf4-a38f-4fc5-88bd-a50576dbcd89">14.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTYtNS0xLTEtMTU0NDY1_a9b863e9-eb59-4d35-ae82-f5d8ac2cd1c3">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTYtNy0xLTEtMTU0NDY1_b103ba13-fd95-4e5f-bc6d-1425705a08c4">72.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTctNS0xLTEtMTU0NDY1_04b17641-6c8c-4f3b-8ace-c91da1a7d4ee">891.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTctNy0xLTEtMTU0NDY1_3a3b68c3-43dd-458e-b9ef-d9b17edcc25a">954.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTgtNS0xLTEtMTU0NDY1_9ed09a96-2df9-4c3c-8154-e187365d1779">191.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTgtNy0xLTEtMTU0NDY1_f7c5e261-e07d-4367-9624-0aca4d87de84">192.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTktNS0xLTEtMTU0NDY1_d96c53f3-37b2-4526-a1a9-68f19fc24d0a">699.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMTktNy0xLTEtMTU0NDY1_86e93adf-ce13-4afb-a9d6-9e8c85007bfb">762.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMjItNS0xLTEtMTU0NDY1_f2cdb180-5c1b-4f29-bfd9-32334360132b">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMjItNy0xLTEtMTU0NDY1_3b65c337-573e-41b3-ba31-24d347570a74">2.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMjMtNS0xLTEtMTU0NDY1_f42b79df-fb4f-4659-9f6a-46a624f76933">2.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMjMtNy0xLTEtMTU0NDY1_b972a980-7ab4-400e-9ce0-54ebe4428e1c">2.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculations:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMjUtNS0xLTEtMTU0NDY1_f1fe4115-551e-4242-9314-9b6f977d278a">257.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMjUtNy0xLTEtMTU0NDY1_d10e25fb-e5f9-498a-b09b-7761621842f4">255.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMjYtNS0xLTEtMTU0NDY1_1d987c6c-66ed-48a8-a849-ea7d0dbb3493">260.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xNi9mcmFnOjUzY2M0ZGRmYzIxYjQ1OWQ5NWUxMDk1MzU1YmViZDJlL3RhYmxlOjNkMDFmYjgwNzA0NTQxODE5N2M2NDVmOWQwM2ExMjM5L3RhYmxlcmFuZ2U6M2QwMWZiODA3MDQ1NDE4MTk3YzY0NWY5ZDAzYTEyMzlfMjYtNy0xLTEtMTU0NDY1_8824b3aa-0ae5-438e-bf26-f1d16c5a8227">257.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note A, &#8220;Basis of Presentation and Accounting Policies,&#8221; for an explanation of amounts reclassified from &#8220;Research and development expenses&#8221; to &#8220;Acquired in-process research and development expenses&#8221; for the three months ended March 31, 2022.</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_19"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)(unaudited)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.054%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfMi01LTEtMS0xNTQ0NjU_d96c53f3-37b2-4526-a1a9-68f19fc24d0a">699.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfMi03LTEtMS0xNTQ0NjU_86e93adf-ce13-4afb-a9d6-9e8c85007bfb">762.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized holding gains (losses) on marketable securities, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNC0wLTEtMS0xNTQ0NjUvdGV4dHJlZ2lvbjpkYzdkOGUzMjcxMDU0NjFmYjkzZmNjOGFhMDE1YjFiZl8xNjQ5MjY3NDQxNzUw_a8c41a51-b4aa-4241-9149-26f0324c2ca9">0.8</ix:nonFraction>) and <ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNC0wLTEtMS0xNTQ0NjUvdGV4dHJlZ2lvbjpkYzdkOGUzMjcxMDU0NjFmYjkzZmNjOGFhMDE1YjFiZl8xNjQ5MjY3NDQxNzU4_3677b138-ac1e-429e-8db0-e254a94c2367">zero</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNC01LTEtMS0xNTQ0NjU_c8c80801-99f7-4a54-b1f5-7ba0fdcda57b">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNC03LTEtMS0xNTQ0NjU_39770467-9887-45bc-92b2-51d3d039764b">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains on foreign currency forward contracts, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNS0wLTEtMS0xNTQ0NjUvdGV4dHJlZ2lvbjplZWQyYTUwYTcyMzY0ZDA2OWFjZDcwZGNlYzlmMzViM184Mg_5554cfbe-d740-498a-8eeb-f9122256ee58">7.4</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNS0wLTEtMS0xNTQ0NjUvdGV4dHJlZ2lvbjplZWQyYTUwYTcyMzY0ZDA2OWFjZDcwZGNlYzlmMzViM184OQ_9bd29da0-3c85-43c8-bb8c-db212a1e8186">2.2</ix:nonFraction>), respectively</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNS01LTEtMS0xNTQ0NjU_d20925e7-a4df-4f1a-b4fe-08d69d2d8238">26.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNS03LTEtMS0xNTQ0NjU_63707ec0-b78e-4d20-bb70-703e38e548bb">10.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNi01LTEtMS0xNTQ0NjU_f6831256-f756-4f53-9954-1a254dbe6c39">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNi03LTEtMS0xNTQ0NjU_97bd58dd-7c9c-4f12-a1d5-40aba671d2bc">12.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNy01LTEtMS0xNTQ0NjU_9ef64563-e99b-4f98-9a82-e706ce22d845">13.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfNy03LTEtMS0xNTQ0NjU_aa2ad59d-3534-4b29-a8d5-04764de29738">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfOC01LTEtMS0xNTQ0NjU_7b749f8e-afdd-4831-89d1-3a706b7f21fe">685.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xOS9mcmFnOjU0ZDY3MThkNmRmMDQzNTI4N2U3Y2U1ZTA3ZjNkNmQ3L3RhYmxlOjIwZTNiNmVmNjUwMzRlMGRhZTI4MmMzNmNjNTE4ZTAxL3RhYmxlcmFuZ2U6MjBlM2I2ZWY2NTAzNGUwZGFlMjgyYzM2Y2M1MThlMDFfOC03LTEtMS0xNTQ0NjU_be51a9f4-9188-4da3-94fe-7b4a9f9de3bc">757.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_22"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except share data)(unaudited)</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.801%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfNC0xLTEtMS0xNTQ0NjU_d53cc6e9-9f76-472f-b38b-b38883c9223c">9,289.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfNC0zLTEtMS0xNTQ0NjU_76abe622-9689-4cdd-b7d6-8ae904a08bc2">10,504.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfNS0xLTEtMS0xNTQ0NjU_d140aec0-5a74-47ca-8fc7-7abf1af9ad2a">1,124.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfNS0zLTEtMS0xNTQ0NjU_73ad7935-938d-4f18-a48d-2e63ea508af3">274.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfNi0xLTEtMS0xNTQ0NjU_233a0bfc-0242-42da-ab18-c414306df058">1,547.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfNi0zLTEtMS0xNTQ0NjU_d2397583-3449-41c8-94e8-823923cfcaa3">1,442.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfNy0xLTEtMS0xNTQ0NjU_a4c95c45-a054-4a3e-86f8-d2639dcd4157">535.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfNy0zLTEtMS0xNTQ0NjU_54eace1f-af72-46ee-aee5-72a9d4d5d13a">460.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfOC0xLTEtMS0xNTQ0NjU_67ace7b1-f483-4874-bdbf-a5ecaedd1adb">468.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfOC0zLTEtMS0xNTQ0NjU_6279f1a5-3941-4654-811e-8b4e805bb20f">553.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfOS0xLTEtMS0xNTQ0NjU_e2f387ea-92ae-4b2c-b428-da857263eb01">12,965.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfOS0zLTEtMS0xNTQ0NjU_dce44bd5-bc0d-48e1-92ba-fddb99411637">13,234.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTAtMS0xLTEtMTU0NDY1_e96ede74-cb44-4a84-8aa6-a2f1038a42aa">1,111.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTAtMy0xLTEtMTU0NDY1_b35b8539-1a4e-44c5-856d-efb406bf703a">1,108.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTEtMS0xLTEtMTU0NDY1_3b712380-4ab4-46cd-b492-efb6516cfc6b">1,088.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTEtMy0xLTEtMTU0NDY1_1ac0943e-8b35-4ad0-8d77-633784552c6d">1,088.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTItMS0xLTEtMTU0NDY1_30a2e134-0fb0-434f-8ad9-4111617d3219">603.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTItMy0xLTEtMTU0NDY1_e5352a1b-ce26-4893-b6f4-4b52bfc2b564">603.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTMtMS0xLTEtMTU0NDY1_5aa112cb-52eb-4570-9b6f-6105a8db8a2c">1,359.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTMtMy0xLTEtMTU0NDY1_0ac2f538-ab45-4ab4-8ab0-87e6e98044cb">1,246.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTQtMS0xLTEtMTU0NDY1_4836bf87-a807-44c2-b318-26ee42848f99">336.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTQtMy0xLTEtMTU0NDY1_4bed4a06-6e81-4455-9df2-c967f0748333">347.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTUtMS0xLTEtMTY3MTA5_b6aa4170-d85b-4415-8697-90c379f09a40">1,081.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTUtMy0xLTEtMTY3MTA5_b3a26530-f1e0-40a3-9bf6-10ff63938017">112.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTUtMS0xLTEtMTU0NDY1_cb637050-ae22-4d25-bd6c-7dd0bad92fe8">427.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTUtMy0xLTEtMTU0NDY1_c018e897-e48f-4b41-91fe-1d66c02f7746">409.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTYtMS0xLTEtMTU0NDY1_6ff163ae-3c06-4cdf-b9d6-eeebed616613">18,974.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTYtMy0xLTEtMTU0NDY1_983db726-1e34-4abe-ab3a-13bcdff72d7e">18,150.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and Shareholders&#8217; Equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTktMS0xLTEtMTU0NDY1_a6be33e5-b1b5-480e-aba0-f2ee1ef81ce2">323.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMTktMy0xLTEtMTU0NDY1_3e270036-2250-4204-b04e-e8574398b87d">303.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjAtMS0xLTEtMTU0NDY1_a7e6519c-da57-4bc5-82b2-cc335aec51b5">2,326.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjAtMy0xLTEtMTU0NDY1_5fa89780-bd13-42d5-9d05-95cfa1a27427">2,126.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjEtMS0xLTEtMTU0NDY1_cec1f556-8b88-43f6-a09d-c1229c21b2ee">377.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjEtMy0xLTEtMTU0NDY1_7d172c2a-fbb1-4957-bc15-42bece55f0cc">311.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjItMS0xLTEtMTU0NDY1_63cd96e2-d897-4dad-a3a1-bf85a41105d3">3,026.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjItMy0xLTEtMTU0NDY1_eab4fdbf-8f06-44c7-9b1c-83287b0ff6b7">2,742.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjMtMS0xLTEtMTU0NDY1_0f452710-793c-4643-8ba4-892fe09bd89b">417.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjMtMy0xLTEtMTU0NDY1_4ea5e951-ef1b-4a1b-924e-bb56ee3f98e4">430.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjQtMS0xLTEtMTU0NDY1_2e17ad09-8662-4880-b5f8-c3fe89100fa5">371.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjQtMy0xLTEtMTU0NDY1_bcece662-76ec-4e7f-9f8e-11d50449cb9c">379.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjYtMS0xLTEtMTU0NDY1_2fc2a4f9-55b6-4a3d-bd83-11f5a16b3c4e">726.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjYtMy0xLTEtMTU0NDY1_6b4c229f-765f-451f-8341-99937dc68071">685.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjctMS0xLTEtMTU0NDY1_5508b6ee-ad2c-44da-a661-0b8313f9bab0">4,541.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjctMy0xLTEtMTU0NDY1_b6b8ebc6-0bc1-4e9f-9df8-463b550ec019">4,238.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjgtMS0xLTEtMTU0NDY1_10881ae8-720f-48f5-9c7f-2985b87fc027">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMjgtMy0xLTEtMTU0NDY1_b5e68685-c1bb-4308-acb1-2fafb67c89cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzAtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246MTkxZjBmMTVmMjNjNDdlNDgzMWMyMzE0MzI0ZjM0ZDZfMjE_32929866-bbed-4e39-b487-120b1ed1d60f"><ix:nonFraction unitRef="usdPerShare" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzAtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246MTkxZjBmMTVmMjNjNDdlNDgzMWMyMzE0MzI0ZjM0ZDZfMjE_b73d45b5-3e2d-420a-8b7c-2777d467d82e">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzAtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246MTkxZjBmMTVmMjNjNDdlNDgzMWMyMzE0MzI0ZjM0ZDZfMzU_93332846-1ae8-4b74-865e-a637c005975d"><ix:nonFraction unitRef="shares" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzAtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246MTkxZjBmMTVmMjNjNDdlNDgzMWMyMzE0MzI0ZjM0ZDZfMzU_98a40a1f-876a-448e-a383-1a713dba3405">1,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzAtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246MTkxZjBmMTVmMjNjNDdlNDgzMWMyMzE0MzI0ZjM0ZDZfNTc_04dadb28-55b9-453d-bc4e-3678c1c7c7c6"><ix:nonFraction unitRef="shares" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzAtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246MTkxZjBmMTVmMjNjNDdlNDgzMWMyMzE0MzI0ZjM0ZDZfNTc_10b7e077-e327-4cc8-a59d-0e78a4ee829e"><ix:nonFraction unitRef="shares" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzAtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246MTkxZjBmMTVmMjNjNDdlNDgzMWMyMzE0MzI0ZjM0ZDZfNTc_b87e84f3-6146-4599-9149-6ac71368c7ea"><ix:nonFraction unitRef="shares" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzAtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246MTkxZjBmMTVmMjNjNDdlNDgzMWMyMzE0MzI0ZjM0ZDZfNTc_f48608fd-53bb-422e-8b12-895134db3012">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzAtMS0xLTEtMTU0NDY1_40e7802e-5ec6-4ab6-a185-5b2d8e539576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzAtMy0xLTEtMTU0NDY1_aceae8f5-3eca-46a8-a532-3009e8a6f23f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzEtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246N2IzNDczODBhOGUxNDI3ZDkwNDIzY2UyMDQ4N2E2M2VfMTg_8c020395-0e5f-44a7-806b-6d9639c6b0c5"><ix:nonFraction unitRef="usdPerShare" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzEtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246N2IzNDczODBhOGUxNDI3ZDkwNDIzY2UyMDQ4N2E2M2VfMTg_e76120d5-07ee-4150-b265-6d978696d340">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzEtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246N2IzNDczODBhOGUxNDI3ZDkwNDIzY2UyMDQ4N2E2M2VfMzI_8dc37972-4271-47bf-ac35-a23d8ce4cf38"><ix:nonFraction unitRef="shares" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzEtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246N2IzNDczODBhOGUxNDI3ZDkwNDIzY2UyMDQ4N2E2M2VfMzI_9cf9f65e-8293-48d3-8ace-622e4e544936">500,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzEtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246N2IzNDczODBhOGUxNDI3ZDkwNDIzY2UyMDQ4N2E2M2VfNTQ_53762a97-5f7c-469a-a084-9a217a505aaa"><ix:nonFraction unitRef="shares" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzEtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246N2IzNDczODBhOGUxNDI3ZDkwNDIzY2UyMDQ4N2E2M2VfNTQ_c6bd3874-136c-4b86-b9d6-747bccc6f0c4">257,509,761</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzEtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246N2IzNDczODBhOGUxNDI3ZDkwNDIzY2UyMDQ4N2E2M2VfNjE_7f41f808-fde5-4f7b-8d69-fd672035369a"><ix:nonFraction unitRef="shares" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzEtMC0xLTEtMTU0NDY1L3RleHRyZWdpb246N2IzNDczODBhOGUxNDI3ZDkwNDIzY2UyMDQ4N2E2M2VfNjE_fd1f20bc-ed7a-4a4e-be9e-eb572e6f4ff6">257,011,628</ix:nonFraction></ix:nonFraction> shares issued and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzEtMS0xLTEtMTU0NDY1_3044be59-d901-4c21-9550-4f1196f97f7e">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzEtMy0xLTEtMTU0NDY1_e5f820a1-e83e-4d60-bc18-6e3d3e220a8e">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzItMS0xLTEtMTU0NDY1_1c663055-9861-4981-b0b9-651ad6a7cc1a">7,220.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzItMy0xLTEtMTU0NDY1_29cb5f25-e653-4c6d-99dc-bd29f3d8dadd">7,386.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzMtMS0xLTEtMTU0NDY1_7783642d-4106-448c-87bf-6add775a67ab">13.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzMtMy0xLTEtMTU0NDY1_9e91f44e-6d52-424a-abe6-2ae61ccbe087">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzQtMS0xLTEtMTU0NDY1_f8b712c5-7ffd-42ec-86d3-187217f721a4">7,222.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzQtMy0xLTEtMTU0NDY1_6a30fb6f-1999-4e63-82d3-cdbda5dc83af">6,522.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzUtMS0xLTEtMTU0NDY1_923bbf64-5f2c-4d90-9f88-3a44db335d11">14,432.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzUtMy0xLTEtMTU0NDY1_aa5bd7d1-ea31-454e-8b33-6625a73bbead">13,912.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzYtMS0xLTEtMTU0NDY1_c0eb4032-a6a1-4d0d-9730-d7f991fccaf4">18,974.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yMi9mcmFnOjZhODg5NmM5OTlkMTQ4ODk5MTg2ZjAwOGRhYmQzYTk4L3RhYmxlOjI1M2NmZmRkMDAwMjRjMmJhZGNhYWVhMjUwOThjNDQyL3RhYmxlcmFuZ2U6MjUzY2ZmZGQwMDAyNGMyYmFkY2FhZWEyNTA5OGM0NDJfMzYtMy0xLTEtMTU0NDY1_6324c4ca-b3bd-469e-983a-0a2e0f1a7d62">18,150.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_25"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.809%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional <br/>Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>Shareholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie9644a4268654e9c8ac1040d8f7e79c9_I20211231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjQtMS0xLTEtMTU0NDY1_f44ccb55-30b0-49f3-8f0b-b33772d5f212">254.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9644a4268654e9c8ac1040d8f7e79c9_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjQtMy0xLTEtMTU0NDY1_6265c1eb-fa30-4f83-aa1f-d9e741f437d6">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if11c93d7fb4c4f3c9c6178a17f8464bd_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjQtNS0xLTEtMTU0NDY1_319cac00-a332-4899-a7fd-7e4831e2a929">6,880.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78dd0b0a3c85467781f9ab6e34e27864_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjQtNy0xLTEtMTU0NDY1_7fe3ac90-ade1-4103-a28d-3866249ebee6">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e315428b573487aa6dbd1c0da1aa056_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjQtOS0xLTEtMTU0NDY1_bc967f0f-bec9-4496-9076-8458e0768bde">3,200.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ed48e03e6e4037bf3e89fb85ccd323_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjQtMTEtMS0xLTE1NDQ2NQ_8bb265e6-1857-49c4-ade4-2c3ba1cc6185">10,100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7612c85cc2ee463982591ad6233a366a_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjUtNy0xLTEtMTU0NDY1_d5bfb537-2571-4ce5-9d5e-6820d3e7b08d">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjUtMTEtMS0xLTE1NDQ2NQ_fe4f231c-7eab-4054-be30-3016d391b0fe">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d5c66c307b4ddbadb7f8693a79b13a_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjYtOS0xLTEtMTU0NDY1_23953a6d-9005-4ecc-84a5-c4357c510811">762.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjYtMTEtMS0xLTE1NDQ2NQ_bbfed0e4-84b4-4a5a-b626-c9ac29679d35">762.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock withheld for employee tax obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i89fc085156c84c1584294f205d4d7704_D20220101-20220331" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjgtMS0xLTEtMTU0NDY1_bbab3c90-f330-4539-a0c5-08ba8d7b9307">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89fc085156c84c1584294f205d4d7704_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjgtMy0xLTEtMTU0NDY1_a6142161-6cf7-403b-9a17-f7cc12378014">0.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9750561a4f8147f4bc490e7a5f0c4719_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjgtNS0xLTEtMTU0NDY1_a0ded205-6286-4781-85a6-0edd5387e151">117.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjgtMTEtMS0xLTE1NDQ2NQ_9468a72f-1724-4ec4-b762-2b6e1fb255aa">117.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i89fc085156c84c1584294f205d4d7704_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjktMS0xLTEtMTU0NDY1_a6860354-bfb7-4972-92ce-e799ce93ca13">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89fc085156c84c1584294f205d4d7704_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjktMy0xLTEtMTU0NDY1_380fbd17-91bb-41e1-8030-090fac8cdaa8">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9750561a4f8147f4bc490e7a5f0c4719_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjktNS0xLTEtMTU0NDY1_4e5d4917-f4a5-492b-a990-c0399d876fc3">36.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMjktMTEtMS0xLTE1NDQ2NQ_45b057bf-da6e-4d44-9cf8-dd21647a5d3f">36.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9750561a4f8147f4bc490e7a5f0c4719_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzAtNS0xLTEtMTU0NDY1_336ad4f5-2dae-4f8c-83d6-4f0e61fcdf1a">130.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzAtMTEtMS0xLTE1NDQ2NQ_7beb4a10-4044-4bf0-857a-43d8f1a8c604">130.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00983d2d8e084d6ea561084fa99ed99f_I20220331" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzEtMS0xLTEtMTU0NDY1_5ca45baa-d0b3-400b-b130-cdc271958792">255.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00983d2d8e084d6ea561084fa99ed99f_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzEtMy0xLTEtMTU0NDY1_7f957b3e-8261-4724-b9ae-5a5d18e303d3">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5dc994fb57941a6994b020468c9c7fb_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzEtNS0xLTEtMTU0NDY1_8eac832e-ba4c-4230-9870-4a36a98dfc3f">6,930.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914f1759975744f481aba609735018e0_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzEtNy0xLTEtMTU0NDY1_9847a639-933a-4b18-8641-1cba6319abdc">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i965b485f68b84496a4a73dfb194953aa_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzEtOS0xLTEtMTU0NDY1_da056cf3-f1e6-4ecf-98c6-4e7e5f1a0ed8">3,962.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1af14e7def84e3590f8cdcf9d63aa32_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzEtMTEtMS0xLTE1NDQ2NQ_25e759b8-dda6-4122-bbc7-a05036854ab8">10,907.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0be4937c73843eca3d724ac6fb90e1a_I20221231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzMtMS0xLTEtMTU0NDY1_1ddeddec-31aa-4d29-8606-2d0558f47633">257.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0be4937c73843eca3d724ac6fb90e1a_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzMtMy0xLTEtMTU0NDY1_6162dae5-d94b-4713-8d4a-9db2cc7350a9">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib977b600bd39401f8c9230b2429ba0e5_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzMtNS0xLTEtMTU0NDY1_fac50c92-5c39-4dab-b4f3-854c82bed1a4">7,386.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8554735455834204b136bf02ee206adf_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzMtNy0xLTEtMTU0NDY1_4648aad9-ad6d-4f94-8346-db9d18184726">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0db3c1abefb42109af3bd73e1178ec6_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzMtOS0xLTEtMTU0NDY1_2c8ea201-7c2a-403a-b625-73712b208d15">6,522.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzMtMTEtMS0xLTE1NDQ2NQ_aa5bd7d1-ea31-454e-8b33-6625a73bbead">13,912.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910580239e48388fdcc461d33f0896_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzQtNy0xLTEtMTU0NDY1_0f0845bd-6f23-4d6a-8ae0-527ae23c816c">13.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzQtMTEtMS0xLTE1NDQ2NQ_5b46be79-da66-4c3f-8156-19b28d0baa50">13.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86a7f4d7e65b4ad8a58d97f90dd851a0_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzUtOS0xLTEtMTU0NDY1_e6ba231d-ca4f-4c85-97f1-20a08731e7a2">699.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzUtMTEtMS0xLTE1NDQ2NQ_56b6db5d-be55-4f6b-ab5e-d8e02b1b72a9">699.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1cee9dd573ad45809f92b1f95bf98b88_D20230101-20230331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzYtMS0xLTEtMTU0NDY1_ac6b28ee-6373-4a29-a3a1-415e543965e8">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cee9dd573ad45809f92b1f95bf98b88_D20230101-20230331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzYtMy0xLTEtMTU0NDY1_ef932a06-41ab-40eb-8b58-1f0b4c7e35b6">0.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9ec51fa63f1409ebacc82d94d16c23d_D20230101-20230331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzYtNS0xLTEtMTU0NDY1_8b820fd1-5825-4378-8653-6f799c51d725">135.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzYtMTEtMS0xLTE1NDQ2NQ_eb7e5ba8-f915-4646-8c4c-ecca053eb716">135.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock withheld for employee tax obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1cee9dd573ad45809f92b1f95bf98b88_D20230101-20230331" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzctMS0xLTEtMTU0NDY1_2fcde930-253f-4684-89ba-ee3e82025097">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cee9dd573ad45809f92b1f95bf98b88_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzctMy0xLTEtMTU0NDY1_38c85a97-8116-4a5a-b805-f4f4d8ce32d4">0.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9ec51fa63f1409ebacc82d94d16c23d_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzctNS0xLTEtMTU0NDY1_1e8578ed-65dd-4d6b-8ddf-9609d2ebede6">166.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzctMTEtMS0xLTE1NDQ2NQ_6265da72-de1d-476d-bc43-fc5fb465ceb4">166.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1cee9dd573ad45809f92b1f95bf98b88_D20230101-20230331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzgtMS0xLTEtMTU0NDY1_b57a0012-52e2-4982-9995-14bc72e745fd">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cee9dd573ad45809f92b1f95bf98b88_D20230101-20230331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzgtMy0xLTEtMTU0NDY1_8158e547-20b7-45e7-9a8b-909268a943a3">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9ec51fa63f1409ebacc82d94d16c23d_D20230101-20230331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzgtNS0xLTEtMTU0NDY1_3563793a-db51-4213-9e7c-6a3f44446c78">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzgtMTEtMS0xLTE1NDQ2NQ_c6daad81-d54d-4ae7-b8bb-05153bfc7a93">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9ec51fa63f1409ebacc82d94d16c23d_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzktNS0xLTEtMTU0NDY1_c483f276-f81e-4169-a267-4c8b810b3b2e">122.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfMzktMTEtMS0xLTE1NDQ2NQ_748ae62d-c4b8-45cd-99ff-c43188bdc558">122.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e809bf63b404ae482a643c548a33cb9_I20230331" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfNDAtMS0xLTEtMTU0NDY1_8fe90e9f-0698-4ae2-b2d9-b5c408026cb8">257.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e809bf63b404ae482a643c548a33cb9_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfNDAtMy0xLTEtMTU0NDY1_e281f05b-70d4-42d5-b067-8c016e80306e">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2025e93e9b9547aabc13afcfb311526b_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfNDAtNS0xLTEtMTU0NDY1_a2837320-e48b-4bbf-92f5-181010635895">7,220.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92ee2dbb965f48489dd427b879f349f8_I20230331" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfNDAtNy0xLTEtMTU0NDY1_ba1dd97d-b4f4-4cc0-98a5-a5677e0033c5">13.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib74fd5062b9c4340bb2c4c5fadcf6657_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfNDAtOS0xLTEtMTU0NDY1_622ad6ea-eb62-4dab-a9f5-d1b4b1f2f615">7,222.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yNS9mcmFnOjIyMzAzZDc1YTU2YjQ2ZjNiMTJkM2Y0ZTFjNzcxMzliL3RhYmxlOjZkYmJhODkzZWI3ZjQzNTI5ZWFjZTM0MGQ4MjVmYWMzL3RhYmxlcmFuZ2U6NmRiYmE4OTNlYjdmNDM1MjllYWNlMzQwZDgyNWZhYzNfNDAtMTEtMS0xLTE1NDQ2NQ_923bbf64-5f2c-4d90-9f88-3a44db335d11">14,432.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_28"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMy0xLTEtMS0xNTQ0NjU_d96c53f3-37b2-4526-a1a9-68f19fc24d0a">699.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMy0zLTEtMS0xNTQ0NjU_86e93adf-ce13-4afb-a9d6-9e8c85007bfb">762.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfNS0xLTEtMS0xNTQ0NjU_5a4d3854-8a22-4021-92ff-8926ccbe0dba">122.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfNS0zLTEtMS0xNTQ0NjU_c4dffdc4-a277-49a2-9205-b28933fd9f8a">130.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfNi0xLTEtMS0xNTQ0NjU_89048113-ea47-4cfc-b985-43d639cd308e">38.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfNi0zLTEtMS0xNTQ0NjU_4fc9f0ab-91d8-4022-83f0-40574eb93305">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfOC0xLTEtMS0xNTQ0NjU_72df0100-dddb-49e2-9a3c-a86e5a979173">113.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfOC0zLTEtMS0xNTQ0NjU_bee63073-763d-46f8-bc6a-58d8cd2a5add">12.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Gains) losses on equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfOS0xLTEtMS0xNTQ0NjU_3a4f8d49-592f-4c99-8b7e-dfcb8c43624f">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfOS0zLTEtMS0xNTQ0NjU_d79a5ec9-9754-41d5-883c-88ef07305d05">75.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTAtMS0xLTEtMTc4MTky_f13b718a-fa40-4ea9-ac8c-9625b3cb0bb9">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTAtMy0xLTEtMTc4MTky_d79d7ea8-52b9-472f-abb9-60e98b6ad151">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTAtMS0xLTEtMTU0NDY1_af0a22e0-cfbc-40e8-98a1-cd26c8dd2465">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTAtMy0xLTEtMTU0NDY1_91da1e93-fc23-413e-acc8-4c452ec7b9dd">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTItMS0xLTEtMTU0NDY1_ab91531e-0139-481d-a26c-3c2dc3973a1c">90.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTItMy0xLTEtMTU0NDY1_b9e372a1-6c21-4f69-b662-0fdfc0db64ea">165.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTMtMS0xLTEtMTU0NDY1_99158edc-277b-463d-bfb2-ab44803eef98">82.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTMtMy0xLTEtMTU0NDY1_24e10f0c-d341-486c-a625-a2d7f1972924">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTQtMS0xLTEtMTU0NDY1_9be7cfe3-83c9-415c-bc9e-1a89868a1477">46.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTQtMy0xLTEtMTU0NDY1_4de94c1d-262c-469a-bfc6-71260a8f1f80">67.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTUtMS0xLTEtMTU0NDY1_d1462289-e7cb-41be-bcc4-7caa345c82fe">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTUtMy0xLTEtMTU0NDY1_ef302495-b468-4e59-b734-651374b4c3cf">14.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTYtMS0xLTEtMTU0NDY1_be3e53a4-bcb3-4a24-aa8f-f505929a8545">140.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTYtMy0xLTEtMTU0NDY1_cd2b1b26-1787-43d4-b29a-e83559d5d344">61.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTctMS0xLTEtMTU0NDY1_88b39642-477b-4917-9114-c4dca709b604">89.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTctMy0xLTEtMTU0NDY1_238d55f9-8736-421c-a5f4-927e0fe534b3">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTgtMS0xLTEtMTU0NDY1_9148a1a4-fe45-4517-aa0b-72df6e8ffb88">899.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMTgtMy0xLTEtMTU0NDY1_2e5730e4-e59a-4a74-9b12-3d028a4eb550">956.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjAtMS0xLTEtMTU0NDY1_bf599631-75c6-4c4e-bf42-62c85c83b1be">1,816.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjAtMy0xLTEtMTU0NDY1_7586f8a8-f420-421a-8e02-8f98ad21e397">117.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Maturities of available-for-sale debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjEtMS0xLTEtMTU0NDY1_9584ead6-232d-4456-b445-f472eded16eb">50.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjEtMy0xLTEtMTU0NDY1_bfe6485f-a191-4313-888b-868f283c8a09">129.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjMtMS0xLTEtMTU0NDY1_aa4ee6ea-6871-4737-91fe-adbe150f7fce">42.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjMtMy0xLTEtMTU0NDY1_2959a706-4e87-445e-ad9c-19006c795d75">63.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjQtMS0xLTEtMTU0NDY1_48bf35c9-4f01-4108-a303-a44c46d3e008">24.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjQtMy0xLTEtMTU0NDY1_947388bf-6b1d-4898-9032-973f060f505e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjYtMS0xLTEtMTU0NDY1_549a75e1-0a9c-4419-8cfd-ef4a465ed458">1,833.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjYtMy0xLTEtMTU0NDY1_f93d10b5-63dd-40a6-b88f-1aeaf6784afb">51.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances of common stock under benefit plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjgtMS0xLTEtMTU0NDY1_5c93c38b-521c-4978-9a15-cc4c24caee9b">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjgtMy0xLTEtMTU0NDY1_f2b82008-b2fc-4881-8c8e-53e6ce3c2c40">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjktMS0xLTEtMTU0NDY1_01c5ad72-fd91-458a-a24c-e49612129acb">132.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMjktMy0xLTEtMTU0NDY1_decb03e6-1a2a-4380-90a7-7928569c9b8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments in connection with common stock withheld for employee tax obligations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzAtMS0xLTEtMTU0NDY1_2a4ad68e-4a7a-42c2-aec5-88e087826266">166.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzAtMy0xLTEtMTU0NDY1_b5a34fe8-fdf0-4e0d-8be8-dec299002a8d">117.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on finance leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzEtMS0xLTEtMTU0NDY1_0675febb-f57c-4142-80e0-0c2243dc2016">10.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzEtMy0xLTEtMTU0NDY1_9aa79ae8-6b0b-4870-9f67-72c71ab63219">12.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzMtMS0xLTEtMTU0NDY1_48549bd5-4162-40f1-9f11-f1be9b9463ef">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzMtMy0xLTEtMTU0NDY1_d211f017-ab46-4fb0-9619-60976779401d">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzQtMS0xLTEtMTU0NDY1_15688f41-b111-40ca-a545-85e5f56151cf">294.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzQtMy0xLTEtMTU0NDY1_ff116d5c-d579-4456-9823-946d2e8ed0d8">95.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of changes in exchange rates on cash</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzUtMS0xLTEtMTU0NDY1_4b9260fe-b198-4b5b-816e-3800b9a10592">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzUtMy0xLTEtMTU0NDY1_746d6a63-dcfa-4ef7-8a27-e1baf21fe4f4">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 59.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzYtMS0xLTEtMTU0NDY1_53dd8db1-ac5c-482c-a86d-40822756db3c">1,216.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzYtMy0xLTEtMTU0NDY1_da6fbf53-3a48-48b8-ae20-1d8eb319c605">803.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash&#8212;beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzctMS0xLTEtMTU0NDY1_6ccf3c73-bd17-4d4f-9ac1-4fd208558535">10,512.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ed48e03e6e4037bf3e89fb85ccd323_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzctMy0xLTEtMTU0NDY1_d328db18-016b-4b9a-8f46-0296610fbf56">6,800.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash&#8212;end of period</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzgtMS0xLTEtMTU0NDY1_fd6590ad-2948-4a41-8011-75bb22e226f6">9,295.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1af14e7def84e3590f8cdcf9d63aa32_I20220331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzgtMy0xLTEtMTU0NDY1_ec2af8c1-bc62-4f0e-8726-b475e4e06649">7,604.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzgtMS0xLTEtMTY4MTk0_982f2d0b-1238-429d-ade4-8ee0098ec743">120.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfMzgtMy0xLTEtMTY4MTk0_6b6ca83d-a707-45bf-a3b4-0eb9ae8e6ec1">85.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfNDEtMS0xLTEtMTU0NDY1_e157895b-8c41-480b-95eb-02d060fe32e0">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8yOC9mcmFnOmJiY2ExM2M2ZGYwMTQ3OWFiMDI2YWJkMjEwYTg1MTcxL3RhYmxlOmQ3OWU4Y2NjNWFlMDRkNTI5YWE0NzdmZDcwZjY4YWFjL3RhYmxlcmFuZ2U6ZDc5ZThjY2M1YWUwNGQ1MjlhYTQ3N2ZkNzBmNjhhYWNfNDEtMy0xLTEtMTU0NDY1_fca59745-f287-4811-a087-8b165a5612ee">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements. </span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_31"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_34"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNC9mcmFnOjVlZjZkMzc2MmJhZjQyYzJhNjg0NzJjMjc2YTJhYzNkL3RleHRyZWdpb246NWVmNmQzNzYyYmFmNDJjMmE2ODQ3MmMyNzZhMmFjM2RfMzA0MA_da07fc1c-f1a5-4f2b-a8ce-154090d9a624" continuedAt="i6deacdaf54594f848dca190b7ed07473" escape="true">Basis of Presentation and Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i6deacdaf54594f848dca190b7ed07473"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNC9mcmFnOjVlZjZkMzc2MmJhZjQyYzJhNjg0NzJjMjc2YTJhYzNkL3RleHRyZWdpb246NWVmNmQzNzYyYmFmNDJjMmE2ODQ3MmMyNzZhMmFjM2RfMzA2Mw_352cba53-cc93-4a91-aef0-6354b63b899e" continuedAt="id7bff9666ffe4220acb83474939698db" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements are unaudited and have been prepared by Vertex Pharmaceuticals Incorporated (&#8220;Vertex,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements reflect the operations of Vertex and our wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated. We operate in <ix:nonFraction unitRef="segment" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNC9mcmFnOjVlZjZkMzc2MmJhZjQyYzJhNjg0NzJjMjc2YTJhYzNkL3RleHRyZWdpb246NWVmNmQzNzYyYmFmNDJjMmE2ODQ3MmMyNzZhMmFjM2RfNTEy_1a225951-b1d6-4393-83e9-9cbca27abb3d">one</ix:nonFraction> segment, pharmaceuticals.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning with the second quarter of 2022, we are separately classifying upfront, contingent milestone, and other payments pursuant to our business development transactions, including collaborations, licenses of third-party technologies, and asset acquisitions as &#8220;Acquired in-process research and development expenses&#8221; in our condensed consolidated statements of income. To conform prior periods to current presentation, we reclassified $<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentInProcess" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNC9mcmFnOjVlZjZkMzc2MmJhZjQyYzJhNjg0NzJjMjc2YTJhYzNkL3RleHRyZWdpb246NWVmNmQzNzYyYmFmNDJjMmE2ODQ3MmMyNzZhMmFjM2RfOTM5_6462c306-7a53-42bf-bf59-5f1c0904e510">2.0</ix:nonFraction> million from &#8220;Research and development expenses&#8221; to &#8220;Acquired in-process research and development expenses&#8221; for the three months ended March 31, 2022. Please refer to Note C, &#8220;Acquired In-Process Research and Development and Other Arrangements,&#8221; for further information on these transactions. We have reclassified certain items from the prior year&#8217;s condensed consolidated balance sheet to conform to the current year&#8217;s presentation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the &#8220;2022 Annual Report on Form&#160;10-K&#8221;) have been condensed or omitted. These interim financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of the financial position and results of income for the interim periods ended March 31, 2023 and 2022.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id7bff9666ffe4220acb83474939698db">The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full fiscal year. These interim financial statements should be read in conjunction with the audited financial statements for the year ended December&#160;31, 2022, which are contained in our 2022 Annual Report on Form&#160;10-K.</ix:continuation> </span></div><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNC9mcmFnOjVlZjZkMzc2MmJhZjQyYzJhNjg0NzJjMjc2YTJhYzNkL3RleHRyZWdpb246NWVmNmQzNzYyYmFmNDJjMmE2ODQ3MmMyNzZhMmFjM2RfMzA0Mg_48f71599-76d5-4cd4-9183-794ac268d17c" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires us to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of our condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. We base our estimates on historical experience and various other assumptions, including in certain circumstances future projections that we believe to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</span></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted and Issued Accounting Standards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of recently adopted accounting pronouncements please refer to Note A, &#8220;Nature of Business and Accounting Policies,&#8221; in our 2022 Annual Report on Form&#160;10-K. We do not expect any recently issued accounting standards to have a significant impact on our condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are described in Note A, &#8220;Nature of Business and Accounting Policies,&#8221; in our 2022 Annual Report on Form&#160;10-K.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_37"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.84pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RleHRyZWdpb246NGIyMjNlZjUxYjJjNDc0OWJjNjQ5Yzk1N2YyMzM5ZjJfMTQ3NA_042a4968-8c7f-4beb-9759-8399b43c840a" continuedAt="ie8ab9bb5449e4da795ec3fa7b23de506" escape="true">Revenue Recognition </ix:nonNumeric></span></div><ix:continuation id="ie8ab9bb5449e4da795ec3fa7b23de506"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenues by Product</span></div><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RleHRyZWdpb246NGIyMjNlZjUxYjJjNDc0OWJjNjQ5Yzk1N2YyMzM5ZjJfMTQ3OA_a8ba2ebf-68a2-4c52-a4eb-5b9cb28c484e" continuedAt="ida20ddf949cf4dbc97d6db57eaa00b3d" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Product revenues, net&#8221; consisted of the following:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:64.159%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRIKAFTA/KAFTRIO</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd4f77cc41374bc7a80cdb0fc196c854_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOjMwNTg0MDM1YzI1ODQyZmQ5ZDg4OWFlNTQ1ZDgxNTkzL3RhYmxlcmFuZ2U6MzA1ODQwMzVjMjU4NDJmZDlkODg5YWU1NDVkODE1OTNfMy01LTEtMS0xNTQ0NjU_9fbb9927-fdc7-4263-b519-dacac99f2b40">2,096.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f36e45386274e77ad47eb2848f0c317_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOjMwNTg0MDM1YzI1ODQyZmQ5ZDg4OWFlNTQ1ZDgxNTkzL3RhYmxlcmFuZ2U6MzA1ODQwMzVjMjU4NDJmZDlkODg5YWU1NDVkODE1OTNfMy03LTEtMS0xNTQ0NjU_9431f82b-156b-485d-8db6-2c3e706b4d71">1,761.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KALYDECO</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5cdadcb40c4a7b9d5fc4a892524206_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOjMwNTg0MDM1YzI1ODQyZmQ5ZDg4OWFlNTQ1ZDgxNTkzL3RhYmxlcmFuZ2U6MzA1ODQwMzVjMjU4NDJmZDlkODg5YWU1NDVkODE1OTNfNC01LTEtMS0xNzA1ODM_0e82cfe7-a4fe-4fb4-be4a-3cb1efdae01f">125.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccac4c61256546d58cc69acb9e2ba857_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOjMwNTg0MDM1YzI1ODQyZmQ5ZDg4OWFlNTQ1ZDgxNTkzL3RhYmxlcmFuZ2U6MzA1ODQwMzVjMjU4NDJmZDlkODg5YWU1NDVkODE1OTNfNC03LTEtMS0xNzA1ODM_b3e8b05c-eb30-4435-b6af-b594a2362540">139.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ORKAMBI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91dc78cd89b2461d83edb8473d0d8a8b_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOjMwNTg0MDM1YzI1ODQyZmQ5ZDg4OWFlNTQ1ZDgxNTkzL3RhYmxlcmFuZ2U6MzA1ODQwMzVjMjU4NDJmZDlkODg5YWU1NDVkODE1OTNfNS01LTEtMS0xNTQ0NjU_42e78a5f-7b74-4172-8aad-791feff153b7">122.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd1bdf70f064b299ffacaeb642c9355_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOjMwNTg0MDM1YzI1ODQyZmQ5ZDg4OWFlNTQ1ZDgxNTkzL3RhYmxlcmFuZ2U6MzA1ODQwMzVjMjU4NDJmZDlkODg5YWU1NDVkODE1OTNfNS03LTEtMS0xNTQ0NjU_207e6f39-657f-4369-9fee-dda6f16e8f7f">132.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SYMDEKO/SYMKEVI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i465ccbd266d140cb8265be3e1437dfe1_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOjMwNTg0MDM1YzI1ODQyZmQ5ZDg4OWFlNTQ1ZDgxNTkzL3RhYmxlcmFuZ2U6MzA1ODQwMzVjMjU4NDJmZDlkODg5YWU1NDVkODE1OTNfNi01LTEtMS0xNTQ0NjU_a4681fa0-3c28-498e-9da6-72e87a7cc7d5">30.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aacc5540aee4a7f92575c5b335f46e9_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOjMwNTg0MDM1YzI1ODQyZmQ5ZDg4OWFlNTQ1ZDgxNTkzL3RhYmxlcmFuZ2U6MzA1ODQwMzVjMjU4NDJmZDlkODg5YWU1NDVkODE1OTNfNi03LTEtMS0xNTQ0NjU_b51ef5c3-eec9-47c8-acbf-8979503fcad0">64.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenues, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOjMwNTg0MDM1YzI1ODQyZmQ5ZDg4OWFlNTQ1ZDgxNTkzL3RhYmxlcmFuZ2U6MzA1ODQwMzVjMjU4NDJmZDlkODg5YWU1NDVkODE1OTNfNy01LTEtMS0xNTQ0NjU_e28603ae-925a-4f3f-8a17-73a157e9b76f">2,374.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOjMwNTg0MDM1YzI1ODQyZmQ5ZDg4OWFlNTQ1ZDgxNTkzL3RhYmxlcmFuZ2U6MzA1ODQwMzVjMjU4NDJmZDlkODg5YWU1NDVkODE1OTNfNy03LTEtMS0xNTQ0NjU_85eb85f3-8cc3-4943-b60d-c4a875879910">2,097.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Revenues by Geographic Location</span></div><ix:continuation id="ida20ddf949cf4dbc97d6db57eaa00b3d"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Product revenues, net&#8221; by geographic region, based on the location of the customer, consisted of the following:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:64.159%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ba7520aa3742e08869dd02bc97113c_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOmEwZDZlMzI3NjQyMzQxMzY5Y2ZjN2VmMTlhMjllZDBmL3RhYmxlcmFuZ2U6YTBkNmUzMjc2NDIzNDEzNjljZmM3ZWYxOWEyOWVkMGZfMy01LTEtMS0xNTQ0NjU_aa8f2cfc-242b-449e-818c-816e1e31a88d">1,403.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65992ec525c0440fb4006df41bf023cf_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOmEwZDZlMzI3NjQyMzQxMzY5Y2ZjN2VmMTlhMjllZDBmL3RhYmxlcmFuZ2U6YTBkNmUzMjc2NDIzNDEzNjljZmM3ZWYxOWEyOWVkMGZfMy03LTEtMS0xNTQ0NjU_5e652023-33c8-4791-9ca5-871682330a97">1,368.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12def64051c340048a7d28c296ea29ae_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOmEwZDZlMzI3NjQyMzQxMzY5Y2ZjN2VmMTlhMjllZDBmL3RhYmxlcmFuZ2U6YTBkNmUzMjc2NDIzNDEzNjljZmM3ZWYxOWEyOWVkMGZfNS01LTEtMS0xNTQ0NjU_1aa78c10-9a01-43db-8e4f-81e0d679b511">807.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6524abece9604a65b92e34f77f73a8a5_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOmEwZDZlMzI3NjQyMzQxMzY5Y2ZjN2VmMTlhMjllZDBmL3RhYmxlcmFuZ2U6YTBkNmUzMjc2NDIzNDEzNjljZmM3ZWYxOWEyOWVkMGZfNS03LTEtMS0xNTQ0NjU_92a803b2-e184-4c63-a3d4-2952c00b6a44">632.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i528415acc74b414dbbaec7b7053d8506_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOmEwZDZlMzI3NjQyMzQxMzY5Y2ZjN2VmMTlhMjllZDBmL3RhYmxlcmFuZ2U6YTBkNmUzMjc2NDIzNDEzNjljZmM3ZWYxOWEyOWVkMGZfNi01LTEtMS0xNTQ0NjU_39668eb4-7bc0-43bf-991c-17743f5386c8">163.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb63d727fe94cc39e39b4d5eea23488_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOmEwZDZlMzI3NjQyMzQxMzY5Y2ZjN2VmMTlhMjllZDBmL3RhYmxlcmFuZ2U6YTBkNmUzMjc2NDIzNDEzNjljZmM3ZWYxOWEyOWVkMGZfNi03LTEtMS0xNTQ0NjU_f2134682-ee00-42f4-bff3-b84f341de8f0">97.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenues outside of the United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0b80a074ccc43f5a47c621d5310c23a_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOmEwZDZlMzI3NjQyMzQxMzY5Y2ZjN2VmMTlhMjllZDBmL3RhYmxlcmFuZ2U6YTBkNmUzMjc2NDIzNDEzNjljZmM3ZWYxOWEyOWVkMGZfNy01LTEtMS0xNTQ0NjU_d3e2ec6b-9013-4b5f-a811-80f6b12b2371">971.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3210a82692ba4c929a81d39788242c43_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOmEwZDZlMzI3NjQyMzQxMzY5Y2ZjN2VmMTlhMjllZDBmL3RhYmxlcmFuZ2U6YTBkNmUzMjc2NDIzNDEzNjljZmM3ZWYxOWEyOWVkMGZfNy03LTEtMS0xNTQ0NjU_0f63f3dc-4dcc-4051-b512-c47ee32b35c5">729.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenues, net</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOmEwZDZlMzI3NjQyMzQxMzY5Y2ZjN2VmMTlhMjllZDBmL3RhYmxlcmFuZ2U6YTBkNmUzMjc2NDIzNDEzNjljZmM3ZWYxOWEyOWVkMGZfOC01LTEtMS0xNTQ0NjU_f79950b1-95a7-4fd8-9077-726dcb543007">2,374.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RhYmxlOmEwZDZlMzI3NjQyMzQxMzY5Y2ZjN2VmMTlhMjllZDBmL3RhYmxlcmFuZ2U6YTBkNmUzMjc2NDIzNDEzNjljZmM3ZWYxOWEyOWVkMGZfOC03LTEtMS0xNTQ0NjU_18301254-71a8-472b-aeb6-f8c69a2798e2">2,097.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had contract liabilities of $<ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RleHRyZWdpb246NGIyMjNlZjUxYjJjNDc0OWJjNjQ5Yzk1N2YyMzM5ZjJfMzE4_785cb373-8be3-41ee-ba52-7a5ab2ab6128">236.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8zNy9mcmFnOjRiMjIzZWY1MWIyYzQ3NDliYzY0OWM5NTdmMjMzOWYyL3RleHRyZWdpb246NGIyMjNlZjUxYjJjNDc0OWJjNjQ5Yzk1N2YyMzM5ZjJfMzI1_af89fd34-a671-4ff8-94d6-046fd79d9726">159.6</ix:nonFraction> million as of March 31, 2023 and December&#160;31, 2022, respectively, related to annual contracts with government-owned and supported customers in international markets that limit the amount of annual reimbursement we can receive. Upon exceeding the annual reimbursement amount, products are provided free of charge, which is a material right. These contracts include upfront payments and fees.&#160;We defer a portion of the consideration received for shipments made up to the annual reimbursement limit as a portion of &#8220;Other current liabilities.&#8221; The deferred amount is recognized as revenue when the free products are shipped. Our product revenue contracts include performance obligations that are one year or less.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract liabilities at the end of each fiscal year relate to contracts with annual reimbursement limits in international markets in which the annual period associated with the contract is not the same as our fiscal year. In these markets, we recognize revenues related to performance obligations satisfied in previous years; however, these revenues do not relate to any performance obligations that were satisfied more than 12 months prior to the beginning of the current year.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_40"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfODIxOA_233d04d7-fd68-40b6-8291-18053fcdd254" continuedAt="i6b67ad8e70a240179f8ac0f2d68d6cea" escape="true">Acquired In-Process Research and Development and Other Arrangements</ix:nonNumeric></span></div><ix:continuation id="i6b67ad8e70a240179f8ac0f2d68d6cea" continuedAt="i7348919a16a341bd83b1aa19ddb3604d"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into numerous agreements with third parties to collaborate on research, development and commercialization programs, license technologies, or acquire assets. Our &#8220;Acquired in-process research and development expenses&#8221; included $<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:ResearchAndDevelopmentInProcess" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMjA3_b36c1bf8-269c-4bab-ba76-2750717e3273">347.1</ix:nonFraction> million for the three months ended March 31, 2023, and $<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentInProcess" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMjQ3_6462c306-7a53-42bf-bf59-5f1c0904e510">2.0</ix:nonFraction> million, for the three months ended March 31, 2022, related to upfront, contingent milestone, or other payments pursuant to our business development transactions, including collaborations, licenses of third-party technologies, and asset acquisitions that qualify as in-process research and development.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our collaboration, licensing and asset acquisition agreements that had a significant impact on our financial statements for the three months ended March 31, 2023 and 2022, or were new or materially revised during the three months ended March 31, 2023, are described below. Additional agreements were described in Note B, &#8220;Acquired In-Process Research and Development and Other Arrangements,&#8221; of our 2022 Annual Report on Form&#160;10-K.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In-license Agreements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into several in-license agreements to advance and obtain access to technologies and services related to our research and early-development activities. We are generally required to make an upfront payment upon execution of our license agreements; development, regulatory and commercialization milestones payments upon the achievement of certain product research, development and commercialization objectives; and royalty payments on future sales, if any, of commercial products resulting from our collaborations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of our in-license agreements, our collaborators typically lead the discovery efforts and we lead all preclinical, development and commercialization activities associated with the advancement of any product candidates and fund all expenses.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically can terminate our in-license agreements by providing advance notice to our collaborators. Our license agreements may be terminated by either party for a material breach by the other, subject to notice and cure provisions. Unless earlier terminated, these license agreements generally remain in effect until the date on which the royalty term and all payment obligations with respect to all products in all countries have expired.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CRISPR Therapeutics AG - CRISPR-Cas9 Gene-editing Therapies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, we entered into a strategic collaboration, option, and license agreement (the &#8220;CRISPR Agreement&#8221;) with CRISPR Therapeutics AG and its affiliates (&#8220;CRISPR&#8221;) to collaborate on the discovery and development of potential new treatments aimed at the underlying genetic causes of human diseases using CRISPR-Cas9 gene-editing technology. We had the exclusive right to license certain targets. In 2019, we elected to exclusively license <ix:nonFraction unitRef="target" contextRef="id96f32d9bccb4f5ba68093ece409879a_D20190101-20191231" decimals="INF" name="vrtx:CollaborativeArrangementRightToLicenseNumberOfTargets" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMjY2OQ_22b481b2-f115-4a1f-b010-083594d848bf">three</ix:nonFraction> targets, including cystic fibrosis, pursuant to the CRISPR Agreement. For each of the <ix:nonFraction unitRef="target" contextRef="id96f32d9bccb4f5ba68093ece409879a_D20190101-20191231" decimals="INF" name="vrtx:CollaborativeArrangementRightToLicenseNumberOfTargets" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMjc1OA_22b481b2-f115-4a1f-b010-083594d848bf">three</ix:nonFraction> targets that we elected to license, CRISPR has the potential to receive up to an additional $<ix:nonFraction unitRef="usd" contextRef="id96f32d9bccb4f5ba68093ece409879a_D20190101-20191231" decimals="INF" name="vrtx:CollaborativeArrangementDevelopmentAndRegulatoryPotentialMilestonePaymentsMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMjg1Mw_a40b8d4e-d7b5-44fa-ade0-f0a79e79bfc0">410.0</ix:nonFraction> million in development, regulatory and commercial milestones as well as royalties on resulting net product sales. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we entered into a joint development and commercialization agreement with CRISPR (the &#8220;CRISPR JDCA&#8221;), which we amended and restated in 2021, pursuant to the terms of the CRISPR Agreement. Under the CRISPR JDCA, we and CRISPR are co-developing and preparing to co-commercialize exagamglogene autotemcel (&#8220;exa-cel&#8221;), for the treatment of hemoglobinopathies, including treatments for sickle cell disease and transfusion-dependent beta thalassemia. Pursuant to the CRISPR JDCA, we lead global development, manufacturing, and commercialization of exa-cel, with support from CRISPR. We also conduct all research, development, manufacturing, and commercialization activities relating to other product candidates and products under the CRISPR JDCA throughout the world subject to CRISPR&#8217;s reserved right to conduct certain activities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the CRISPR JDCA, CRISPR has the potential to receive a one-time $<ix:nonFraction unitRef="usd" contextRef="i1ac5aca29e3145cea1ae716e1ace4fcc_D20210401-20210630" decimals="-5" name="vrtx:CollaborativeArrangementDevelopmentAndRegulatoryPotentialMilestonePaymentsMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfNDc2Ng_24912647-8715-42b3-a8be-30750c073647">200.0</ix:nonFraction> million milestone payment upon receipt of the first marketing approval of exa-cel from the U.S. Food and Drug Administration or the European Commission.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the CRISPR JDCA as a cost-sharing arrangement, with costs incurred related to exa-cel allocated <ix:nonFraction unitRef="number" contextRef="id397992e0b004888b8845d29138cc50c_I20210701" decimals="2" name="vrtx:CollaborativeArrangementAllocationOfNetProfitsAndLossesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfNTEyNQ_7280c098-cd10-4bae-bdd6-5b88d6b3bff7">60</ix:nonFraction>% to us and <ix:nonFraction unitRef="number" contextRef="i3037c05af4d7452dba1bbfbd1a6512be_I20210701" decimals="2" name="vrtx:CollaborativeArrangementAllocationOfNetProfitsAndLossesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfNTEzOA_7125e2a6-69b0-4355-bc49-39403901bea8">40</ix:nonFraction>% to CRISPR, subject to certain adjustments. During the three months ended March 31, 2023 and 2022, we recognized the net impact of the CRISPR JDCA as &#8220;Research and development expenses&#8221; of $<ix:nonFraction unitRef="usd" contextRef="i6dc0c51184ba46bf9d104a0d64b0a205_D20230101-20230331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMTY0OTI2NzQ2Njg5Nw_5c22533a-d2ac-438e-a1e7-43ac510896cc">60.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i526aab6a6d8042eaa0634e3b89fca4cd_D20220101-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMTY0OTI2NzQ2NjkwMQ_01c8bb99-0227-474d-8015-46b008e7a531">36.2</ix:nonFraction> </span></div></ix:continuation><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><ix:continuation id="i7348919a16a341bd83b1aa19ddb3604d"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million, respectively, and &#8220;Selling, general and administrative expenses&#8221; of $<ix:nonFraction unitRef="usd" contextRef="i6dc0c51184ba46bf9d104a0d64b0a205_D20230101-20230331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMTY0OTI2NzQ2Njk5NA_4f6ae771-db72-449e-bac3-b22a2cd31e86">16.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i526aab6a6d8042eaa0634e3b89fca4cd_D20220101-20220331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMTY0OTI2NzQ2NzAwMg_98854f33-fa42-4fa9-9763-370ded5a9c5b">9.8</ix:nonFraction> million, respectively, within our condensed consolidated statements of income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, we entered into a non-exclusive license agreement (&#8220;the CRISPR T1D Agreement&#8221;) for the use of CRISPR&#8217;s CRISPR-Cas9 gene-editing technology to accelerate the development of our hypoimmune cell therapies for type 1 diabetes. Pursuant to the CRISPR T1D Agreement, we made a $<ix:nonFraction unitRef="usd" contextRef="i167ddb8e36774d78b74cf96f19056563_D20230301-20230331" decimals="-5" name="vrtx:CollaborativeArrangementUpFrontLicenseFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMTY0OTI2NzQ1OTM0MQ_d53efe23-ab04-4372-aa13-53872cd02240">100.0</ix:nonFraction> million upfront payment to CRISPR. CRISPR is also eligible to receive up to an additional $<ix:nonFraction unitRef="usd" contextRef="i167ddb8e36774d78b74cf96f19056563_D20230301-20230331" decimals="-5" name="vrtx:CollaborativeArrangementDevelopmentAndRegulatoryPotentialMilestonePaymentsMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMTY0OTI2NzQ1OTM2OQ_03ee095f-26ee-468b-95dd-a3fc96fba326">230.0</ix:nonFraction> million in research, development, regulatory and commercial milestones for any products that may result from the agreement, as well as royalties on resulting net product sales. We determined that substantially all the fair value of the collaboration agreement was attributable to in-process research and development and no substantive processes were acquired that would constitute a business. We concluded that there is no alternative future use for the acquired in-process research and development and recorded the upfront payment to &#8220;Acquired in-process research and development expenses.&#8221; </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Entrada Therapeutics, Inc.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, we closed a strategic collaboration and license agreement (the &#8220;Entrada Agreement&#8221;) with Entrada Therapeutics, Inc. (&#8220;Entrada&#8221;) focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV) therapeutics for myotonic dystrophy type 1 (&#8220;DM1&#8221;). Upon closing, we made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ieed5c5b2cca4423798a0da7b3c4ed75d_D20230201-20230228" decimals="-5" name="vrtx:CollaborativeArrangementUpFrontLicenseFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMTY0OTI2NzQ1NjEyNA_07677a58-6a4e-42ef-9c47-df6b78d3d1f8">225.1</ix:nonFraction> million to Entrada, and purchased $<ix:nonFraction unitRef="usd" contextRef="ieed5c5b2cca4423798a0da7b3c4ed75d_D20230201-20230228" decimals="-5" name="vrtx:PaymentToAcquireCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMTY0OTI2NzQ1NjE1Ng_7b0dcdd1-6172-4056-9e9e-b6fdd80add92">24.9</ix:nonFraction> million of Entrada&#8217;s common stock in connection with the Entrada Agreement. Entrada is eligible to receive up to an additional $<ix:nonFraction unitRef="usd" contextRef="ieed5c5b2cca4423798a0da7b3c4ed75d_D20230201-20230228" decimals="-5" name="vrtx:CollaborativeArrangementDevelopmentAndRegulatoryPotentialMilestonePaymentsMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80MC9mcmFnOjA4NWZkNmVkMGI4NjQ5YjBiNDFmMmIzYzc2NThhNTU2L3RleHRyZWdpb246MDg1ZmQ2ZWQwYjg2NDliMGI0MWYyYjNjNzY1OGE1NTZfMTY0OTI2NzQ1NjE3NQ_4c6a128a-b687-4065-84cb-3bc5d76f36ac">485.0</ix:nonFraction> million in research, development, regulatory and commercial milestones for any products that may result from the Entrada Agreement, as well as royalties on resulting net product sales. We determined that substantially all the fair value of the collaboration agreement was attributable to in-process research and development and no substantive processes were acquired that would constitute a business. We concluded that there is no alternative future use for the acquired in-process research and development and recorded the upfront payment to &#8220;Acquired in-process research and development expenses.&#8221; We recorded the investment in Entrada&#8217;s common stock at fair value within our condensed consolidated balance sheet within &#8220;Marketable securities.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cystic Fibrosis Foundation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2004, we entered into a collaboration agreement with the Cystic Fibrosis Foundation, as successor in interest to the Cystic Fibrosis Foundation Therapeutics, Inc., to support research and development activities. Pursuant to the collaboration agreement, as amended, we have agreed to pay tiered royalties ranging from single digits to sub-teens on covered compounds first synthesized and/or tested during a research term on or before February 28, 2014, including ivacaftor, lumacaftor and tezacaftor and royalties ranging from low-single digits to mid-single digits on potential net sales of certain compounds first synthesized and/or tested between March 1, 2014 and August 31, 2016, including elexacaftor. We do not have any royalty obligations on compounds first synthesized and tested on or after September 1, 2016. For combination products, such as ORKAMBI, SYMDEKO/SYMKEVI and TRIKAFTA/KAFTRIO, sales are allocated equally to each of the active pharmaceutical ingredients in the combination product. We record our royalties payable to the Cystic Fibrosis Foundation to &#8220;Cost of sales.&#8221;</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_46"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RleHRyZWdpb246NWQyOGNiYWY3ZjA4NGUzYTkyOTJhN2Y1ZTBhZjUzOGJfMzMz_0f4e1d8a-5f46-47d3-9781-36a4ee57a0a3" continuedAt="i93675cb79ae546948bbe8402883e2178" escape="true">Earnings Per Share</ix:nonNumeric></span></div><ix:continuation id="i93675cb79ae546948bbe8402883e2178"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RleHRyZWdpb246NWQyOGNiYWY3ZjA4NGUzYTkyOTJhN2Y1ZTBhZjUzOGJfMzIy_3ff862da-a95d-4d96-b504-85bfc57ac6ae" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per common share for the periods ended:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:64.159%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfMy01LTEtMS0xNTQ0NjU_70fc5c46-935a-4d88-9811-0bf09b9311c9">699.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfMy03LTEtMS0xNTQ0NjU_beb7a386-e628-4628-a9d6-80dd76d5bffe">762.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfNS01LTEtMS0xNTQ0NjU_e6aac0e2-cfad-4108-baa3-cd9df0a25169">257.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfNS03LTEtMS0xNTQ0NjU_16d0cbff-a0ee-4107-9cc4-ce965bdb34b8">255.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of potentially dilutive securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c84da8c391241e2910335bfe14620b5_D20230101-20230331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfNy01LTEtMS0xNTQ0NjU_3f028ab7-95a7-45e6-960b-cc9cb8d308a0">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e510f4ce851440bbfd4b3bfdaa33205_D20220101-20220331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfNy03LTEtMS0xNTQ0NjU_5d5f5183-6e49-498f-800d-8057518eed82">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units (including PSUs)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i50480a6a862a46a89bf686dd930034e6_D20230101-20230331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfOC01LTEtMS0xNTQ0NjU_98ca3171-e540-4427-8d80-25560b953c60">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44b72b8950a648979b11f67a50f078a7_D20220101-20220331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfOC03LTEtMS0xNTQ0NjU_758fddad-71d2-49a4-b196-602f6f7c9de8">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase program</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfOS01LTEtMS0xNTQ0NjU_aee14f4e-919f-4f2c-adc1-753c466b078e">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfOS03LTEtMS0xNTQ0NjU_3d759eee-c06f-41d7-8b52-3a0596e89840">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfMTAtNS0xLTEtMTU0NDY1_e94fa67d-9059-46af-b9f3-7fde70f49f75">260.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfMTAtNy0xLTEtMTU0NDY1_fba8f717-425f-4794-924b-0cff3760952a">257.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per common share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfMTItNS0xLTEtMTU0NDY1_a77d105b-cace-453c-8714-fb610b342ef0">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfMTItNy0xLTEtMTU0NDY1_4edd8d4c-8076-46db-bece-4c7b5ca51915">2.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per common share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfMTMtNS0xLTEtMTU0NDY1_194969bf-e864-4879-aee9-45d8421b5801">2.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOjY4YzIzMjdjNzQwNTRkMGQ5NjU1MzY0MWMxNDkxNmQ0L3RhYmxlcmFuZ2U6NjhjMjMyN2M3NDA1NGQwZDk2NTUzNjQxYzE0OTE2ZDRfMTMtNy0xLTEtMTU0NDY1_a271cb0c-f4ef-4ce3-badc-377a4aae29c5">2.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RleHRyZWdpb246NWQyOGNiYWY3ZjA4NGUzYTkyOTJhN2Y1ZTBhZjUzOGJfMzMw_f88e4ae2-3c92-4f7b-a528-0dab18fdddb4" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not include the securities in the following table in the computation of the diluted net income per common share because the effect would have been anti-dilutive during each period:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:64.159%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i308dad806e734f57ae8103ccbe049621_D20230101-20230331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOmRlZTM3NTc3NGZmZjRkM2ZhNWZlYTg2NGZhNTE1ZmQ3L3RhYmxlcmFuZ2U6ZGVlMzc1Nzc0ZmZmNGQzZmE1ZmVhODY0ZmE1MTVmZDdfMy01LTEtMS0xNTQ0NjU_18624f93-71ee-4bc2-9665-14f8f7390505">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i496dac79d34b408fb7efb45910444a88_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOmRlZTM3NTc3NGZmZjRkM2ZhNWZlYTg2NGZhNTE1ZmQ3L3RhYmxlcmFuZ2U6ZGVlMzc1Nzc0ZmZmNGQzZmE1ZmVhODY0ZmE1MTVmZDdfMy03LTEtMS0xNTQ0NjU_6d2a8426-f6b0-454a-954b-4d5792cd5ca0">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock units (including PSUs)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2777e8e16f2433c947bc7879312f93f_D20230101-20230331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOmRlZTM3NTc3NGZmZjRkM2ZhNWZlYTg2NGZhNTE1ZmQ3L3RhYmxlcmFuZ2U6ZGVlMzc1Nzc0ZmZmNGQzZmE1ZmVhODY0ZmE1MTVmZDdfNC01LTEtMS0xNTQ0NjU_a86096e3-d024-4ed3-aea1-0fca7423383c">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe1679ca0f4743158bdaf62b05b26efc_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80Ni9mcmFnOjVkMjhjYmFmN2YwODRlM2E5MjkyYTdmNWUwYWY1MzhiL3RhYmxlOmRlZTM3NTc3NGZmZjRkM2ZhNWZlYTg2NGZhNTE1ZmQ3L3RhYmxlcmFuZ2U6ZGVlMzc1Nzc0ZmZmNGQzZmE1ZmVhODY0ZmE1MTVmZDdfNC03LTEtMS0xNTQ0NjU_3db088f5-48aa-4f6b-8cf3-cf2c82fac0fa">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_49"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.84pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RleHRyZWdpb246OTMxNzUzYWVkMTI2NDk5ZGI3N2ZiOTRkOTNiNTBmOTNfNDA5NQ_517d4d22-a071-4a0f-8709-5cfd5f57d0d7" continuedAt="ib503d50e7eee46afabbee4fb64f381d2" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="ib503d50e7eee46afabbee4fb64f381d2" continuedAt="iabb9797eee3d4c8b95e894ef745bf8cf"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following fair value hierarchy is used to classify assets and liabilities based on observable inputs and unobservable inputs used in order to determine the fair value of our financial assets and liabilities:</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.392%"><tr><td style="width:1.0%"></td><td style="width:11.189%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.611%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;1:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;2:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Observable inputs other than Level&#160;1 inputs. Examples of Level&#160;2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;3:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment strategy is focused on capital preservation. We invest in instruments that meet the credit quality standards outlined in our investment policy, which also limits the amount of credit exposure to any one issue or type of instrument. We maintain strategic equity investments separately from the investment policy that governs our other cash, cash equivalents and marketable securities as described in Note F, &#8220;Marketable Securities and Equity Investments.&#8221; Additionally, we utilize foreign currency forward contracts intended to mitigate the effect of changes in foreign exchange rates on our condensed consolidated statement of income.</span></div></ix:continuation><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><ix:continuation id="iabb9797eee3d4c8b95e894ef745bf8cf" continuedAt="ice413772c6c64e88bad1468a01bcb2e3"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RleHRyZWdpb246OTMxNzUzYWVkMTI2NDk5ZGI3N2ZiOTRkOTNiNTBmOTNfNDA5Mw_3dd64120-6d51-4ec8-b3f4-d2def4097a65" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth our financial assets and liabilities subject to fair value measurements by level within the fair value hierarchy (and does not include $<ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-8" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RleHRyZWdpb246OTMxNzUzYWVkMTI2NDk5ZGI3N2ZiOTRkOTNiNTBmOTNfOTgz_760f9efb-26a9-4284-ad75-5bca69fa1d05">2.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-8" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RleHRyZWdpb246OTMxNzUzYWVkMTI2NDk5ZGI3N2ZiOTRkOTNiNTBmOTNfOTkw_03b8b56b-4118-4b62-89ab-305dd2f52a9a">3.1</ix:nonFraction> billion of cash as of March 31, 2023 and December&#160;31, 2022, respectively):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.899%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="48" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial instruments carried at fair value (asset positions):</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-6.75pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i951d6dd52836455092fe29cb8e926f82_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNS0xLTEtMS0xNTQ0NjU_86cbba7e-7737-42cc-8ac6-af4d8c392a02">4,954.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e1b5f45469c4b2f9542ef9056135420_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNS0zLTEtMS0xNTQ0NjU_5b4c7ca6-0a6a-4de5-9c53-8a3ccebaa103">4,954.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1172b544a5e4dfeaec557b7f54b8c2e_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNS01LTEtMS0xNTQ0NjU_a9845e35-2721-46dd-9c04-bd7bc6cce838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdcf94ce627c4be4a03c2b555eb02850_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNS03LTEtMS0xNTQ0NjU_de95c21a-128e-4826-ac73-febfff20f422">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19df7d41a2664fb0a6a67b075b15daf4_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNS05LTEtMS0xNTQ0NjU_80030a3d-f00c-4e0a-bc5a-c6af29d274cc">5,162.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a7e4f7cb4e41729070a784a25c8e23_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNS0xMS0xLTEtMTU0NDY1_b5228f4e-93f9-4db4-8385-fb572c30f950">5,162.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b76dd557cc44c5a7683f6822150efc_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNS0xMy0xLTEtMTU0NDY1_09ab33ff-4ea5-42cd-ba64-ccaf7d149d72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed0527849db4ddc810087f8269e6a64_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNS0xNS0xLTEtMTU0NDY1_89274824-e0d5-48b5-8242-3dd718192cb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-6.75pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic343766e206f4789942ef9275cda71a5_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNi0xLTEtMS0xNTQ0NjU_1e10f2a1-07ff-4404-b245-8dac1589a1e4">1,600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i131b6f1d70f94c9f90dfedcdc7a01ff5_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNi0zLTEtMS0xNTQ0NjU_e6df1d7f-6c74-431d-94cf-21c18de8134a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99eafb1412f04883bb2ae4db33955742_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNi01LTEtMS0xNTQ0NjU_9e96519a-3c1b-4c2d-96c7-c4efa510d321">1,600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c490bcc66894ea98d7429a3117bfa3b_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNi03LTEtMS0xNTQ0NjU_0b7610c8-4f2a-4eff-92ea-3f95c8f73bf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db63b9d16fd41768755596324d96881_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNi05LTEtMS0xNTQ0NjU_945b7ede-723a-4db8-8149-89be4a93f9b0">2,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7ccae904db4bb594d5120e116b9807_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNi0xMS0xLTEtMTU0NDY1_f853f9f2-1dc9-42df-8636-512be05eabe1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90aaba6347244ab085a0aa1f4b89a042_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNi0xMy0xLTEtMTU0NDY1_ae58fced-939f-40b7-9bfd-91c38408e46e">2,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fb1005043c447909f914296771d03db_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNi0xNS0xLTEtMTU0NDY1_a04a607a-378c-4457-9f14-5bc3d4a3318d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-6.75pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c93b1377c664c448dcf6673205406fe_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xLTEtMS0xNzQ5NjI_9b49e1c0-4e5a-4565-9f8a-3a900a0bebbf">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5919ceaa00e4362ab8fbb121c59317d_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0zLTEtMS0xNzQ5NjI_0c3e0ead-bb11-4ec6-a87d-c4faafd3b041">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1782d4264f424222af51258f6a4ae9a6_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy01LTEtMS0xNzQ5NjI_4682f0d7-8080-4c2a-8348-f347842bbeb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181055a8f6ac466285fd64c2fef5df1a_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy03LTEtMS0xNzQ5NjI_2c13db74-8454-40c6-b74d-a07c995c600e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bb10fbf88cd4d00b87defa7c623ee5b_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy05LTEtMS0xNzU2MjE_03340bd0-4aef-42df-a906-dc3fe9419274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015bdda56ff0453f891016f489d1e086_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xMS0xLTEtMTc1NjIx_7063eae5-a236-4a41-9496-c759fcc510e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib66f13223992427f902c8fa1ca24c95c_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xMy0xLTEtMTc1NjIx_09677da0-d8ce-4e49-b269-b3f2692e0127">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e746950de04d5793a708d0939a53f2_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xNS0xLTEtMTc1NjIx_9deb8418-52c4-42da-b7f8-55e3f3a5b0b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-6.75pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Government-sponsored enterprise securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460b99888b4f4a44bdc3579e4daa8cb0_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOC0xLTEtMS0xNzQ5NjI_230de9bd-9d9a-44e6-9101-313b3bb4e7c5">129.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i826c05e248484749a5b7f1e659cdf99a_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOC0zLTEtMS0xNzQ5NjI_008132c0-6332-4975-8c31-33bb5d1e9d82">129.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic14a4abd2a6847819be82dc64adca15d_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOC01LTEtMS0xNzQ5NjI_1152d60b-c5f2-46b1-b29a-cf0649aedadb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe42df834c8a4f769cf33ae1eab132d7_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOC03LTEtMS0xNzQ5NjI_70ebd580-e910-4846-9f52-805f3bb0bd73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b5cc7ed365c4cd594b8d5efd9e1b4fb_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOC05LTEtMS0xNzU2MjU_b6f8266d-b9da-4685-abec-e9508514f29d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ab3546549914211ba6c58294b8ef2ba_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOC0xMS0xLTEtMTc1NjI1_0f9f8cdd-a656-4a0e-9e8e-1a278cc13ec3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27cb56654e1c4d8b9e6bfe1ad91ed595_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOC0xMy0xLTEtMTc1NjI1_8c4160f8-a0c9-41a7-b3ca-84e4b5ffe5ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1f02e67c014e458edc4f0ecad75d48_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOC0xNS0xLTEtMTc1NjI1_375649c3-034c-4e85-b25d-b66652ab8608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-6.75pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ae332addf24f6ea1ef3591d8d5ffc1_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xLTEtMS0xNjQwNjA_fc1607e5-2d19-4ef7-929e-e6407102cb66">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8142c561d704f2cb44c76e8dc1f64c2_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0zLTEtMS0xNjQwNjA_7cb096d2-c2d6-49e6-87ac-7734ac00d56e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3fe7f7698094ecc904e5bb0b8ed7b86_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy01LTEtMS0xNjQwNjA_a0bd4ac2-7bc8-4013-bc39-cfc1a31e5f66">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2def3af1f037408e85c5c12d51c98a90_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy03LTEtMS0xNjQwNjA_5666f7aa-8b20-451a-b036-d615b9b4634d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858376dc0f0c436fbd3f2789d576c706_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy05LTEtMS0xNjQ3ODA_91046a57-7ec8-4e5e-b3c8-c1279356a3e1">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9148dcf280149118c7e0db009df819b_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xMS0xLTEtMTY0Nzgw_70ab40d0-c263-4028-9f10-c142de9e5e1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171a9edec9b549f0989290feafdd6ad4_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xMy0xLTEtMTY0Nzgw_9b743f6b-3673-4b57-8939-f8ad7aa63840">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07323877662742d7923c69c73715f083_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xNS0xLTEtMTY0Nzgw_d241a9ca-7d03-47cf-8630-915f1d670c65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-6.75pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09a23a85394040289cb08604ba588cd1_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xLTEtMS0xNTQ0NjU_bcb02340-843b-44dd-bf9b-6e964f50873f">408.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f33ba770f9d4332b8449fa051e6f298_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0zLTEtMS0xNTQ0NjU_3025fb6e-ce8c-4e41-bd6e-b493443a2849">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf98e5400e8f4988acb66dd43618d188_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy01LTEtMS0xNTQ0NjU_3f045a23-df5b-4baa-96c7-342f0756449e">408.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c1c0034f76249d3accf2067044e47e5_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy03LTEtMS0xNTQ0NjU_27f0eeff-de20-4928-b387-7eb614f8da95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic409c3dae38841c4b7b3df9e310a1a62_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy05LTEtMS0xNTQ0NjU_0fed57c5-2a72-4789-a001-e10f2fcc94d7">204.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i794718dd416648e39771ffbb2f2ad9bd_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xMS0xLTEtMTU0NDY1_47e1e743-c834-42b2-b128-abd148cc12d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i743ccaf5675a44b2991a40aa6f855311_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xMy0xLTEtMTU0NDY1_a0938edc-75aa-4444-8432-5e42ee17f68d">204.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5c5072ec2243548cbbd937eafa1d4c_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfNy0xNS0xLTEtMTU0NDY1_4b22fd0f-a59c-4397-86ea-34eee4828097">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marketable securities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdbd1ac532d74157a2c355f92e0ebe09_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOS0xLTEtMS0xNTQ0NjU_7875c83e-6212-4a49-b3f8-1afea9a93a2d">148.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4d81680f1fe4c619f9630996ccde6c9_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOS0zLTEtMS0xNTQ0NjU_3b7b965c-a0be-4bf0-9ad4-b0ac9c83a495">127.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f2d45f662849808db19555d9490b75_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOS01LTEtMS0xNTQ0NjU_dd159149-a77f-492d-95e5-33f71ea05a92">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d7bf8e231f432895a57c796d5e7dcc_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOS03LTEtMS0xNTQ0NjU_27ac4277-fde1-4d0a-a4f5-9ae9bda2fd1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cbdb33ee2764495aa0d5503b0448a57_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOS05LTEtMS0xNTQ0NjU_54f478f8-6f00-4a59-a1e6-6dbbb95d51e9">116.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i601b3ddb8fbf47b4a23246f8836f08db_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOS0xMS0xLTEtMTU0NDY1_bfaf6b1a-478e-41ef-a686-a8ebf9275d8f">88.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc24eb02c014453492edaff2729d75ea_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOS0xMy0xLTEtMTU0NDY1_fdd33326-145d-45f2-8172-8c28acf6687e">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c75ce76e1d844df8f0223492f1dff9e_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfOS0xNS0xLTEtMTU0NDY1_7b0b7e6d-b5c5-4a3f-879e-e7a92308ad01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c93b1377c664c448dcf6673205406fe_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTAtMS0xLTEtMTU0NDY1_93b3c40f-71d4-46d0-87a1-56f0d9730909">276.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5919ceaa00e4362ab8fbb121c59317d_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTAtMy0xLTEtMTU0NDY1_51948a36-9084-4610-9f4b-e20822bb4bc5">276.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1782d4264f424222af51258f6a4ae9a6_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTAtNS0xLTEtMTU0NDY1_b884e1f3-5b49-42a8-8525-8f5ad750a018">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181055a8f6ac466285fd64c2fef5df1a_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTAtNy0xLTEtMTU0NDY1_82e88201-2c11-4c0c-8549-fb9eec4881d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bb10fbf88cd4d00b87defa7c623ee5b_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTAtOS0xLTEtMTU0NDY1_d8f0f940-cf6d-4271-a063-99fb0c18a4c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015bdda56ff0453f891016f489d1e086_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTAtMTEtMS0xLTE1NDQ2NQ_83fde859-0230-4716-80af-4c9298e92366">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib66f13223992427f902c8fa1ca24c95c_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTAtMTMtMS0xLTE1NDQ2NQ_e0408b83-b1ae-49ff-98e4-c7f7559d73fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e746950de04d5793a708d0939a53f2_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTAtMTUtMS0xLTE1NDQ2NQ_ec106616-a6d4-4295-bde6-2336583abc7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Government-sponsored enterprise securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460b99888b4f4a44bdc3579e4daa8cb0_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTEtMS0xLTEtMTU0NDY1_87fd3180-e199-4db7-bde1-dd7e09348fec">532.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i826c05e248484749a5b7f1e659cdf99a_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTEtMy0xLTEtMTU0NDY1_3e120750-52af-4332-a2b3-1bf183b31eff">532.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic14a4abd2a6847819be82dc64adca15d_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTEtNS0xLTEtMTU0NDY1_a61f7497-aad4-4ffe-9835-01de846c495a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe42df834c8a4f769cf33ae1eab132d7_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTEtNy0xLTEtMTU0NDY1_c3c86518-0037-4011-81ed-427e8b44e6ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b5cc7ed365c4cd594b8d5efd9e1b4fb_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTEtOS0xLTEtMTU0NDY1_5871bf8d-0a3f-4770-a8bf-6d3f962960c6">127.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ab3546549914211ba6c58294b8ef2ba_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTEtMTEtMS0xLTE1NDQ2NQ_068784f3-b9c3-49c9-a6a2-b1091da9e959">127.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27cb56654e1c4d8b9e6bfe1ad91ed595_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTEtMTMtMS0xLTE1NDQ2NQ_69196b2e-4f21-44e6-83aa-d409be59dac3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1f02e67c014e458edc4f0ecad75d48_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTEtMTUtMS0xLTE1NDQ2NQ_32f4cf3c-b48b-4530-abc0-a858d18d13c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic839f9440412484a8780bed0df44e3f5_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtMS0xLTEtMTc0OTg3_8ea5bdb3-faa7-443c-848b-a78998f01dd6">117.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24dc16db341473b9b690dd888d7044a_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtMy0xLTEtMTc0OTg3_3fba222b-65e4-45cf-bf66-cce7b0260023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341cbe1625c7434e845c240c80916396_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtNS0xLTEtMTc0OTg3_b5053b2e-1349-46af-a36f-24c7b5203078">117.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia26a2cb8333a43819c70d40501127a7f_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtNy0xLTEtMTc0OTg3_efa2d1b7-efb0-4c09-888a-f24ccbfb7b53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a677cbbda2d4e229af873a225992bcb_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtOS0xLTEtMTc1NjI4_790b85bd-5bc4-4a0b-953a-f935dfe26021">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i731a196828414206b0a07510cafbbff3_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtMTEtMS0xLTE3NTYyOA_7fd0f2fe-937c-4a76-b537-cf385f5ec9f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f032b45b53947a98d7eab1538fb03ce_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtMTMtMS0xLTE3NTYyOA_03e14444-efc2-49c2-9085-7b280caacdb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566604ceb3cd40c18cb5699884878aa0_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtMTUtMS0xLTE3NTYyOA_3060357a-9f08-4a88-a0bc-b81b41a8ae08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7152b487895c4221adb3eec300a99ea6_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTYtMS0xLTEtMTc0OTg3_b6733bdc-ed4d-4852-a361-b31bde28c6c7">44.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i058acce7d553477abe4b88dbdeaed279_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTYtMy0xLTEtMTc0OTg3_da994922-a19a-4815-bd6f-f0d3afb48552">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie01b816a88f1486a9d98a071e20c2447_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTYtNS0xLTEtMTc0OTg3_d1f1b1bc-b278-4e5a-bdfc-fff81d6688fd">44.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba25a1abe7e45c0b2f06fc40962333a_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTYtNy0xLTEtMTc0OTg3_112b9ef8-0843-4f8b-b64c-7d735404e383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b4493082f544900818b20256cd2ba59_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTYtOS0xLTEtMTc1NjMw_a2dd6fed-5831-4697-ba68-f97a0dc4ff2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6fcb82eb1446b9b8b976728cb94899_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTYtMTEtMS0xLTE3NTYzMA_ef87e0ee-941b-4ca1-9fe2-5a2242e015f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d45e4815ddf48a0a311ecd258a7964b_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTYtMTMtMS0xLTE3NTYzMA_26c3462f-e4d9-47c8-ae89-1a261840276e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2df0bf70c0467987e636b3687fb433_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTYtMTUtMS0xLTE3NTYzMA_39224722-a80e-46a2-aaab-6317d7c1316e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ae332addf24f6ea1ef3591d8d5ffc1_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTItMS0xLTEtMTU0NDY1_c613583e-7527-4ac5-8d77-39eb226c1877">771.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8142c561d704f2cb44c76e8dc1f64c2_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTItMy0xLTEtMTU0NDY1_847ae9bf-f642-4d9a-855f-d571ea8527b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3fe7f7698094ecc904e5bb0b8ed7b86_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTItNS0xLTEtMTU0NDY1_3b87fd75-ea0e-4110-a293-213d7299f3a7">771.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2def3af1f037408e85c5c12d51c98a90_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTItNy0xLTEtMTU0NDY1_16a91c27-1451-41e6-b823-989fbf83fbe3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858376dc0f0c436fbd3f2789d576c706_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTItOS0xLTEtMTU0NDY1_f5be34e5-1549-4ba7-970d-5490943ae2e3">87.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9148dcf280149118c7e0db009df819b_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTItMTEtMS0xLTE1NDQ2NQ_62522051-1737-4c6d-89f4-fdce12dc7c48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171a9edec9b549f0989290feafdd6ad4_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTItMTMtMS0xLTE1NDQ2NQ_df790c9e-2699-434e-af07-2666519a5f30">87.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07323877662742d7923c69c73715f083_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTItMTUtMS0xLTE1NDQ2NQ_81ec052c-150c-4fef-a43e-3d0c2f4d230b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09a23a85394040289cb08604ba588cd1_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTMtMS0xLTEtMTU0NDY1_bd81a20f-d347-47ec-8675-54a82ed76638">314.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f33ba770f9d4332b8449fa051e6f298_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTMtMy0xLTEtMTU0NDY1_ccc7f52d-79f0-4b07-a582-6ecdf3964abb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf98e5400e8f4988acb66dd43618d188_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTMtNS0xLTEtMTU0NDY1_42c7cf8d-8341-4009-8be0-80aea93898c2">314.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c1c0034f76249d3accf2067044e47e5_I20230331" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTMtNy0xLTEtMTU0NDY1_a0feada3-0f76-4796-a819-e42f6e07f0f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic409c3dae38841c4b7b3df9e310a1a62_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTMtOS0xLTEtMTU0NDY1_87d492b4-9c11-44cf-ae55-1baf12978458">55.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i794718dd416648e39771ffbb2f2ad9bd_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTMtMTEtMS0xLTE1NDQ2NQ_3b9bfb2a-9239-447f-9344-a46ec79636db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i743ccaf5675a44b2991a40aa6f855311_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTMtMTMtMS0xLTE1NDQ2NQ_0f4d4521-9091-4ca0-b69b-24fff574eeb6">55.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5c5072ec2243548cbbd937eafa1d4c_I20221231" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTMtMTUtMS0xLTE1NDQ2NQ_a6faae9a-05f1-4ec8-8989-1e869a03d7eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb59fbd9724a4ceca9f28e9783d88ddd_I20230331" decimals="-5" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtMS0xLTEtMTU0NDY1_6ad174eb-e7c1-4668-b57a-dafedc6f656c">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f68503c2134982b2667a09e5cb81e6_I20230331" decimals="-5" name="us-gaap:DerivativeAssetsCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtMy0xLTEtMTU0NDY1_d9f73eac-aadc-4e7c-ad53-38d993e057de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca37e70e82847a68b12c9859eb40575_I20230331" decimals="-5" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtNS0xLTEtMTU0NDY1_122eebc8-5ba3-46e3-9915-94d25b583b77">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2eb573b1a64097a177338f5347c5c3_I20230331" decimals="-5" name="us-gaap:DerivativeAssetsCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtNy0xLTEtMTU0NDY1_51cdc81b-1ba4-4cf7-862d-1dfc334be866">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36fd34154c814cd6a86bb6aaa2dbfd49_I20221231" decimals="-5" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtOS0xLTEtMTU0NDY1_d6212b27-ed1e-4c30-9ed3-0ad18d676d8d">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349b5de63331495fa55c332e27a15ad6_I20221231" decimals="-5" name="us-gaap:DerivativeAssetsCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtMTEtMS0xLTE1NDQ2NQ_3e7a129e-684e-42c3-a090-d7a1eba7732f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d5c17249984a9cbb2bf43a0c90847a_I20221231" decimals="-5" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtMTMtMS0xLTE1NDQ2NQ_324df589-9cb7-438b-bdd6-4b0dfb93e337">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dbd6f5eca0d4aa2848c9e9ac7b0c90e_I20221231" decimals="-5" name="us-gaap:DerivativeAssetsCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTUtMTUtMS0xLTE1NDQ2NQ_ce97a9f8-bafa-468c-9d4e-b832282fa1c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb59fbd9724a4ceca9f28e9783d88ddd_I20230331" decimals="-5" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTctMS0xLTEtMTU0NDY1_b7aa7814-8cd3-47ba-817f-1b275c059bfa">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f68503c2134982b2667a09e5cb81e6_I20230331" decimals="-5" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTctMy0xLTEtMTU0NDY1_af6a826c-2d49-4616-8d92-363a52862edb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca37e70e82847a68b12c9859eb40575_I20230331" decimals="-5" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTctNS0xLTEtMTU0NDY1_92e77b65-77f3-451d-aeea-e39f0a693619">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2eb573b1a64097a177338f5347c5c3_I20230331" decimals="-5" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTctNy0xLTEtMTU0NDY1_d8cf8f0b-9dc5-4c7a-a64a-d1ce427b707c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36fd34154c814cd6a86bb6aaa2dbfd49_I20221231" decimals="-5" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTctOS0xLTEtMTU0NDY1_9d152bd9-f30b-4c45-a34e-5efa0ecf7263">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349b5de63331495fa55c332e27a15ad6_I20221231" decimals="-5" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTctMTEtMS0xLTE1NDQ2NQ_57f4d09d-3149-40d7-8bdc-95856d79947c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d5c17249984a9cbb2bf43a0c90847a_I20221231" decimals="-5" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTctMTMtMS0xLTE1NDQ2NQ_15ba04be-985b-430b-9fba-1e4f51447875">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dbd6f5eca0d4aa2848c9e9ac7b0c90e_I20221231" decimals="-5" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTctMTUtMS0xLTE1NDQ2NQ_f423180c-f517-4d64-852b-56a06dc1381f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36.75pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total financial assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb59fbd9724a4ceca9f28e9783d88ddd_I20230331" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTgtMS0xLTEtMTU0NDY1_f8c1c791-6e43-4405-8ac4-14b648fa3b5e">9,405.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f68503c2134982b2667a09e5cb81e6_I20230331" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTgtMy0xLTEtMTU0NDY1_0d203450-e7a2-4349-ab18-46b7f6188832">6,106.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca37e70e82847a68b12c9859eb40575_I20230331" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTgtNS0xLTEtMTU0NDY1_bcc29168-f626-421b-9f92-3fcccb8bd64b">3,299.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2eb573b1a64097a177338f5347c5c3_I20230331" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTgtNy0xLTEtMTU0NDY1_ecdbc1bb-f915-4359-9e9b-b6a3c579f1e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36fd34154c814cd6a86bb6aaa2dbfd49_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTgtOS0xLTEtMTU0NDY1_6f8b4e68-edc1-4ce6-b16e-4ca53ca17af2">7,807.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349b5de63331495fa55c332e27a15ad6_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTgtMTEtMS0xLTE1NDQ2NQ_79986d06-946a-4a1e-8a16-6d64c8901b2f">5,378.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d5c17249984a9cbb2bf43a0c90847a_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTgtMTMtMS0xLTE1NDQ2NQ_c3fd1784-a351-436e-afe5-d1bdad9ebbf2">2,429.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dbd6f5eca0d4aa2848c9e9ac7b0c90e_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMTgtMTUtMS0xLTE1NDQ2NQ_6aec4e71-0dbf-4a0c-846a-a1ebf85e15c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 10pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 10pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 10pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 10pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">:</span></td></tr><tr><td colspan="48" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial instruments carried at fair value (liability positions):</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb59fbd9724a4ceca9f28e9783d88ddd_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjItMS0xLTEtMTU0NDY1_b437af92-9e69-447d-badc-10623c646331">20.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f68503c2134982b2667a09e5cb81e6_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjItMy0xLTEtMTU0NDY1_34ce5b37-b475-40c8-80a1-59c9acf28a67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ca37e70e82847a68b12c9859eb40575_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjItNS0xLTEtMTU0NDY1_edbded9c-9b7e-4a61-b8c5-e77de4608ec5">20.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2eb573b1a64097a177338f5347c5c3_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjItNy0xLTEtMTU0NDY1_2d2258c8-30ad-4b43-9c2f-27d7faeea0af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36fd34154c814cd6a86bb6aaa2dbfd49_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjItOS0xLTEtMTU0NDY1_405570b3-9bda-4936-b2c4-f2b075d1c98b">14.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349b5de63331495fa55c332e27a15ad6_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjItMTEtMS0xLTE1NDQ2NQ_09edbfe3-b4eb-443c-a107-bdd33b172910">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6d5c17249984a9cbb2bf43a0c90847a_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjItMTMtMS0xLTE1NDQ2NQ_4a83651a-6017-4972-bcca-31d4874340a2">14.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dbd6f5eca0d4aa2848c9e9ac7b0c90e_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjItMTUtMS0xLTE1NDQ2NQ_63829fe7-6bf1-4c5b-b1e0-83a7e93edb61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb59fbd9724a4ceca9f28e9783d88ddd_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjQtMS0xLTEtMTY0MTUx_14def2ed-82a3-45be-8586-2f39ae8fa473">14.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f68503c2134982b2667a09e5cb81e6_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjQtMy0xLTEtMTY0MTUx_3966fa36-1862-456a-bee8-2ec2ec5d9a96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca37e70e82847a68b12c9859eb40575_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjQtNS0xLTEtMTY0MTUx_76d10ca4-cc12-4674-b7b9-2448bcef1e87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe2eb573b1a64097a177338f5347c5c3_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjQtNy0xLTEtMTY0MTUx_3781f3de-81a4-48f1-ac90-30845c873db8">14.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36fd34154c814cd6a86bb6aaa2dbfd49_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjQtOS0xLTEtMTY0NTI4_d5e02e77-1c93-449a-8cb6-a68d04082f3a">14.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349b5de63331495fa55c332e27a15ad6_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjQtMTEtMS0xLTE2NDc4Ng_f874e573-b54a-4242-a8e0-0752d9427ca8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d5c17249984a9cbb2bf43a0c90847a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjQtMTMtMS0xLTE2NDc4Ng_3990610b-026c-4221-9b31-dc760a616f61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dbd6f5eca0d4aa2848c9e9ac7b0c90e_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjQtMTUtMS0xLTE2NDUyOA_4c2046f4-89b4-480d-8700-3a6896bb479d">14.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb59fbd9724a4ceca9f28e9783d88ddd_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtMS0xLTEtMTY2MDE0_9978ba86-52fb-49f4-8667-6cdede9f9f4c">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f68503c2134982b2667a09e5cb81e6_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtMy0xLTEtMTY2MDE0_6ad91641-189e-419b-b2f5-7847ddb447f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ca37e70e82847a68b12c9859eb40575_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtNS0xLTEtMTY2MDE0_33ca015e-e725-4ef4-8ab7-c14509d4398b">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2eb573b1a64097a177338f5347c5c3_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtNy0xLTEtMTY2MDE0_8d00d41c-7dca-4962-8707-ddac3e1c0f9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36fd34154c814cd6a86bb6aaa2dbfd49_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtOS0xLTEtMTY0NTI4_bd7a4f0d-4639-4413-acc4-52cc47a9f2c8">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349b5de63331495fa55c332e27a15ad6_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtMTEtMS0xLTE3MDMxNA_9ead4164-d720-485d-b0e8-2ce1ccf64355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6d5c17249984a9cbb2bf43a0c90847a_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtMTMtMS0xLTE2NDUyOA_51861a12-5e16-4c73-ac23-52a31f9a801f">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dbd6f5eca0d4aa2848c9e9ac7b0c90e_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtMTUtMS0xLTE3MDMxNA_e084b32f-a41a-449d-afe2-7635214632d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb59fbd9724a4ceca9f28e9783d88ddd_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjUtMS0xLTEtMTU0NDY1_0e32a66b-1b88-4312-9e6b-9dd07ea644dd">112.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f68503c2134982b2667a09e5cb81e6_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjUtMy0xLTEtMTU0NDY1_59220cef-0c22-4185-8ac9-dc89d7ba88fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca37e70e82847a68b12c9859eb40575_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjUtNS0xLTEtMTU0NDY1_2eef055c-82eb-457e-8fb6-82e4f4486a15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe2eb573b1a64097a177338f5347c5c3_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjUtNy0xLTEtMTU0NDY1_d1e2dcf1-369f-4482-be8b-4eafe9a1b7e4">112.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36fd34154c814cd6a86bb6aaa2dbfd49_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjUtOS0xLTEtMTU0NDY1_5acc6aa8-937b-4444-a7ad-6a708f4ad6bd">114.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349b5de63331495fa55c332e27a15ad6_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjUtMTEtMS0xLTE1NDQ2NQ_65a143b2-df35-4ad6-9cdb-4a933de54323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d5c17249984a9cbb2bf43a0c90847a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjUtMTMtMS0xLTE1NDQ2NQ_59a14892-d2cb-4eb2-a287-c7e3296ebb01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dbd6f5eca0d4aa2848c9e9ac7b0c90e_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjUtMTUtMS0xLTE1NDQ2NQ_322f5737-b992-4ddf-86c6-4a3a3e2a1211">114.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:36.75pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total financial liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb59fbd9724a4ceca9f28e9783d88ddd_I20230331" decimals="-5" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtMS0xLTEtMTU0NDY1_141dc168-9372-4c7e-bc30-807d025dddb0">148.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f68503c2134982b2667a09e5cb81e6_I20230331" decimals="-5" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtMy0xLTEtMTU0NDY1_8c072e7a-8245-400c-b5e0-ae39ae68ba4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ca37e70e82847a68b12c9859eb40575_I20230331" decimals="-5" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtNS0xLTEtMTU0NDY1_007c0c59-6e3d-49e3-9f79-25b918638b0e">21.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe2eb573b1a64097a177338f5347c5c3_I20230331" decimals="-5" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtNy0xLTEtMTU0NDY1_237da015-7ac6-42b5-b296-99effd897d02">127.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36fd34154c814cd6a86bb6aaa2dbfd49_I20221231" decimals="-5" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtOS0xLTEtMTU0NDY1_71dd96da-a31a-4827-9a30-80ea073fdbdb">144.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349b5de63331495fa55c332e27a15ad6_I20221231" decimals="-5" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtMTEtMS0xLTE1NDQ2NQ_5c4b61b9-1d0b-4a7e-bd08-d1465819b6ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6d5c17249984a9cbb2bf43a0c90847a_I20221231" decimals="-5" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtMTMtMS0xLTE1NDQ2NQ_69717002-6180-4ff1-b7e8-dedb65655b31">15.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dbd6f5eca0d4aa2848c9e9ac7b0c90e_I20221231" decimals="-5" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOjZhM2EyNGIyMWZiMjRiNTliYTUxMTM2MTYwYmQ3ZjE2L3RhYmxlcmFuZ2U6NmEzYTI0YjIxZmIyNGI1OWJhNTExMzYxNjBiZDdmMTZfMjYtMTUtMS0xLTE1NDQ2NQ_156fa7a2-4861-4776-88b3-19ebbfde0433">129.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note F, &#8220;Marketable Securities and Equity Investments,&#8221; for the carrying amount and related unrealized gains (losses) by type of investment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Corporate Equity Securities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify our investments in publicly traded corporate equity securities as &#8220;Marketable securities&#8221; on our condensed consolidated balance sheets. Generally, our investments in the common stock of publicly traded companies are valued based on Level 1 inputs because they have readily determinable fair values. However, certain of our investments in publicly traded companies have been or continue to be valued based on Level 2 inputs due to transfer restrictions associated with these investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, several of our investments in publicly traded corporate equity securities were subject to contractual sales restrictions expiring in 2023, 2024 and 2025 with a total fair value of $<ix:nonFraction unitRef="usd" contextRef="i64aef10fd68344e1a6be0ffc774989a0_I20230331" decimals="-5" name="us-gaap:RestrictedInvestmentsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RleHRyZWdpb246OTMxNzUzYWVkMTI2NDk5ZGI3N2ZiOTRkOTNiNTBmOTNfMTY0OTI2NzQ0NzMyNw_305bf596-7c02-4cbd-aa9b-a1a4a6c6a0d9">42.8</ix:nonFraction> million. We purchased these investments directly from these publicly traded companies in 2022 and the first quarter of 2023, and do not anticipate any circumstances that would cause these restrictions to lapse prior to the periods listed above.</span></div></ix:continuation><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><ix:continuation id="ice413772c6c64e88bad1468a01bcb2e3"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note F, &#8220;Marketable Securities and Equity Investments,&#8221; for further information on these investments.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Contingent Consideration</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we acquired Exonics Therapeutics, Inc. (&#8220;Exonics&#8221;), a privately-held company focused on creating transformative gene-editing therapies to repair mutations that cause Duchenne muscular dystrophy and other severe neuromuscular diseases, including DM1. Our Level 3 contingent consideration liabilities are related to $<ix:nonFraction unitRef="usd" contextRef="i0a7cd8e256674846a711534e9b618407_I20230331" decimals="-5" name="vrtx:BusinessCombinationRemainingMilestonePayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RleHRyZWdpb246OTMxNzUzYWVkMTI2NDk5ZGI3N2ZiOTRkOTNiNTBmOTNfMjExMA_1521a732-7c0b-4656-9877-501499776e86">678.3</ix:nonFraction> million of development and regulatory milestones potentially payable to former Exonics equity holders. We base our estimates of the probability of achieving the milestones relevant to the fair value of contingent payments, which could include milestone, royalty and option payments, on industry data attributable to rare diseases and our knowledge of the progress and viability of the programs. The discount rates used in the valuation model for contingent payments, which were between <ix:nonFraction unitRef="number" contextRef="i8a91ba5b083946cd879b4f82a5acd934_I20230331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RleHRyZWdpb246OTMxNzUzYWVkMTI2NDk5ZGI3N2ZiOTRkOTNiNTBmOTNfMjUzMA_69d1c38a-c8f0-40b4-b917-62516662e218">4.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ie77bd3b24a5d45718fbfd42904d612c8_I20230331" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RleHRyZWdpb246OTMxNzUzYWVkMTI2NDk5ZGI3N2ZiOTRkOTNiNTBmOTNfMjUzNw_32bff177-cd3f-4e08-b1e8-a7231b6b1e24">5.8</ix:nonFraction>% as of March 31, 2023, represent a measure of credit risk and market risk associated with settling the liabilities. Significant judgment is used in determining the appropriateness of these assumptions at each reporting period. Due to the uncertainties associated with development and commercialization of product candidates in the pharmaceutical industry and the effects of changes in other assumptions including discount rates, we expect our estimates regarding the fair value of contingent consideration to change in the future, resulting in adjustments to the fair value of our contingent consideration liabilities, and the effect of any such adjustments&#160;could be material.</span></div><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RleHRyZWdpb246OTMxNzUzYWVkMTI2NDk5ZGI3N2ZiOTRkOTNiNTBmOTNfNDEwNA_991d3225-b7ee-4aa6-beb2-f739e1defbf3" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a rollforward of the fair value of our contingent consideration liabilities:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.315%"><tr><td style="width:1.0%"></td><td style="width:73.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.854%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOmQ5Yzg2MDlhYjZlZTQ4NWRhMWVkMzFkNDk3OTgwYTQ0L3RhYmxlcmFuZ2U6ZDljODYwOWFiNmVlNDg1ZGExZWQzMWQ0OTc5ODBhNDRfMi0xLTEtMS0xNTQ0NjU_923fbca3-eace-42e7-ab68-876290c18a2e">129.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in fair value of contingent payments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOmQ5Yzg2MDlhYjZlZTQ4NWRhMWVkMzFkNDk3OTgwYTQ0L3RhYmxlcmFuZ2U6ZDljODYwOWFiNmVlNDg1ZGExZWQzMWQ0OTc5ODBhNDRfMy0xLTEtMS0xNTQ0NjU_f13b718a-fa40-4ea9-ac8c-9625b3cb0bb9">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl80OS9mcmFnOjkzMTc1M2FlZDEyNjQ5OWRiNzdmYjk0ZDkzYjUwZjkzL3RhYmxlOmQ5Yzg2MDlhYjZlZTQ4NWRhMWVkMzFkNDk3OTgwYTQ0L3RhYmxlcmFuZ2U6ZDljODYwOWFiNmVlNDg1ZGExZWQzMWQ0OTc5ODBhNDRfNC0xLTEtMS0xNTQ0NjU_1b3d1897-9e89-47da-bd67-9715405066cd">127.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_52"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:9.4pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RleHRyZWdpb246ODY4ZjQxMjZkNTJjNGZmMmI0ZjYyYjA3NGU5YTc0ZmVfMTI5MA_6ede882f-8762-460e-9a29-f64f22ec6d40" continuedAt="id7f97169350240088a276fd1b9374dad" escape="true">Marketable Securities and Equity Investments</ix:nonNumeric></span></div><ix:continuation id="id7f97169350240088a276fd1b9374dad" continuedAt="iabbd6e9f83b143aa913ff2a4555b77f6"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RleHRyZWdpb246ODY4ZjQxMjZkNTJjNGZmMmI0ZjYyYjA3NGU5YTc0ZmVfMTI4OA_b1180d91-4647-4a75-a722-cf45e1224745" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our cash equivalents and marketable securities, which are recorded at fair value (and do not include $<ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-8" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RleHRyZWdpb246ODY4ZjQxMjZkNTJjNGZmMmI0ZjYyYjA3NGU5YTc0ZmVfMTIz_760f9efb-26a9-4284-ad75-5bca69fa1d05">2.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-8" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RleHRyZWdpb246ODY4ZjQxMjZkNTJjNGZmMmI0ZjYyYjA3NGU5YTc0ZmVfMTMx_03b8b56b-4118-4b62-89ab-305dd2f52a9a">3.1</ix:nonFraction> billion of cash as of March 31, 2023 and December&#160;31, 2022, respectively), is shown below:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:25.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair </span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair </span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148e26f7d2fe46b7bb59dd368e3eae12_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNC0xLTEtMS0xNTQ0NjU_3f9439c4-0d27-4b9d-be01-54caa50d2ef6">4,954.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148e26f7d2fe46b7bb59dd368e3eae12_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNC03LTEtMS0xNTQ0NjU_debf13f4-6743-4fb4-b14f-7deb6dcb2911">4,954.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75c22c506edf4ea8b1ba6a5fa91fd631_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNC05LTEtMS0xNTQ0NjU_3981cdab-6b2a-4c28-960e-c6b56165085b">5,162.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75c22c506edf4ea8b1ba6a5fa91fd631_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNC0xNS0xLTEtMTU0NDY1_2cb9b359-bdf6-4dea-8b7c-94ea211f9541">5,162.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f2005ea5d94ee7bbb58bf806bcee1e_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNS0xLTEtMS0xNTQ0NjU_6e07e0a2-92cb-44b0-b986-74f120173db8">1,600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f2005ea5d94ee7bbb58bf806bcee1e_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNS03LTEtMS0xNTQ0NjU_f560e322-fb97-41ce-bc8a-e865a49e844b">1,600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i182b3503a8864d01b321392ea01ed794_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNS05LTEtMS0xNTQ0NjU_87876e2f-d835-47ef-899c-3b4f051593bc">2,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i182b3503a8864d01b321392ea01ed794_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNS0xNS0xLTEtMTU0NDY1_31e4ca8d-e670-48dc-a8f5-2d86fcc46370">2,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6938f8447e4f23af33ae0f174a67d9_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi0xLTEtMS0xNzQ3ODk_fa06dc33-2851-4bfb-a643-2d45e79ab34e">86.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6938f8447e4f23af33ae0f174a67d9_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleGrossUnrealizedGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi0zLTEtMS0xNzQ3ODk_ec645c32-13ac-4e93-91a6-ac27051ad5ed">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6938f8447e4f23af33ae0f174a67d9_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi03LTEtMS0xNzQ3ODk_d17a170b-3fba-4db1-b59c-2728efce18f2">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605e263269d24c96978db991134781c2_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi05LTEtMS0xNzYwNDE_51dce60e-44e8-471b-9b06-d76682bab015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605e263269d24c96978db991134781c2_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi0xNS0xLTEtMTc2MDQx_6aa0145c-7952-42ac-bf97-451316c2df37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Government-sponsored enterprise securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8259f1f6ca4894bbf96d2eb350c313_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNy0xLTEtMS0xNzQ3ODk_73fd3701-300d-42ba-9bf2-50b6a1693e86">129.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8259f1f6ca4894bbf96d2eb350c313_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleGrossUnrealizedGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNy0zLTEtMS0xNzQ3ODk_46b7feed-b0df-4e2f-8652-f6910dae43b7">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8259f1f6ca4894bbf96d2eb350c313_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNy03LTEtMS0xNzQ3ODk_391abc80-accf-4b35-a7eb-6d954e6b2861">129.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadcb4043793c416ca9f8733dfb8ea957_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNy05LTEtMS0xNzYwNDE_9c2868c3-6e66-4ba8-b674-d85e57f540dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadcb4043793c416ca9f8733dfb8ea957_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNy0xNS0xLTEtMTc2MDQx_9b0752e7-bb5d-4979-b795-1769ac1b4f7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd741e8c3b8145bcb180c65bbd50f481_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi0xLTEtMS0xNjYwMzQ_e8593bfd-3fb1-4fd1-8413-57b2a715abe8">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd741e8c3b8145bcb180c65bbd50f481_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi03LTEtMS0xNjYwMzQ_306d1255-1419-47a8-a886-07b339c6af48">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484a922f34254d179c7b9454d5ddc8cd_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi05LTEtMS0xNjQ3OTA_c3f15d7e-326c-4f67-9b2c-bdf40267b88d">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484a922f34254d179c7b9454d5ddc8cd_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi0xNS0xLTEtMTY0Nzkw_f550aa8f-f958-48d6-b29d-1ca08d7c6bda">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415cea4547f4489d8e4c2f211e8dadb4_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi0xLTEtMS0xNTQ0NjU_76a8bc29-83f2-414b-bae9-b1d60aa3d24d">408.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415cea4547f4489d8e4c2f211e8dadb4_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi03LTEtMS0xNTQ0NjU_85f42940-97db-482b-82eb-59519f034c13">408.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cead76d8658403490c6650e993fdb09_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi05LTEtMS0xNTQ0NjU_b86e28a9-0573-41cf-9674-dca80151b965">204.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cead76d8658403490c6650e993fdb09_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNi0xNS0xLTEtMTU0NDY1_88430a48-128e-442d-ba1e-0f7682a766fd">204.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total cash equivalents</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNy0xLTEtMS0xNTQ0NjU_493c254b-eb6b-4918-a8c0-9c8cb92e732d">7,179.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleGrossUnrealizedGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTAtMy0xLTEtMTc1NjM4_427c845a-622d-43b0-b230-ae5587732afa">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNy03LTEtMS0xNTQ0NjU_34463c27-b915-4a7f-aa5b-864a3b24b5cd">7,179.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNy05LTEtMS0xNTQ0NjU_f2e5b451-6cb9-424c-82cf-58256630915c">7,372.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="vrtx:CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfNy0xNS0xLTEtMTU0NDY1_1423d83f-c587-47b4-b2d7-3a10269a3827">7,372.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6938f8447e4f23af33ae0f174a67d9_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfOS0xLTEtMS0xNTQ0NjU_8dde2ee9-7dda-4d18-b678-4e631e076240">274.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6938f8447e4f23af33ae0f174a67d9_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfOS0zLTEtMS0xNTQ0NjU_00159f3d-5820-4465-8515-960f69d06242">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6938f8447e4f23af33ae0f174a67d9_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfOS01LTEtMS0xNTQ0NjU_54b2ee82-34e6-4f59-9b26-3e0b91ee04ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6938f8447e4f23af33ae0f174a67d9_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfOS03LTEtMS0xNTQ0NjU_fbbe119f-740f-4300-bfa9-7bf2a8582d98">276.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605e263269d24c96978db991134781c2_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfOS05LTEtMS0xNTQ0NjU_e003ec5a-8811-443a-9abe-3a89ee300e41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605e263269d24c96978db991134781c2_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfOS0xMS0xLTEtMTU0NDY1_fe8ec058-ceb7-4d9b-9ecb-1363a3b4835f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605e263269d24c96978db991134781c2_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfOS0xMy0xLTEtMTU0NDY1_5e49fb8d-60a1-4eb3-bf88-ab979aba537f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605e263269d24c96978db991134781c2_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfOS0xNS0xLTEtMTU0NDY1_d27040a9-2004-442b-9e30-2856e05af8f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Government-sponsored enterprise securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8259f1f6ca4894bbf96d2eb350c313_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTAtMS0xLTEtMTU0NDY1_b5c5b8a6-727b-4d22-a5d5-91eb370ec4d5">532.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8259f1f6ca4894bbf96d2eb350c313_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTAtMy0xLTEtMTU0NDY1_2ec88796-15d8-4ec7-ab6d-51225e27fc8d">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8259f1f6ca4894bbf96d2eb350c313_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTAtNS0xLTEtMTU0NDY1_b6e13716-20c3-4f17-a75d-4d71dc08e1da">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8259f1f6ca4894bbf96d2eb350c313_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTAtNy0xLTEtMTU0NDY1_bb77907d-8a45-472b-80dc-65d02c83a740">532.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadcb4043793c416ca9f8733dfb8ea957_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTAtOS0xLTEtMTU0NDY1_4799e672-5c58-4829-97a6-36ae46ad2773">127.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadcb4043793c416ca9f8733dfb8ea957_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTAtMTEtMS0xLTE1NDQ2NQ_1263ca9b-c814-423c-b8c1-edc3b002178b">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadcb4043793c416ca9f8733dfb8ea957_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTAtMTMtMS0xLTE1NDQ2NQ_c30d4604-c255-4d18-b4ba-28d53c100827">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadcb4043793c416ca9f8733dfb8ea957_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTAtMTUtMS0xLTE1NDQ2NQ_f0c0a70c-b7ca-4fa3-a91e-18d02a015040">127.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed3df94f04c4269afb2d20a9b77f1dc_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMS0xLTEtMTc0ODc3_e5940d50-d3ef-4efa-b249-da360e3e02da">118.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed3df94f04c4269afb2d20a9b77f1dc_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMy0xLTEtMTc0ODc3_0522ca6a-d0ee-437c-8511-b9c5280b2524">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ed3df94f04c4269afb2d20a9b77f1dc_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtNS0xLTEtMTc0ODc3_8e856452-28f6-4083-84bf-dbb386df7490">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed3df94f04c4269afb2d20a9b77f1dc_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtNy0xLTEtMTc0ODc3_dce9a369-1a63-46ed-8353-1d4b315f7e99">117.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70b63a884f94134a4a548039da0324b_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtOS0xLTEtMTc2MDQ1_2e42a70e-b862-4226-b25c-5acf09b2a441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70b63a884f94134a4a548039da0324b_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMTEtMS0xLTE3NjA0NQ_cbe9ec44-aec3-4c4c-a871-c6a8bc4f74cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70b63a884f94134a4a548039da0324b_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMTMtMS0xLTE3NjA0NQ_e59ab3ca-848c-4965-b7d6-05ccfdb6bce7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70b63a884f94134a4a548039da0324b_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMTUtMS0xLTE3NjA0NQ_d2f17f17-c4f8-4429-9fb4-cefc8aad0a92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb32021800c4e4fa52f9b6e0801f59a_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMS0xLTEtMTc0ODAx_4a588fb6-70ff-4812-8238-b43e0cfc66b7">44.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb32021800c4e4fa52f9b6e0801f59a_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMy0xLTEtMTc0ODAx_487bd8a0-0b54-43ec-85be-13fa03c0b0f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb32021800c4e4fa52f9b6e0801f59a_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtNS0xLTEtMTc0ODAx_911b2c36-656e-4d78-92e3-2ef7629ab1d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb32021800c4e4fa52f9b6e0801f59a_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtNy0xLTEtMTc0ODAx_b387800f-a594-49d5-a99f-e266203bc394">44.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffdbad2314543c4b842e0519cea4c96_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtOS0xLTEtMTc2MDQ1_fbcdfcbe-105a-44b3-b25b-9b210f53914c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffdbad2314543c4b842e0519cea4c96_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtMTEtMS0xLTE3NjA0NQ_cc3112d7-8c53-44d2-8043-e181eb5d177d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffdbad2314543c4b842e0519cea4c96_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtMTMtMS0xLTE3NjA0NQ_4e3c6e31-dfc8-4104-9e7a-bb431db27f12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffdbad2314543c4b842e0519cea4c96_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtMTUtMS0xLTE3NjA0NQ_9e739b8a-6bb5-499b-84a4-d234b41f7b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd741e8c3b8145bcb180c65bbd50f481_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTEtMS0xLTEtMTU0NDY1_3f260211-0689-4af6-8b35-9a2d705870a8">770.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd741e8c3b8145bcb180c65bbd50f481_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTEtMy0xLTEtMTU0NDY1_2d5246bf-820b-4224-baa1-f7ff05c79686">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd741e8c3b8145bcb180c65bbd50f481_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTEtNS0xLTEtMTU0NDY1_24beeb94-6c60-4fb8-98de-01c411d0a91d">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd741e8c3b8145bcb180c65bbd50f481_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTEtNy0xLTEtMTU0NDY1_284dbd2a-c072-4901-a165-e3961811647a">771.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484a922f34254d179c7b9454d5ddc8cd_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTEtOS0xLTEtMTU0NDY1_1cd99321-046a-4ed3-834c-7e77f7372cff">87.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484a922f34254d179c7b9454d5ddc8cd_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTEtMTEtMS0xLTE1NDQ2NQ_0fc5517d-eeed-44ef-90ae-f101f455d97e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484a922f34254d179c7b9454d5ddc8cd_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTEtMTMtMS0xLTE1NDQ2NQ_cbc8c48c-3fe8-4bef-a105-0dae13fcedbe">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484a922f34254d179c7b9454d5ddc8cd_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTEtMTUtMS0xLTE1NDQ2NQ_758ddd58-f8be-4192-aa80-d3df9c3a2f30">87.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c53293cfe9440db0139788931e7042_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTItMS0xLTEtMTU0NDY1_ab97e6d2-c1bc-4377-bd62-247039eac96f">314.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c53293cfe9440db0139788931e7042_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTItMy0xLTEtMTU0NDY1_449f47ce-564d-4303-974f-4c9056aa5364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72c53293cfe9440db0139788931e7042_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTItNS0xLTEtMTU0NDY1_c45421c2-9eb5-46fb-959b-9fcf205a9730">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c53293cfe9440db0139788931e7042_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTItNy0xLTEtMTU0NDY1_a0b97bd9-ca0e-4e08-affc-5dd590785368">314.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5e1168452db44dbaccf71b9f4935933_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTItOS0xLTEtMTU0NDY1_38ebd72f-c4d6-4a18-b93d-c47665e24e81">55.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5e1168452db44dbaccf71b9f4935933_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTItMTEtMS0xLTE1NDQ2NQ_151a5849-144d-4601-9d01-1e5dc0c18cbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5e1168452db44dbaccf71b9f4935933_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTItMTMtMS0xLTE1NDQ2NQ_2c1f0b50-eb8e-449e-8096-7182ea8fac52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5e1168452db44dbaccf71b9f4935933_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTItMTUtMS0xLTE1NDQ2NQ_34b6d7ac-15ed-4805-bdbd-49203b11deb1">55.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total marketable debt securities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib69a994adbdc483cbed6810d023feb05_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTMtMS0xLTEtMTU0NDY1_265c6146-333b-4a68-9a16-765d32c04590">2,054.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib69a994adbdc483cbed6810d023feb05_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTMtMy0xLTEtMTU0NDY1_a57d55d7-6438-4a57-b081-6506403cf8a6">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib69a994adbdc483cbed6810d023feb05_I20230331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTMtNS0xLTEtMTU0NDY1_13dbb81c-879d-4d44-a89c-6624d493e781">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib69a994adbdc483cbed6810d023feb05_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTMtNy0xLTEtMTU0NDY1_9f1e8419-7483-465a-a013-efd76c92d372">2,057.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db26a92f6514cd88c8471039b7932aa_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTMtOS0xLTEtMTU0NDY1_009e9f08-34e7-42a0-9d58-59500c8d8441">270.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db26a92f6514cd88c8471039b7932aa_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTMtMTEtMS0xLTE1NDQ2NQ_50c7b9d3-d0ea-4d05-ba09-bb376d6da01e">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5db26a92f6514cd88c8471039b7932aa_I20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTMtMTMtMS0xLTE1NDQ2NQ_7cf5ecf6-dc10-422a-abae-30ee694ee9d8">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db26a92f6514cd88c8471039b7932aa_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTMtMTUtMS0xLTE1NDQ2NQ_b69fa283-2f1c-4a18-b59e-9e889ee6d7f7">269.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate equity securities </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMS0xLTEtMTU0NDY1_2a17066d-7eed-4e42-ad55-6344d7421cbb">129.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMy0xLTEtMTU0NDY1_299bad4e-1538-4dd1-a9c5-43c00556ead9">47.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtNS0xLTEtMTU0NDY1_75959eba-4aca-4cd1-a106-0581dd3a295b">28.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtNy0xLTEtMTU0NDY1_568cf42b-bd54-4d3a-8b3a-416fdc48dea3">148.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtOS0xLTEtMTU0NDY1_825a9d9f-3f36-41d7-b620-b47a7b848b9d">104.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMTEtMS0xLTE1NDQ2NQ_54a98664-d443-47b6-916c-918ed3a9eef0">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMTMtMS0xLTE1NDQ2NQ_bd155dbc-4d71-4138-b749-f2af6883fc2c">18.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTQtMTUtMS0xLTE1NDQ2NQ_6d489880-8bba-401f-9dcc-d1ccad32a1d0">116.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total marketable securities</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="vrtx:DebtandEquitySecuritiesCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtMS0xLTEtMTU0NDY1_00279087-b955-4975-9f78-ed1e5a5569dc">2,183.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="vrtx:DebtandEquitySecuritiesUnrealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtMy0xLTEtMTU0NDY1_059810c8-8255-4244-92f5-5304d316cd8e">52.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="vrtx:DebtandEquitySecuritiesUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtNS0xLTEtMTU0NDY1_76447ccd-7ea0-41e8-a9ed-d2caa45753bc">30.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="vrtx:DebtandEquitySecuritiesFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtNy0xLTEtMTU0NDY1_c916f583-fc5f-42ea-89af-10919b3e9146">2,205.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="vrtx:DebtandEquitySecuritiesCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtOS0xLTEtMTU0NDY1_ee230db6-98a2-40f6-94a4-237ad51c10e0">374.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="vrtx:DebtandEquitySecuritiesUnrealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtMTEtMS0xLTE1NDQ2NQ_f7e25c45-0160-4280-a8d9-dcbe50e70c3e">31.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="vrtx:DebtandEquitySecuritiesUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtMTMtMS0xLTE1NDQ2NQ_45e384b2-ff75-413e-bcc4-97eece425318">18.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="vrtx:DebtandEquitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmE1NmM1ZjA2MTdmNDQyOTg5YzM0ODRkNmQzMDRkNzdmL3RhYmxlcmFuZ2U6YTU2YzVmMDYxN2Y0NDI5ODljMzQ4NGQ2ZDMwNGQ3N2ZfMTUtMTUtMS0xLTE1NDQ2NQ_1c4b7111-0147-4539-834b-20e7008d407c">386.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities were classified on our condensed consolidated balance sheets at fair value as follows:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.458%"><tr><td style="width:1.0%"></td><td style="width:44.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791a7bbbc18d48e5b2b196484732a23b_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmEyMzRjYzlmMWFlNzRjMDU5NjE3YTNhMWE3M2MxZmQ1L3RhYmxlcmFuZ2U6YTIzNGNjOWYxYWU3NGMwNTk2MTdhM2ExYTczYzFmZDVfMi0xLTEtMS0xNTQ0NjU_05753dc6-0800-467e-a8fd-0ed4722f7d95">5,579.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f3f564c5871417a8ad1a1335612f366_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmEyMzRjYzlmMWFlNzRjMDU5NjE3YTNhMWE3M2MxZmQ1L3RhYmxlcmFuZ2U6YTIzNGNjOWYxYWU3NGMwNTk2MTdhM2ExYTczYzFmZDVfMi0zLTEtMS0xNTQ0NjU_ef7a4f81-8669-4d84-87fd-b9f5e2a6696e">5,372.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd27dba152a49de9cf1dd071b4c6c4e_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmEyMzRjYzlmMWFlNzRjMDU5NjE3YTNhMWE3M2MxZmQ1L3RhYmxlcmFuZ2U6YTIzNGNjOWYxYWU3NGMwNTk2MTdhM2ExYTczYzFmZDVfMy0xLTEtMS0xNTQ0NjU_7e7837f4-d01a-469d-b3c5-02c42b599244">976.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482139101e6848e6aa8d56b9a8e9b92e_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmEyMzRjYzlmMWFlNzRjMDU5NjE3YTNhMWE3M2MxZmQ1L3RhYmxlcmFuZ2U6YTIzNGNjOWYxYWU3NGMwNTk2MTdhM2ExYTczYzFmZDVfMy0zLTEtMS0xNTQ0NjU_9f759cf4-7035-4612-8245-6c2b163797b6">157.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8887406a8084124983bf6fd7e465db0_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmEyMzRjYzlmMWFlNzRjMDU5NjE3YTNhMWE3M2MxZmQ1L3RhYmxlcmFuZ2U6YTIzNGNjOWYxYWU3NGMwNTk2MTdhM2ExYTczYzFmZDVfNC0xLTEtMS0xNjQ3OTI_4775b958-6e05-4275-bfce-42855a979680">1,081.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44aaabd69e6e4cbfbe1300dca8ecba7a_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmEyMzRjYzlmMWFlNzRjMDU5NjE3YTNhMWE3M2MxZmQ1L3RhYmxlcmFuZ2U6YTIzNGNjOWYxYWU3NGMwNTk2MTdhM2ExYTczYzFmZDVfNC0zLTEtMS0xNjQ3OTI_8721b886-2731-400f-8398-c224c9c6de3d">112.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmEyMzRjYzlmMWFlNzRjMDU5NjE3YTNhMWE3M2MxZmQ1L3RhYmxlcmFuZ2U6YTIzNGNjOWYxYWU3NGMwNTk2MTdhM2ExYTczYzFmZDVfNC0xLTEtMS0xNTQ0NjU_436da032-b97e-4c56-80bd-6b3c9fa3d0fb">7,637.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOmEyMzRjYzlmMWFlNzRjMDU5NjE3YTNhMWE3M2MxZmQ1L3RhYmxlcmFuZ2U6YTIzNGNjOWYxYWU3NGMwNTk2MTdhM2ExYTczYzFmZDVfNC0zLTEtMS0xNTQ0NjU_50113adb-4e40-4dd9-ab7d-0f866680e88d">5,642.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities by contractual maturity were as follows:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.458%"><tr><td style="width:1.0%"></td><td style="width:44.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matures within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOjZhNDQxYTY0ZWNiMTRkNTU5YjQ1NGVmYTkxOWZjOWM4L3RhYmxlcmFuZ2U6NmE0NDFhNjRlY2IxNGQ1NTliNDU0ZWZhOTE5ZmM5YzhfMi0xLTEtMS0xNTQ0NjU_dd71130d-97b5-4f95-af25-e64180cad318">6,555.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOjZhNDQxYTY0ZWNiMTRkNTU5YjQ1NGVmYTkxOWZjOWM4L3RhYmxlcmFuZ2U6NmE0NDFhNjRlY2IxNGQ1NTliNDU0ZWZhOTE5ZmM5YzhfMi0zLTEtMS0xNTQ0NjU_61749082-9964-432f-a779-d5c85e3f4321">5,530.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matures after one year through five years</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOjZhNDQxYTY0ZWNiMTRkNTU5YjQ1NGVmYTkxOWZjOWM4L3RhYmxlcmFuZ2U6NmE0NDFhNjRlY2IxNGQ1NTliNDU0ZWZhOTE5ZmM5YzhfMy0xLTEtMS0xNTQ0NjU_5f6a870f-9c3e-48ed-89e0-bb945ad8d818">1,081.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOjZhNDQxYTY0ZWNiMTRkNTU5YjQ1NGVmYTkxOWZjOWM4L3RhYmxlcmFuZ2U6NmE0NDFhNjRlY2IxNGQ1NTliNDU0ZWZhOTE5ZmM5YzhfMy0zLTEtMS0xNTQ0NjU_b614ced6-6949-4d08-92a8-5a1a6484cb18">112.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOjZhNDQxYTY0ZWNiMTRkNTU5YjQ1NGVmYTkxOWZjOWM4L3RhYmxlcmFuZ2U6NmE0NDFhNjRlY2IxNGQ1NTliNDU0ZWZhOTE5ZmM5YzhfNC0xLTEtMS0xNTQ0NjU_d54613ba-ea40-4a74-afca-f4233e6e4129">7,637.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOjZhNDQxYTY0ZWNiMTRkNTU5YjQ1NGVmYTkxOWZjOWM4L3RhYmxlcmFuZ2U6NmE0NDFhNjRlY2IxNGQ1NTliNDU0ZWZhOTE5ZmM5YzhfNC0zLTEtMS0xNTQ0NjU_d16134d2-4be9-4a27-ad9e-45c602a74ac9">5,642.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did <ix:nonFraction unitRef="usd" contextRef="ic1af14e7def84e3590f8cdcf9d63aa32_I20220331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RleHRyZWdpb246ODY4ZjQxMjZkNTJjNGZmMmI0ZjYyYjA3NGU5YTc0ZmVfNjYw_0be41550-a566-494d-8efa-61088bc7f583"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RleHRyZWdpb246ODY4ZjQxMjZkNTJjNGZmMmI0ZjYyYjA3NGU5YTc0ZmVfNjYw_76ea2806-0787-45a1-adb6-e0c1ec025c76">no</ix:nonFraction></ix:nonFraction>t record any allowances for credit losses to adjust the fair value of available-for-sale debt securities or gross realized gains or losses in the three months ended March 31, 2023 and 2022. As of March 31, 2023, we held available-for-sale debt securities with a total fair value of $<ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RleHRyZWdpb246ODY4ZjQxMjZkNTJjNGZmMmI0ZjYyYjA3NGU5YTc0ZmVfMTY0OTI2NzQ0MzU5MQ_2f0d31c9-383c-4d73-836d-6bdfd4bf96b1">702.7</ix:nonFraction> million that were in unrealized loss positions; however, <ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RleHRyZWdpb246ODY4ZjQxMjZkNTJjNGZmMmI0ZjYyYjA3NGU5YTc0ZmVfMzI5ODUzNDg4NTI0MQ_26cfe347-a62f-402a-b790-1478643b682b">none</ix:nonFraction> of these investments had been in an unrealized loss position for greater than twelve months.</span></div></ix:continuation><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><ix:continuation id="iabbd6e9f83b143aa913ff2a4555b77f6"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record changes in the fair value of our investments in corporate equity securities to &#8220;Other income (expense), net&#8221; in our condensed consolidated statements of income. <ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RleHRyZWdpb246ODY4ZjQxMjZkNTJjNGZmMmI0ZjYyYjA3NGU5YTc0ZmVfMTI5Nw_89f66e7c-5fb7-4d35-bace-638159bef39e" continuedAt="i31d51aa7237e4a80ac6f8bb9ddea42ef" escape="true">During the three months ended March 31, 2023 and 2022, our net unrealized gains (losses) on corporate equity securities held at the conclusion of each period were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><ix:continuation id="i31d51aa7237e4a80ac6f8bb9ddea42ef"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.482%"><tr><td style="width:1.0%"></td><td style="width:60.753%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOjhjYWU0YTViNzU5NzRlZjViNjAzZGFkYTlhMWNjNzc4L3RhYmxlcmFuZ2U6OGNhZTRhNWI3NTk3NGVmNWI2MDNkYWRhOWExY2M3NzhfMy01LTEtMS0xNTQ0NjU_39c1d063-2829-4b67-84da-606dfe19f7de">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RhYmxlOjhjYWU0YTViNzU5NzRlZjViNjAzZGFkYTlhMWNjNzc4L3RhYmxlcmFuZ2U6OGNhZTRhNWI3NTk3NGVmNWI2MDNkYWRhOWExY2M3NzhfMy03LTEtMS0xNTQ0NjU_243aa46f-3efc-488f-bbbf-6a879c120e95">75.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the carrying value of our equity investments without readily determinable fair values, which are recorded in &#8220;Other assets&#8221; on our condensed consolidated balance sheets, was $<ix:nonFraction unitRef="usd" contextRef="i2b71db6377cd4cdab4cdfbdc6c2d519e_I20230331" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81Mi9mcmFnOjg2OGY0MTI2ZDUyYzRmZjJiNGY2MmIwNzRlOWE3NGZlL3RleHRyZWdpb246ODY4ZjQxMjZkNTJjNGZmMmI0ZjYyYjA3NGU5YTc0ZmVfMTI3Nw_423999ca-1745-41c0-b1aa-0657bc4f0957">98.6</ix:nonFraction> million.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_55"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">G.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.73pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RleHRyZWdpb246ODNhZDQ0NGQzMTBlNDA1YmI0MjAzOTNmNWM3NjBjNDRfMTE1_3d1ccab6-d96b-4ab6-95df-a4bd9bc1dd06" continuedAt="ia584318e60ba478d953ecc9b09780e63" escape="true">Accumulated Other Comprehensive Income (Loss)</ix:nonNumeric></span></div><ix:continuation id="ia584318e60ba478d953ecc9b09780e63"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RleHRyZWdpb246ODNhZDQ0NGQzMTBlNDA1YmI0MjAzOTNmNWM3NjBjNDRfMTMw_12086f77-7eed-4188-bb06-3f62d718e1a7" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in accumulated other comprehensive income (loss) by component:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Holding Gains (Losses), Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">On Available-For-Sale Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">On Foreign Currency Forward Contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6373ebcbf5f48f494faefeab52b0a31_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMy0xLTEtMS0xNTQ0NjU_29883275-8a23-4a26-aa4d-1196182e759d">25.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic875365bdccf4fdfadcacda1068e90b0_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMy0zLTEtMS0xNTQ0NjU_7a6070cb-8f44-4344-b01b-691324ebcabe">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia097b2ea579e471cbb8389aeb6857267_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMy01LTEtMS0xNTQ0NjU_5dd429b3-c7a8-4569-9227-7ad52c2b61bb">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8554735455834204b136bf02ee206adf_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMy03LTEtMS0xNTQ0NjU_702ad56d-ca2d-4796-bc1d-507283942641">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69e25ace2084e9faf9daa19d31da608_D20230101-20230331" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNC0xLTEtMS0xNTQ0NjU_b305ed72-ca34-4eb1-8edd-69354711f0f4">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4450dd2feca843868a5df5bdae53a781_D20230101-20230331" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNC0zLTEtMS0xNTQ0NjU_b4cca77e-4541-419e-bd9f-7f2b800d9274">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d6acf971364adf93cbee5ddda04052_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNC01LTEtMS0xNTQ0NjU_b3f5a990-cf21-42e9-8a31-0d0305deff16">9.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNC03LTEtMS0xNTQ0NjU_642c19af-d11e-48dd-b9ad-f040aad7b30c">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69e25ace2084e9faf9daa19d31da608_D20230101-20230331" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNS0xLTEtMS0xNTQ0NjU_56094854-869b-4ce6-87da-a59b92c49ce0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4450dd2feca843868a5df5bdae53a781_D20230101-20230331" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNS0zLTEtMS0xNTQ0NjU_b4d4fc89-3b3f-4b8b-b9e2-79028a38f05a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d6acf971364adf93cbee5ddda04052_D20230101-20230331" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNS01LTEtMS0xNTQ0NjU_07d7fa3c-bafa-475d-8e24-fe65c75512e7">17.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNS03LTEtMS0xNTQ0NjU_a3538b7c-e18b-42a9-bca3-f6ede84dd641">17.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69e25ace2084e9faf9daa19d31da608_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNi0xLTEtMS0xNTQ0NjU_2ea4257b-d984-41a9-9ccf-fcf3b554381a">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4450dd2feca843868a5df5bdae53a781_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNi0zLTEtMS0xNTQ0NjU_0221671b-8b36-4d38-8934-ec6de7a4d296">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d6acf971364adf93cbee5ddda04052_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNi01LTEtMS0xNTQ0NjU_e55c6a18-c7fe-4da8-bb75-6e37662942a2">26.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNi03LTEtMS0xNTQ0NjU_6e25638c-9b25-49d1-89f4-b6e8d7a30978">13.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7b3fc1cef494189960db6785b28d54f_I20230331" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNy0xLTEtMS0xNTQ0NjU_29235d40-021e-4b82-a88f-4d9099f6ee5d">15.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b38015e7d9842408c2f21c66edea33c_I20230331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNy0zLTEtMS0xNTQ0NjU_406a4f65-c2d6-410c-83eb-11dab3e73790">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i362c0db1e14d479eb5d71580ef8d640c_I20230331" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNy01LTEtMS0xNTQ0NjU_8e02010b-a326-4c35-a0d6-108d1768bc55">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92ee2dbb965f48489dd427b879f349f8_I20230331" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfNy03LTEtMS0xNTQ0NjU_619637bf-2ad2-4f2e-b9d8-88500e717174">13.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if40387e6a37d4de5bc0d23ac3a122239_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfOS0xLTEtMS0xNTQ0NjU_357879e9-4bdb-44c7-9a79-2fc087558636">13.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia11b3ad2463c4525b2c6a2b8c38a65b8_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfOS0zLTEtMS0xNTQ0NjU_d91bd951-c3de-41eb-a3c9-c99a1de33166">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic62ad0a2c3d44d0a810b4a9b0c542cea_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfOS01LTEtMS0xNTQ0NjU_2b138fad-2dff-49b6-a708-0cd5703da97e">30.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78dd0b0a3c85467781f9ab6e34e27864_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfOS03LTEtMS0xNTQ0NjU_f5b47990-5621-494b-b527-42a768380e1f">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4003919acf2e41de909e937dc581073f_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTAtMS0xLTEtMTU0NDY1_ccd0ca95-dd14-42ca-aa58-0923dad9c0b8">12.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i969eeb4d24704dceb2c378052f60b3f9_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTAtMy0xLTEtMTU0NDY1_af343b6a-d5a6-43b3-a383-54af7b59fbff">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7425ec7db87d45dd89f2916c71d3b693_D20220101-20220331" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTAtNS0xLTEtMTU0NDY1_e4eb9b70-6dd4-4097-aa34-c6636c7eab92">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTAtNy0xLTEtMTU0NDY1_4d02bfdb-88d7-48ff-84fe-77607c29159a">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4003919acf2e41de909e937dc581073f_D20220101-20220331" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTEtMS0xLTEtMTU0NDY1_a7271223-6f22-4f52-b70a-64489108dbb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969eeb4d24704dceb2c378052f60b3f9_D20220101-20220331" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTEtMy0xLTEtMTU0NDY1_b8765048-6a4d-47e5-a72f-545d384e1ebb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7425ec7db87d45dd89f2916c71d3b693_D20220101-20220331" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTEtNS0xLTEtMTU0NDY1_57a34028-b03f-4513-b572-cad12d0066ea">15.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTEtNy0xLTEtMTU0NDY1_bb0c3cea-7d02-4434-986b-db1aaf6fd7a1">15.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4003919acf2e41de909e937dc581073f_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTItMS0xLTEtMTU0NDY1_1a2d00b5-c619-471e-bba4-166faf1f8fa7">12.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i969eeb4d24704dceb2c378052f60b3f9_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTItMy0xLTEtMTU0NDY1_87e5610c-60cb-4469-a368-415d99de5288">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7425ec7db87d45dd89f2916c71d3b693_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTItNS0xLTEtMTU0NDY1_bbac44f0-3a68-415f-b61d-4e3ab891f75d">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTItNy0xLTEtMTU0NDY1_655f5265-9fed-4e86-ab3f-3776632bf65a">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1879c547204409c8d3f60d01810144c_I20220331" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTMtMS0xLTEtMTU0NDY1_a87a6228-0db5-4522-a659-c12eb4e57fdf">26.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i407c5c8db382405ab870dfbad9a9ac17_I20220331" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTMtMy0xLTEtMTU0NDY1_daa08a0d-ae0a-4711-8091-be26b3c52e25">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577c589d96dc40628404d8e5c67a33b0_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTMtNS0xLTEtMTU0NDY1_50e3c070-9cb4-44ef-9fe8-fb93d401e4f5">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914f1759975744f481aba609735018e0_I20220331" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81NS9mcmFnOjgzYWQ0NDRkMzEwZTQwNWJiNDIwMzkzZjVjNzYwYzQ0L3RhYmxlOjc3NmYzNWExMGUzYjQ5NDdiYjE5ZGVkOGY5MGJkN2FlL3RhYmxlcmFuZ2U6Nzc2ZjM1YTEwZTNiNDk0N2JiMTlkZWQ4ZjkwYmQ3YWVfMTMtNy0xLTEtMTU0NDY1_cee12b28-786f-4e9a-baac-d90450e6ba0d">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_58"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">H.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.73pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfMzkyMA_c046273e-e2b7-44a4-adb9-6b5b9391d903" continuedAt="i9f5b1ea56ea74e77a6e11b5800b7dfa8" escape="true">Hedging </ix:nonNumeric></span></div><ix:continuation id="i9f5b1ea56ea74e77a6e11b5800b7dfa8" continuedAt="i9c646b54ee9f43c280409c5dffcbda51"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency forward contracts - Designated as hedging instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a hedging program intended to mitigate the effect of changes in foreign exchange rates for a portion of our forecasted product revenues denominated in certain foreign currencies. The program includes foreign currency forward contracts that are designated as cash flow hedges under U.S. GAAP having contractual durations from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfNDE4_d1c0c737-93ce-41cb-b05c-df6e20f05e94">one</span> to <ix:nonNumeric contextRef="i99106f8f60db40709282c8dddc2f957b_D20230101-20230331" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfNDI0_b4cd746d-f47c-4c5b-8ea4-ebbefa420586">eighteen months</ix:nonNumeric>. We recognize realized gains and losses for the effective portion of such contracts in &#8220;Product revenues, net&#8221; in our condensed consolidated statements of income in the same period that we recognize the product revenues that were impacted by the hedged foreign exchange rate changes. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We formally document the relationship between foreign currency forward contracts (hedging instruments) and forecasted product revenues (hedged items), as well as our risk management objective and strategy for undertaking various hedging </span></div></ix:continuation><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><ix:continuation id="i9c646b54ee9f43c280409c5dffcbda51" continuedAt="i01465c23ed3944f9ae2173cc9f3b397d"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activities, which includes matching all foreign currency forward contracts that are designated as cash flow hedges to forecasted transactions. We also formally assess, both at the hedge&#8217;s inception and on an ongoing basis, whether the foreign currency forward contracts are highly effective in offsetting changes in cash flows of hedged items on a prospective and retrospective basis. If we were to determine that a (i) foreign currency forward contract is not highly effective as a cash flow hedge, (ii) foreign currency forward contract has ceased to be a highly effective hedge or (iii) forecasted transaction is no longer probable of occurring, we would discontinue hedge accounting treatment prospectively. We measure effectiveness based on the change in fair value of the forward contracts and the fair value of the hypothetical foreign currency forward contracts with terms that match the critical terms of the risk being hedged. As of March 31, 2023, all hedges were determined to be highly effective.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the impact of our counterparties&#8217; credit risk on the fair value of the foreign currency forward contracts. As of&#160;March 31, 2023&#160;and&#160;December&#160;31, 2022, credit risk did not change the fair value of our foreign currency forward contracts.</span></div><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfMzkyOQ_d0e5cf6e-8e03-4a30-98ab-72b73f4530ca" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the notional amount in U.S. dollars of our outstanding foreign currency forward contracts designated as cash flow hedges under U.S. GAAP:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.458%"><tr><td style="width:1.0%"></td><td style="width:44.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ac87b05cc0141978ceb195b2fdce104_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfMi0xLTEtMS0xNTQ0NjU_5fbe0260-60ff-46f2-8ed4-f4aef5536f84">1,325.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddfb6891c7c24c079494516ee3b71857_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfMi0zLTEtMS0xNTQ0NjU_921b228f-3dc4-410a-bde8-280168d0856f">1,497.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British pound sterling</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a57f43f5e384e97927f460413351772_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfMy0xLTEtMS0xNjQ3OTQ_7f8ffff9-e6a6-4cdc-a20d-de523e7d08e8">243.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibef3a7c3851a4758a7ac884cf237c64c_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfMy0zLTEtMS0xNjQ3OTQ_981b2adb-9516-46c3-8e19-6fb7d4c425cb">247.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian dollar</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791e9aff90374493ad38f58b1f0c2800_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfMy0xLTEtMS0xNTQ0NjU_2c7c861b-5010-465b-ac96-69d969c5e22e">231.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f78c4320d340889a50077eaeb2f6bd_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfMy0zLTEtMS0xNTQ0NjU_2727f9a3-3aaa-4984-b22d-409a5036d4c4">216.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australian dollar</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c65bbde98f643c382b0467b736c9aff_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfNS0xLTEtMS0xNTQ0NjU_a1e19a4b-f55c-4e8a-89ba-c037eb50c2e9">180.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb98e3e6592b4728a7b017926d2963df_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfNS0zLTEtMS0xNTQ0NjU_e8e76726-68d9-4ef6-b390-d23aba2ea379">174.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swiss Franc</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd55ca1ba3204fc4843341c209d0c58b_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfNi0xLTEtMS0xNTQ0NjU_5bcf70e8-addd-4a21-912a-dbff41c625e5">65.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1633a9f256fd47c7ae8f5503a46e98f3_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfNi0zLTEtMS0xNTQ0NjU_1bdf27bd-65b5-4397-88cc-afeb34d78b8a">65.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign currency forward contracts</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfNy0xLTEtMS0xNTQ0NjU_be1cf660-0429-40c7-9b52-e0a98a73d78b">2,046.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmYzMjY3YWU1Zjc0ZTQ0OWFhZTk0YzcwMDUxMDY3Nzk5L3RhYmxlcmFuZ2U6ZjMyNjdhZTVmNzRlNDQ5YWFlOTRjNzAwNTEwNjc3OTlfNy0zLTEtMS0xNTQ0NjU_51a29a35-ae88-4558-ba68-de8d9b3026cb">2,201.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency forward contracts - Not designated as hedging instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also enter into foreign currency forward contracts with contractual maturities of less than <ix:nonNumeric contextRef="i23fe0afde1cd458bb33f64f4dd947b25_D20230101-20230331" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfMjQ5NA_247738e6-f412-4af4-b683-a398c28a423a">one month</ix:nonNumeric>, which are designed to mitigate the effect of changes in foreign exchange rates on monetary assets and liabilities, including intercompany balances. These contracts are not designated as hedging instruments under U.S. GAAP. We recognize realized gains and losses for such contracts in &#8220;Other income (expense), net&#8221; in our condensed consolidated statements of income each period. As of&#160;March 31, 2023, the notional amount of our outstanding foreign currency forward contracts where hedge accounting under U.S. GAAP is not applied was&#160;$<ix:nonFraction unitRef="usd" contextRef="ia45a80fbfa8b413799aab519c086a013_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfNTQ5NzU1ODE3OTE5_e339028a-7078-40a3-83d1-bee99c67230b">541.3</ix:nonFraction> million. </span></div><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfMzkzMA_7a59e9e8-7694-4e7a-bb4d-92aac7e867b6" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023 and 2022, we recognized the following related to foreign currency forward contracts in our condensed consolidated statements of income:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"></td><td style="width:65.670%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Designated as hedging instruments - Reclassified from AOCI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenues, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac4a35b6dee84645b2e1cba9306d6c09_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjFlNDlhZTljMzgwNTQ1Y2FhYjg4ZWU5MDhiYjU5NzljL3RhYmxlcmFuZ2U6MWU0OWFlOWMzODA1NDVjYWFiODhlZTkwOGJiNTk3OWNfNC01LTEtMS0xNTQ0NjU_1a177681-7496-4f0d-ac28-dc2811b09925">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8da2164469417381f3fbab7a1fcaa6_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjFlNDlhZTljMzgwNTQ1Y2FhYjg4ZWU5MDhiYjU5NzljL3RhYmxlcmFuZ2U6MWU0OWFlOWMzODA1NDVjYWFiODhlZTkwOGJiNTk3OWNfNC03LTEtMS0xNTQ0NjU_2cd9247a-cb45-4c34-85f8-8efa7c3900a3">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Not designated as hedging instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i137713e1e1434b0c88d15339138d9e89_D20230101-20230331" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjFlNDlhZTljMzgwNTQ1Y2FhYjg4ZWU5MDhiYjU5NzljL3RhYmxlcmFuZ2U6MWU0OWFlOWMzODA1NDVjYWFiODhlZTkwOGJiNTk3OWNfNi01LTEtMS0xNTQ0NjU_c744f0f1-cefc-46a8-a4a6-446581a4d63a">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i498f13f4b18f4dcd992573844c575682_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjFlNDlhZTljMzgwNTQ1Y2FhYjg4ZWU5MDhiYjU5NzljL3RhYmxlcmFuZ2U6MWU0OWFlOWMzODA1NDVjYWFiODhlZTkwOGJiNTk3OWNfNi03LTEtMS0xNTQ0NjU_14fe780b-8a78-496a-ba9e-9dec18507551">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total reported in the Condensed Consolidated Statements of Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenues, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjFlNDlhZTljMzgwNTQ1Y2FhYjg4ZWU5MDhiYjU5NzljL3RhYmxlcmFuZ2U6MWU0OWFlOWMzODA1NDVjYWFiODhlZTkwOGJiNTk3OWNfOS01LTEtMS0xNTQ0NjU_e30e170d-434c-4624-8bf2-f92ccd70287d">2,374.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjFlNDlhZTljMzgwNTQ1Y2FhYjg4ZWU5MDhiYjU5NzljL3RhYmxlcmFuZ2U6MWU0OWFlOWMzODA1NDVjYWFiODhlZTkwOGJiNTk3OWNfOS03LTEtMS0xNTQ0NjU_f7012786-1cdd-4538-8d62-0fdad3116d6d">2,097.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjFlNDlhZTljMzgwNTQ1Y2FhYjg4ZWU5MDhiYjU5NzljL3RhYmxlcmFuZ2U6MWU0OWFlOWMzODA1NDVjYWFiODhlZTkwOGJiNTk3OWNfMTAtNS0xLTEtMTU0NDY1_a9b863e9-eb59-4d35-ae82-f5d8ac2cd1c3">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjFlNDlhZTljMzgwNTQ1Y2FhYjg4ZWU5MDhiYjU5NzljL3RhYmxlcmFuZ2U6MWU0OWFlOWMzODA1NDVjYWFiODhlZTkwOGJiNTk3OWNfMTAtNy0xLTEtMTU0NDY1_b103ba13-fd95-4e5f-bc6d-1425705a08c4">72.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><ix:continuation id="i01465c23ed3944f9ae2173cc9f3b397d"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfMzk0NQ_32a1e691-d8ad-4505-922f-635c3b51b8c3" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of our outstanding foreign currency forward contracts designated as cash flow hedges under U.S. GAAP included on our condensed consolidated balance sheets:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45dea239c6874c28ae70eafc6d0b2044_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjk5Yjc2MmYwMDhiMjRlNWE4MDFjMTM0NzY5NTM4ZjMzL3RhYmxlcmFuZ2U6OTliNzYyZjAwOGIyNGU1YTgwMWMxMzQ3Njk1MzhmMzNfNC0yLTEtMS0xNTQ0NjU_58350d97-421c-4ab4-8792-f822a4211f2b">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32fdedd938524ba18a3a76ff8d21eaa3_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjk5Yjc2MmYwMDhiMjRlNWE4MDFjMTM0NzY5NTM4ZjMzL3RhYmxlcmFuZ2U6OTliNzYyZjAwOGIyNGU1YTgwMWMxMzQ3Njk1MzhmMzNfNC02LTEtMS0xNTQ0NjU_f867a1c5-cbad-42e0-8838-2df3983126c4">20.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21aabf003faf4de0853a5a437028da46_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjk5Yjc2MmYwMDhiMjRlNWE4MDFjMTM0NzY5NTM4ZjMzL3RhYmxlcmFuZ2U6OTliNzYyZjAwOGIyNGU1YTgwMWMxMzQ3Njk1MzhmMzNfNS0yLTEtMS0xNTQ0NjU_f0ff4ba9-54c0-4005-8f56-3d832eb16d39">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b323f0f34054e90b07db59a177754d8_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjk5Yjc2MmYwMDhiMjRlNWE4MDFjMTM0NzY5NTM4ZjMzL3RhYmxlcmFuZ2U6OTliNzYyZjAwOGIyNGU1YTgwMWMxMzQ3Njk1MzhmMzNfNS02LTEtMS0xNTQ0NjU_397e3b89-4e2e-4527-a748-ad1e71768d6d">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:21pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjk5Yjc2MmYwMDhiMjRlNWE4MDFjMTM0NzY5NTM4ZjMzL3RhYmxlcmFuZ2U6OTliNzYyZjAwOGIyNGU1YTgwMWMxMzQ3Njk1MzhmMzNfNi0yLTEtMS0xNTQ0NjU_ebb0f04f-db62-40b4-a9c1-9d103d480c75">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjk5Yjc2MmYwMDhiMjRlNWE4MDFjMTM0NzY5NTM4ZjMzL3RhYmxlcmFuZ2U6OTliNzYyZjAwOGIyNGU1YTgwMWMxMzQ3Njk1MzhmMzNfNi02LTEtMS0xNTQ0NjU_690b0de7-73be-4d8e-a6f1-b766162de4d4">21.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b3c9fbffa344dfb792a557883ca887_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmQ3MGM0OGY5ODNiNDQzNTU4OTA5MWQyYzlkNDhlYWI0L3RhYmxlcmFuZ2U6ZDcwYzQ4Zjk4M2I0NDM1NTg5MDkxZDJjOWQ0OGVhYjRfNC0yLTEtMS0xNTQ0NjU_683c9d1b-81aa-43c8-b766-f8ba4dc3832e">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i003858b3945e4cdc80aa86397d139171_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmQ3MGM0OGY5ODNiNDQzNTU4OTA5MWQyYzlkNDhlYWI0L3RhYmxlcmFuZ2U6ZDcwYzQ4Zjk4M2I0NDM1NTg5MDkxZDJjOWQ0OGVhYjRfNC02LTEtMS0xNTQ0NjU_36c22aea-2b97-486e-8e73-a5fd2efc7c23">14.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c42dff4082943b9b2f971a97f36270a_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmQ3MGM0OGY5ODNiNDQzNTU4OTA5MWQyYzlkNDhlYWI0L3RhYmxlcmFuZ2U6ZDcwYzQ4Zjk4M2I0NDM1NTg5MDkxZDJjOWQ0OGVhYjRfNS0yLTEtMS0xNTQ0NjU_7d62799e-8812-41e3-93eb-c8596284bb7c">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88be060b3a3e4813959cd282733b2a01_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmQ3MGM0OGY5ODNiNDQzNTU4OTA5MWQyYzlkNDhlYWI0L3RhYmxlcmFuZ2U6ZDcwYzQ4Zjk4M2I0NDM1NTg5MDkxZDJjOWQ0OGVhYjRfNS02LTEtMS0xNTQ0NjU_813948f2-ce9d-4d08-95e8-02e332cb5dce">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmQ3MGM0OGY5ODNiNDQzNTU4OTA5MWQyYzlkNDhlYWI0L3RhYmxlcmFuZ2U6ZDcwYzQ4Zjk4M2I0NDM1NTg5MDkxZDJjOWQ0OGVhYjRfNi0yLTEtMS0xNTQ0NjU_79a61296-b02b-4008-9a15-ef6148c4954c">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOmQ3MGM0OGY5ODNiNDQzNTU4OTA5MWQyYzlkNDhlYWI0L3RhYmxlcmFuZ2U6ZDcwYzQ4Zjk4M2I0NDM1NTg5MDkxZDJjOWQ0OGVhYjRfNi02LTEtMS0xNTQ0NjU_f57ae77d-b849-48a3-b00b-526b6b0696ee">15.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, we expect the amounts that are related to foreign exchange forward contracts designated as cash flow hedges under U.S. GAAP recorded in &#8220;Prepaid expenses and other current assets&#8221; and &#8220;Other current liabilities&#8221; to be reclassified to earnings within twelve months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present the fair value of our foreign currency forward contracts on a gross basis within our condensed consolidated balance sheets. <ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:OffsettingAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfMzkxNg_083ab804-2334-45ce-b1d7-f4a72f0e8458" continuedAt="i57305bb5c38344aba3a8b60b5fee7d18" escape="true"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:OffsettingLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RleHRyZWdpb246MGEzOWVhMDZlYTgzNDlhNWIxMmQ1MjUxMzEyMDcyNjZfMzkxOQ_a7e735d9-9b37-4b20-817b-a689fdb1d01a" continuedAt="i4d213da347f64589ab3b63a054fb7585" escape="true">The following table summarizes the potential effect of offsetting derivatives by type of financial instrument designated as cash flow hedges under U.S. GAAP on our condensed consolidated balance sheets:</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i57305bb5c38344aba3a8b60b5fee7d18"><ix:continuation id="i4d213da347f64589ab3b63a054fb7585"><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Amounts Recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Amounts Offset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Amounts Presented</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Amounts Not Offset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Legal Offset</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency forward contracts</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjAxNTVhMzFjMTg3NzQwOWI5ZmU2NzhhYWQ0N2JkOWM4L3RhYmxlcmFuZ2U6MDE1NWEzMWMxODc3NDA5YjlmZTY3OGFhZDQ3YmQ5YzhfMy0xLTEtMS0xNTQ0NjU_3fa72bbb-ca88-482f-ab2e-ee42a8e5aaa7">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeAssetFairValueGrossLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjAxNTVhMzFjMTg3NzQwOWI5ZmU2NzhhYWQ0N2JkOWM4L3RhYmxlcmFuZ2U6MDE1NWEzMWMxODc3NDA5YjlmZTY3OGFhZDQ3YmQ5YzhfMy0zLTEtMS0xNTQ0NjU_939f3170-e622-4061-81eb-e5edf3c9e14c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjAxNTVhMzFjMTg3NzQwOWI5ZmU2NzhhYWQ0N2JkOWM4L3RhYmxlcmFuZ2U6MDE1NWEzMWMxODc3NDA5YjlmZTY3OGFhZDQ3YmQ5YzhfMy01LTEtMS0xNTQ0NjU_ae76da75-b197-4fea-8e36-784cd00463b0">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjAxNTVhMzFjMTg3NzQwOWI5ZmU2NzhhYWQ0N2JkOWM4L3RhYmxlcmFuZ2U6MDE1NWEzMWMxODc3NDA5YjlmZTY3OGFhZDQ3YmQ5YzhfMy03LTEtMS0xNTQ0NjU_5ddd1877-52a7-42fb-b5ea-1b21c6b55daa">19.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjAxNTVhMzFjMTg3NzQwOWI5ZmU2NzhhYWQ0N2JkOWM4L3RhYmxlcmFuZ2U6MDE1NWEzMWMxODc3NDA5YjlmZTY3OGFhZDQ3YmQ5YzhfMy05LTEtMS0xNTQ0NjU_f0e64402-3879-4043-a81c-6199a85368b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjAxNTVhMzFjMTg3NzQwOWI5ZmU2NzhhYWQ0N2JkOWM4L3RhYmxlcmFuZ2U6MDE1NWEzMWMxODc3NDA5YjlmZTY3OGFhZDQ3YmQ5YzhfNC0xLTEtMS0xNTQ0NjU_e3705be7-e827-434a-8d57-5591eb1fbbe9">21.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjAxNTVhMzFjMTg3NzQwOWI5ZmU2NzhhYWQ0N2JkOWM4L3RhYmxlcmFuZ2U6MDE1NWEzMWMxODc3NDA5YjlmZTY3OGFhZDQ3YmQ5YzhfNC0zLTEtMS0xNTQ0NjU_a95f288d-f6bd-49b4-8bf4-9681afd15c2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjAxNTVhMzFjMTg3NzQwOWI5ZmU2NzhhYWQ0N2JkOWM4L3RhYmxlcmFuZ2U6MDE1NWEzMWMxODc3NDA5YjlmZTY3OGFhZDQ3YmQ5YzhfNC01LTEtMS0xNTQ0NjU_7cca386d-70aa-495d-9b64-96973ed1a4d3">21.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjAxNTVhMzFjMTg3NzQwOWI5ZmU2NzhhYWQ0N2JkOWM4L3RhYmxlcmFuZ2U6MDE1NWEzMWMxODc3NDA5YjlmZTY3OGFhZDQ3YmQ5YzhfNC03LTEtMS0xNTQ0NjU_6efe107c-9707-4eb4-873d-91f845df6d63">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d8da6988daf4ab5a3cc36305fd391d2_I20230331" decimals="-5" name="us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjAxNTVhMzFjMTg3NzQwOWI5ZmU2NzhhYWQ0N2JkOWM4L3RhYmxlcmFuZ2U6MDE1NWEzMWMxODc3NDA5YjlmZTY3OGFhZDQ3YmQ5YzhfNC05LTEtMS0xNTQ0NjU_9e7d6e9f-9a99-45b5-a40f-c4e2d0959d8f">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Amounts Recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Amounts Offset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Amounts Presented</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Amounts Not Offset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Legal Offset</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency forward contracts</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjYwYjE5M2RiOTljYzQ2MmJiNTBmYTkxOGVlY2UyNmEyL3RhYmxlcmFuZ2U6NjBiMTkzZGI5OWNjNDYyYmI1MGZhOTE4ZWVjZTI2YTJfMy0xLTEtMS0xNTQ0NjU_f89e43aa-85ff-43de-b2ca-adcd5aff4ee4">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeAssetFairValueGrossLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjYwYjE5M2RiOTljYzQ2MmJiNTBmYTkxOGVlY2UyNmEyL3RhYmxlcmFuZ2U6NjBiMTkzZGI5OWNjNDYyYmI1MGZhOTE4ZWVjZTI2YTJfMy0zLTEtMS0xNTQ0NjU_f1b44f7e-3fb5-40dc-a985-8b375883992d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjYwYjE5M2RiOTljYzQ2MmJiNTBmYTkxOGVlY2UyNmEyL3RhYmxlcmFuZ2U6NjBiMTkzZGI5OWNjNDYyYmI1MGZhOTE4ZWVjZTI2YTJfMy01LTEtMS0xNTQ0NjU_47344d3c-5ede-4e7e-a100-70fe207d5dcc">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjYwYjE5M2RiOTljYzQ2MmJiNTBmYTkxOGVlY2UyNmEyL3RhYmxlcmFuZ2U6NjBiMTkzZGI5OWNjNDYyYmI1MGZhOTE4ZWVjZTI2YTJfMy03LTEtMS0xNTQ0NjU_8fadbf14-20e5-46eb-b810-b1da836425de">15.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjYwYjE5M2RiOTljYzQ2MmJiNTBmYTkxOGVlY2UyNmEyL3RhYmxlcmFuZ2U6NjBiMTkzZGI5OWNjNDYyYmI1MGZhOTE4ZWVjZTI2YTJfMy05LTEtMS0xNTQ0NjU_117e2fc6-2c80-4c68-8bdf-fa98396e71c1">33.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjYwYjE5M2RiOTljYzQ2MmJiNTBmYTkxOGVlY2UyNmEyL3RhYmxlcmFuZ2U6NjBiMTkzZGI5OWNjNDYyYmI1MGZhOTE4ZWVjZTI2YTJfNC0xLTEtMS0xNTQ0NjU_a9103c8d-3c9a-4ddd-bf99-c43700626110">15.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjYwYjE5M2RiOTljYzQ2MmJiNTBmYTkxOGVlY2UyNmEyL3RhYmxlcmFuZ2U6NjBiMTkzZGI5OWNjNDYyYmI1MGZhOTE4ZWVjZTI2YTJfNC0zLTEtMS0xNTQ0NjU_bac40b51-93d2-4f1a-b559-e773402356be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjYwYjE5M2RiOTljYzQ2MmJiNTBmYTkxOGVlY2UyNmEyL3RhYmxlcmFuZ2U6NjBiMTkzZGI5OWNjNDYyYmI1MGZhOTE4ZWVjZTI2YTJfNC01LTEtMS0xNTQ0NjU_24b49afa-0a45-44c9-a72f-4fad2c97f598">15.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjYwYjE5M2RiOTljYzQ2MmJiNTBmYTkxOGVlY2UyNmEyL3RhYmxlcmFuZ2U6NjBiMTkzZGI5OWNjNDYyYmI1MGZhOTE4ZWVjZTI2YTJfNC03LTEtMS0xNTQ0NjU_b97e080e-3159-4c5f-ac26-7a21860e6c4b">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbfbb4865d64d418b740fd61d14b3dc_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl81OC9mcmFnOjBhMzllYTA2ZWE4MzQ5YTViMTJkNTI1MTMxMjA3MjY2L3RhYmxlOjYwYjE5M2RiOTljYzQ2MmJiNTBmYTkxOGVlY2UyNmEyL3RhYmxlcmFuZ2U6NjBiMTkzZGI5OWNjNDYyYmI1MGZhOTE4ZWVjZTI2YTJfNC05LTEtMS0xNTQ0NjU_1d59d375-7892-47cb-9b4e-acaec0253fbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_1054"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xMDU0L2ZyYWc6MTE5MTliZmU2ZDU1NGY2YTgxNWEyMjExNTg0ZTY0ODMvdGV4dHJlZ2lvbjoxMTkxOWJmZTZkNTU0ZjZhODE1YTIyMTE1ODRlNjQ4M180OQ_18107c93-0441-4c1c-8ea6-2baf3acd46d0" continuedAt="i3e4bfaecf65e4f0293e3f1b763bb6e79" escape="true">Inventories</ix:nonNumeric></span></div><ix:continuation id="i3e4bfaecf65e4f0293e3f1b763bb6e79"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xMDU0L2ZyYWc6MTE5MTliZmU2ZDU1NGY2YTgxNWEyMjExNTg0ZTY0ODMvdGV4dHJlZ2lvbjoxMTkxOWJmZTZkNTU0ZjZhODE1YTIyMTE1ODRlNjQ4M181MA_1cf5de6e-c03e-4779-83f8-55e210ecf662" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following:</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.458%"><tr><td style="width:1.0%"></td><td style="width:44.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xMDU0L2ZyYWc6MTE5MTliZmU2ZDU1NGY2YTgxNWEyMjExNTg0ZTY0ODMvdGFibGU6MDA2OGY0NmYyYmVkNGYzZjliNDRjODFiYmFiZjU0MTgvdGFibGVyYW5nZTowMDY4ZjQ2ZjJiZWQ0ZjNmOWI0NGM4MWJiYWJmNTQxOF8yLTEtMS0xLTE2MDkyMw_4b690d96-c04a-434e-ad08-556651cf4dc5">58.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xMDU0L2ZyYWc6MTE5MTliZmU2ZDU1NGY2YTgxNWEyMjExNTg0ZTY0ODMvdGFibGU6MDA2OGY0NmYyYmVkNGYzZjliNDRjODFiYmFiZjU0MTgvdGFibGVyYW5nZTowMDY4ZjQ2ZjJiZWQ0ZjNmOWI0NGM4MWJiYWJmNTQxOF8yLTMtMS0xLTE2MDkyMw_373e8df1-a8bf-4fdf-a86e-0a09dba07a9d">38.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xMDU0L2ZyYWc6MTE5MTliZmU2ZDU1NGY2YTgxNWEyMjExNTg0ZTY0ODMvdGFibGU6MDA2OGY0NmYyYmVkNGYzZjliNDRjODFiYmFiZjU0MTgvdGFibGVyYW5nZTowMDY4ZjQ2ZjJiZWQ0ZjNmOWI0NGM4MWJiYWJmNTQxOF8zLTEtMS0xLTE2MDkyMw_32cb1a65-6fb0-4408-949f-12a78fb3d8bd">341.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xMDU0L2ZyYWc6MTE5MTliZmU2ZDU1NGY2YTgxNWEyMjExNTg0ZTY0ODMvdGFibGU6MDA2OGY0NmYyYmVkNGYzZjliNDRjODFiYmFiZjU0MTgvdGFibGVyYW5nZTowMDY4ZjQ2ZjJiZWQ0ZjNmOWI0NGM4MWJiYWJmNTQxOF8zLTMtMS0xLTE2MDkyMw_85367455-a468-40c6-8432-1b63f0a55a76">260.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xMDU0L2ZyYWc6MTE5MTliZmU2ZDU1NGY2YTgxNWEyMjExNTg0ZTY0ODMvdGFibGU6MDA2OGY0NmYyYmVkNGYzZjliNDRjODFiYmFiZjU0MTgvdGFibGVyYW5nZTowMDY4ZjQ2ZjJiZWQ0ZjNmOWI0NGM4MWJiYWJmNTQxOF80LTEtMS0xLTE2MDkyMw_6bf69580-cdd3-4519-8112-c170ce47b2b6">135.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xMDU0L2ZyYWc6MTE5MTliZmU2ZDU1NGY2YTgxNWEyMjExNTg0ZTY0ODMvdGFibGU6MDA2OGY0NmYyYmVkNGYzZjliNDRjODFiYmFiZjU0MTgvdGFibGVyYW5nZTowMDY4ZjQ2ZjJiZWQ0ZjNmOWI0NGM4MWJiYWJmNTQxOF80LTMtMS0xLTE2MDkyMw_4df6867a-62b0-426c-b81f-130c5efcdfcf">161.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xMDU0L2ZyYWc6MTE5MTliZmU2ZDU1NGY2YTgxNWEyMjExNTg0ZTY0ODMvdGFibGU6MDA2OGY0NmYyYmVkNGYzZjliNDRjODFiYmFiZjU0MTgvdGFibGVyYW5nZTowMDY4ZjQ2ZjJiZWQ0ZjNmOWI0NGM4MWJiYWJmNTQxOF81LTEtMS0xLTE2MDkyMw_4e4ae154-fc4a-486e-9009-5aa52c54e8a0">535.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl8xMDU0L2ZyYWc6MTE5MTliZmU2ZDU1NGY2YTgxNWEyMjExNTg0ZTY0ODMvdGFibGU6MDA2OGY0NmYyYmVkNGYzZjliNDRjODFiYmFiZjU0MTgvdGFibGVyYW5nZTowMDY4ZjQ2ZjJiZWQ0ZjNmOWI0NGM4MWJiYWJmNTQxOF81LTMtMS0xLTE2MDkyMw_e89bb4da-7530-4478-bd82-11ac2433c456">460.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_64"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">J.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RleHRyZWdpb246ZmFhOTM5ZmZjN2EyNGE5ODhkYmI0NzlhYmQxMGIwYzFfOTg3_c80cfcc6-2e95-4f5b-b509-90b516d4dc81" continuedAt="if7d31e0e35ec4a76b1e1ed8d9925e29a" escape="true">Stock-based Compensation Expense and Share Repurchase Programs</ix:nonNumeric></span></div><ix:continuation id="if7d31e0e35ec4a76b1e1ed8d9925e29a"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation expense </span></div><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RleHRyZWdpb246ZmFhOTM5ZmZjN2EyNGE5ODhkYmI0NzlhYmQxMGIwYzFfOTcz_6d9b84a4-4584-4677-aba2-44b5e6bea13c" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023 and 2022, we recognized the following stock-based compensation expense:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.482%"><tr><td style="width:1.0%"></td><td style="width:60.753%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense by type of award:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units (including PSUs)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36591897228a412aacb120f083844e93_D20230101-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfNC01LTEtMS0xNTQ0NjU_6f745c9b-7c75-4414-9c02-37cde9e68f36">115.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17adf051053446b88959a159709af08_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfNC03LTEtMS0xNTQ0NjU_40819b65-4409-443a-99f7-3c691c83b06b">118.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c84da8c391241e2910335bfe14620b5_D20230101-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfNS01LTEtMS0xNTQ0NjU_5ad98cc5-a4ae-460c-b427-36680a3710ad">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e510f4ce851440bbfd4b3bfdaa33205_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfNS03LTEtMS0xNTQ0NjU_30333705-d7c1-44b1-b721-cfa42fb2d160">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP share issuances</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656bb92a0277415cb8bbe0b9e56f15a2_D20230101-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfNi01LTEtMS0xNTQ0NjU_8ff8f708-6dbf-4585-86bc-9bba32ab0f24">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47188c6696d43f783a095257f822fa0_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfNi03LTEtMS0xNTQ0NjU_9bb5deab-98f6-4b15-81c3-0a9ec9c49bc7">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense related to inventories</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfNy01LTEtMS0xNTQ0NjU_1807c900-ee2a-4b74-80d2-d1dc04ee8059">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfNy03LTEtMS0xNTQ0NjU_e98d5871-33e1-4a20-a331-c3d07fe29a38">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense included in &#8220;Total costs and expenses&#8221;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfOC01LTEtMS0xNTQ0NjU_5605084e-cdcd-4df8-80ec-a359479d7a04">122.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfOC03LTEtMS0xNTQ0NjU_f8becc88-3ddf-4578-8f50-cae659a48bfb">130.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense by line item:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83507af2ac3a4a3fb6e00e4c990a3bd5_D20230101-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTEtNS0xLTEtMTU0NDY1_baf3c953-beb9-4ef8-98f1-a054b93f04fc">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4481d52a03e244f7af2ed89bfbea4ec5_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTEtNy0xLTEtMTU0NDY1_01c33214-b375-4c35-bab9-4a2e30866d61">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe64753d4f0d46208f21adb58f70f790_D20230101-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTItNS0xLTEtMTU0NDY1_6b480c2e-fade-4cd3-87aa-ec14a11820bd">76.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6357aba6e8814ca3b607e5e909aea6b2_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTItNy0xLTEtMTU0NDY1_361fd1a4-cc21-41bf-9791-fe1952572e21">80.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f75883c03934f8b9f0845d4876ded39_D20230101-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTMtNS0xLTEtMTU0NDY1_f923469b-7cd3-45f1-8493-e1a9ef0befd4">44.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4165b4e35c744a5ead585d77ab64ec81_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTMtNy0xLTEtMTU0NDY1_6a6705d7-461d-4eee-91ef-600b6608bc1b">47.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense included in costs and expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTQtNS0xLTEtMTU0NDY1_70640e21-c86d-46c4-931b-a3426fa260aa">122.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTQtNy0xLTEtMTU0NDY1_154aabae-8082-4bed-ad13-73147a4092c3">130.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax effect</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTUtNS0xLTEtMTU0NDY1_ffed168c-07f5-475e-88cb-a5747e299ae8">40.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTUtNy0xLTEtMTU0NDY1_18f89afd-0f4b-40fa-a9b6-7a274950a753">36.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTYtNS0xLTEtMTU0NDY1_bec59110-ea97-483c-92cc-1853c9ad2b28">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RhYmxlOjRiZTk0NmZmMTNmZjQxMDlhMWFiZDljNWM1MzU4MjJhL3RhYmxlcmFuZ2U6NGJlOTQ2ZmYxM2ZmNDEwOWExYWJkOWM1YzUzNTgyMmFfMTYtNy0xLTEtMTU0NDY1_b99717d6-a9e6-4bd8-8dfa-cb64b8774149">94.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share repurchase program</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, our Board of Directors approved a share repurchase program (our &#8220;Share Repurchase Program&#8221;), pursuant to which we are authorized to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i31e9bb0a22cd4e68b09b3fbafbd81752_I20230228" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RleHRyZWdpb246ZmFhOTM5ZmZjN2EyNGE5ODhkYmI0NzlhYmQxMGIwYzFfNTQ5NzU1ODE1Njg3_223a7b59-855f-4de1-90d8-e9ef09517b06">3.0</ix:nonFraction>&#160;billion of our common stock. Our Share Repurchase Program does not have an expiration date and can be discontinued at any time. During the three months ended March 31, 2023, we repurchased&#160;<ix:nonFraction unitRef="shares" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RleHRyZWdpb246ZmFhOTM5ZmZjN2EyNGE5ODhkYmI0NzlhYmQxMGIwYzFfMTY0OTI2NzQ0NDY5OQ_59c94e5f-8c79-43b9-aee9-788436501c31">459,017</ix:nonFraction> shares of our common stock under our Share Repurchase Program for an aggregate of $<ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RleHRyZWdpb246ZmFhOTM5ZmZjN2EyNGE5ODhkYmI0NzlhYmQxMGIwYzFfMTY0OTI2NzQ0NDczNw_3d3b1597-e35d-4d19-9ab6-6198488192d6">135.6</ix:nonFraction> million. As of March 31, 2023, a total of $<ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82NC9mcmFnOmZhYTkzOWZmYzdhMjRhOTg4ZGJiNDc5YWJkMTBiMGMxL3RleHRyZWdpb246ZmFhOTM5ZmZjN2EyNGE5ODhkYmI0NzlhYmQxMGIwYzFfMTY0OTI2NzQ0NDc1NQ_56149a96-9bb4-4555-9214-6902c1acaf31">2.9</ix:nonFraction> billion remained authorized for future repurchases.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_67"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">K.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.73pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82Ny9mcmFnOjU3ZjE5ZDhlZjc2NTQ3Yzg5YTRhZTRmMmMzNjk5NGQ4L3RleHRyZWdpb246NTdmMTlkOGVmNzY1NDdjODlhNGFlNGYyYzM2OTk0ZDhfMjEwMA_037812a2-4608-43dc-8c92-4b7e8ab5770f" continuedAt="iebd038b726644d22b31764b546728136" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="iebd038b726644d22b31764b546728136" continuedAt="i3a366d46518244788307867167589364"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to U.S. federal, state, and foreign income taxes. <ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82Ny9mcmFnOjU3ZjE5ZDhlZjc2NTQ3Yzg5YTRhZTRmMmMzNjk5NGQ4L3RleHRyZWdpb246NTdmMTlkOGVmNzY1NDdjODlhNGFlNGYyYzM2OTk0ZDhfMjEwNA_20a8223a-1bd2-4dbd-925e-0a5454001d57" continuedAt="ia6d43f59c8c44e0287b1c3c749660953" escape="true">During the three months ended March 31, 2023 and 2022, we recorded the following provisions for income taxes and effective tax rates as compared to our income before provision for income taxes:</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><ix:continuation id="ia6d43f59c8c44e0287b1c3c749660953"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.482%"><tr><td style="width:1.0%"></td><td style="width:60.753%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82Ny9mcmFnOjU3ZjE5ZDhlZjc2NTQ3Yzg5YTRhZTRmMmMzNjk5NGQ4L3RhYmxlOjFmNTJjN2I4NGNiZDRlZTFiMjQzZDg3NTk2NmI4YzNmL3RhYmxlcmFuZ2U6MWY1MmM3Yjg0Y2JkNGVlMWIyNDNkODc1OTY2YjhjM2ZfMy01LTEtMS0xNTQ0NjU_04b17641-6c8c-4f3b-8ace-c91da1a7d4ee">891.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82Ny9mcmFnOjU3ZjE5ZDhlZjc2NTQ3Yzg5YTRhZTRmMmMzNjk5NGQ4L3RhYmxlOjFmNTJjN2I4NGNiZDRlZTFiMjQzZDg3NTk2NmI4YzNmL3RhYmxlcmFuZ2U6MWY1MmM3Yjg0Y2JkNGVlMWIyNDNkODc1OTY2YjhjM2ZfMy03LTEtMS0xNTQ0NjU_3a3b68c3-43dd-458e-b9ef-d9b17edcc25a">954.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82Ny9mcmFnOjU3ZjE5ZDhlZjc2NTQ3Yzg5YTRhZTRmMmMzNjk5NGQ4L3RhYmxlOjFmNTJjN2I4NGNiZDRlZTFiMjQzZDg3NTk2NmI4YzNmL3RhYmxlcmFuZ2U6MWY1MmM3Yjg0Y2JkNGVlMWIyNDNkODc1OTY2YjhjM2ZfNC01LTEtMS0xNTQ0NjU_9ed09a96-2df9-4c3c-8154-e187365d1779">191.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82Ny9mcmFnOjU3ZjE5ZDhlZjc2NTQ3Yzg5YTRhZTRmMmMzNjk5NGQ4L3RhYmxlOjFmNTJjN2I4NGNiZDRlZTFiMjQzZDg3NTk2NmI4YzNmL3RhYmxlcmFuZ2U6MWY1MmM3Yjg0Y2JkNGVlMWIyNDNkODc1OTY2YjhjM2ZfNC03LTEtMS0xNTQ0NjU_f7c5e261-e07d-4367-9624-0aca4d87de84">192.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.482%"><tr><td style="width:1.0%"></td><td style="width:60.753%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective tax rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82Ny9mcmFnOjU3ZjE5ZDhlZjc2NTQ3Yzg5YTRhZTRmMmMzNjk5NGQ4L3RhYmxlOjhkZDgzNDNkNjU3NDRjYzhiODE0NDJjODlkMmFjMWY5L3RhYmxlcmFuZ2U6OGRkODM0M2Q2NTc0NGNjOGI4MTQ0MmM4OWQyYWMxZjlfMC01LTEtMS0xNTQ0NjU_d43222b3-687f-40d5-b496-dc124ab95382">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i958319be58924dda85ec929ff7eda4fb_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82Ny9mcmFnOjU3ZjE5ZDhlZjc2NTQ3Yzg5YTRhZTRmMmMzNjk5NGQ4L3RhYmxlOjhkZDgzNDNkNjU3NDRjYzhiODE0NDJjODlkMmFjMWY5L3RhYmxlcmFuZ2U6OGRkODM0M2Q2NTc0NGNjOGI4MTQ0MmM4OWQyYWMxZjlfMC03LTEtMS0xNTQ0NjU_d44292b7-0502-4c93-9859-a2130dd9564e">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three months ended March 31, 2023 was higher than the U.S. statutory rate primarily due to an increase in our unrecognized tax benefits partially offset by excess tax benefits related to stock-based compensation. Our effective tax rate for the three months ended March 31, 2022 was lower than the U.S. statutory rate primarily due to excess tax benefits related to stock-based compensation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed the tax positions taken, or to be taken, in our tax returns for all tax years currently open to examination by a taxing authority. As of March 31, 2023 and December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82Ny9mcmFnOjU3ZjE5ZDhlZjc2NTQ3Yzg5YTRhZTRmMmMzNjk5NGQ4L3RleHRyZWdpb246NTdmMTlkOGVmNzY1NDdjODlhNGFlNGYyYzM2OTk0ZDhfODUw_a3195854-cbb6-46ae-9420-3bec8214882b">232.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl82Ny9mcmFnOjU3ZjE5ZDhlZjc2NTQ3Yzg5YTRhZTRmMmMzNjk5NGQ4L3RleHRyZWdpb246NTdmMTlkOGVmNzY1NDdjODlhNGFlNGYyYzM2OTk0ZDhfODU3_2259265b-3ec0-435c-87c0-05ccd156bc23">208.5</ix:nonFraction> million, respectively, of net unrecognized tax benefits, which would affect our tax rate if recognized.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3a366d46518244788307867167589364">We file U.S. federal income tax returns and income tax returns in various state, local and foreign jurisdictions. We have various income tax audits ongoing at any time throughout the world. Except for jurisdictions where we have net operating losses or tax credit carryforwards, we are no longer subject to any tax assessment from tax authorities for years prior to 2014 in jurisdictions that have a material impact on our consolidated financial statements.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_70"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">L.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.84pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfNTg5OA_9278dc3e-6507-476a-bfd5-e9f67b0a4838" continuedAt="i4698e67314754897b76b5f77252824ca" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i4698e67314754897b76b5f77252824ca" continuedAt="ia8e89b79154b413aba04a2cec205c02d"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Credit Facility</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, Vertex and certain of its subsidiaries entered into a $<ix:nonFraction unitRef="usd" contextRef="i1dd8aa202cc44acba501ace4f542abbe_I20220731" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfOTg_866a3cd0-9efb-42cd-bd43-b0cf7c074648">500.0</ix:nonFraction> million unsecured revolving facility (the &#8220;Credit Agreement&#8221;) with Bank of America, N.A., as administrative agent and the lenders referred to therein (the &#8220;Lenders&#8221;), which matures on July 1, 2027. The Credit Agreement was not drawn upon at closing and we have not drawn upon it to date. Amounts drawn pursuant to the Credit Agreement, if any, will be used for general corporate purposes. Subject to satisfaction of certain conditions, we may request that the borrowing capacity for the Credit Agreement be increased by an additional $<ix:nonFraction unitRef="usd" contextRef="i1dd8aa202cc44acba501ace4f542abbe_I20220731" decimals="INF" name="vrtx:LineOfCreditFacilityAdditionalBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfNjI3_d700cde6-6ced-436e-b512-9af22715edb2">500.0</ix:nonFraction> million. Additionally, the Credit Agreement provides a sublimit of $<ix:nonFraction unitRef="usd" contextRef="i449ced1d194f43f2af675a42b7885c1e_I20220731" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfNjg5_18284c11-579a-468b-bec8-f52d7ef3f929">100.0</ix:nonFraction> million for letters of credit.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any amounts borrowed under the Credit Agreement will bear interest, at our option, at either a base rate or a Secured Overnight Financing Rate (&#8220;SOFR&#8221;), in each case plus an applicable margin. Under the Credit Agreement, the applicable margins on base rate loans range from <ix:nonFraction unitRef="number" contextRef="i31bb714a138e462eba7e3bb4db8bd563_D20220701-20220731" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfOTU3_7f978f34-7274-485e-8137-1716467acbc3">0.000</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i43c2fa6156f84d49b34f2bb5ed60c77c_D20220701-20220731" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfOTYz_e1e6bba3-4152-4b6d-a0fd-0ac9a1977063">0.500</ix:nonFraction>% and the applicable margins on SOFR loans range from <ix:nonFraction unitRef="number" contextRef="i3eba170c9dc9498eaead0dc958583ae7_D20220701-20220731" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfMTAxOA_4d8eb8d7-536a-4e53-868c-5a4e959d7066">1.000</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="icb3213a8e90a40d188b46faeb6d69bea_D20220701-20220731" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfMTAyNA_16f0f1ff-d982-424a-b8ae-bbd2a8af87e5">1.500</ix:nonFraction>%, in each case based on our consolidated leverage ratio (the ratio of our total consolidated funded indebtedness to our consolidated EBITDA for the most recently completed four fiscal quarter period). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any amounts borrowed pursuant to the Credit Agreement are guaranteed by certain of our existing and future domestic subsidiaries, subject to certain exceptions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary representations and warranties and affirmative and negative covenants, including a financial covenant to maintain subject to certain limited exceptions, a consolidated leverage ratio of <ix:nonFraction unitRef="number" contextRef="if290886dd10b49529443a59282d6069d_D20220701-20220731" decimals="INF" name="vrtx:DebtCovenantConsolidatedLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfMTYxNg_957ef10e-8c9e-4e69-af6b-6afee6ff9146">3.50</ix:nonFraction> to 1.00, subject to an increase to <ix:nonFraction unitRef="number" contextRef="if290886dd10b49529443a59282d6069d_D20220701-20220731" decimals="INF" name="vrtx:DebtCovenantIncreaseInConsolidatedLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfMTY1Mg_9b4d8f7e-114b-48ed-9407-5273270a6279">4.00</ix:nonFraction> to 1.00 following a material acquisition. As of March 31, 2023, we were in compliance with the covenants described above. The Credit Agreement also contains customary events of default. In the case of a continuing event of default, the administrative agent would be entitled to exercise various remedies, including the acceleration of amounts due under outstanding loans.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct costs related to the Credit Agreement are recorded over its term and were not material to our financial statements. </span></div></ix:continuation><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VERTEX PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div></div><ix:continuation id="ia8e89b79154b413aba04a2cec205c02d"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guaranties and Indemnifications</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted under Massachusetts law, our Articles of Organization and By-laws provide that we will indemnify certain of our officers and directors for certain claims asserted against them in connection with their service as an officer or director. The maximum potential amount of future payments that we could be required to make under these indemnification provisions is unlimited. However, we have purchased directors&#8217; and officers&#8217; liability insurance policies that could reduce our monetary exposure and enable us to recover a portion of any future amounts paid. <ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="INF" name="vrtx:IndemnificationClaims" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfMjk5Nw_acba2c97-ef96-45a2-b1e2-35ceb493d685">No</ix:nonFraction> indemnification claims currently are outstanding, and we believe the estimated fair value of these indemnification arrangements is minimal.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We customarily agree in the ordinary course of our business to indemnification provisions in agreements with clinical trial investigators and sites in our product development programs, sponsored research agreements with academic and not-for-profit institutions, various comparable agreements involving parties performing services for us, and our real estate leases. We also customarily agree to certain indemnification provisions in our drug discovery, development and commercialization collaboration agreements. With respect to our clinical trials and sponsored research agreements, these indemnification provisions typically apply to any claim asserted against the investigator or the investigator&#8217;s institution relating to personal injury or property damage, violations of law or certain breaches of our contractual obligations arising out of the research or clinical testing of our compounds or product candidates. With respect to lease agreements, the indemnification provisions typically apply to claims asserted against the landlord relating to personal injury or property damage caused by us, to violations of law by us or to certain breaches of our contractual obligations. The indemnification provisions appearing in our collaboration agreements are similar to those for the other agreements discussed above, but in addition provide some limited indemnification for our collaborator in the event of third-party claims alleging infringement of intellectual property rights. In each of the cases above, the indemnification obligation generally survives the termination of the agreement for some extended period, although we believe the obligation typically has the most relevance during the contract term and for a short period of time thereafter. The maximum potential amount of future payments that we could be required to make under these provisions is generally unlimited. We have purchased insurance policies covering personal injury, property damage and general liability that reduce our exposure for indemnification and would enable us in many cases to recover all or a portion of any future amounts paid. We have never paid any material amounts to defend lawsuits or settle claims related to these indemnification provisions. Accordingly, we believe the estimated fair value of these indemnification arrangements is minimal.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain contingent liabilities that arise in the ordinary course of our business activities. We accrue for such contingent liabilities when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. Other than our contingent consideration liabilities discussed in Note E, &#8220;Fair Value Measurements,&#8221; there were <ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="vrtx:ContingentLiabilities" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfNTgzOA_1a9a6f31-5fad-40af-ad5d-fb8956e02188"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="vrtx:ContingentLiabilities" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83MC9mcmFnOjAxZDQwMzEyNDRhMTQwYjM4YTBlMmYzOWViYmFiZGIzL3RleHRyZWdpb246MDFkNDAzMTI0NGExNDBiMzhhMGUyZjM5ZWJiYWJkYjNfNTgzOA_8dc6d7bb-4269-48c4-a9bc-7faa357d249e">no</ix:nonFraction></ix:nonFraction> material contingent liabilities accrued as of March 31, 2023 or December&#160;31, 2022.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_73"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">M.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.07pt"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RleHRyZWdpb246NjYyZjA4YTA1MjdlNDBhY2I0N2EwOTlkYWM2OTc0ODVfMTkz_2bf47bf9-ec0b-4f3a-a9bf-f9335665ae94" continuedAt="i64c66056d6a04d9992505096e784625f" escape="true">Additional Cash Flow Information</ix:nonNumeric></span></div><ix:continuation id="i64c66056d6a04d9992505096e784625f"><ix:nonNumeric contextRef="i92c3c9bfd59749f283eff9b369a6a244_D20230101-20230331" name="srt:ScheduleOfCondensedCashFlowStatementTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RleHRyZWdpb246NjYyZjA4YTA1MjdlNDBhY2I0N2EwOTlkYWM2OTc0ODVfMTk1_dcb2e466-f0c9-48b7-8696-0e7fe25a375b" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash, cash equivalents and restricted cash at the beginning and ending of each period presented in our condensed consolidated statements of cash flows consisted of the following:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.809%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning of period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">End of period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning of period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">End of period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNC0xLTEtMS0xNTQ0NjU_34291cf4-6316-4af0-aa67-6630fd9dedf4">10,504.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNC0zLTEtMS0xNTQ0NjU_ca1747a8-45a6-4182-b002-b40874072f72">9,289.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ed48e03e6e4037bf3e89fb85ccd323_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNC01LTEtMS0xNTQ0NjU_b8ece38f-79e7-4449-b248-cbd3c3121062">6,795.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1af14e7def84e3590f8cdcf9d63aa32_I20220331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNC03LTEtMS0xNTQ0NjU_e936749d-3838-4008-bdc9-012adf903162">7,600.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNS0xLTEtMS0xNTQ0NjU_3fc8f538-030d-4438-9bb4-59af6b2b674e">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNS0zLTEtMS0xNTQ0NjU_b15a7782-fea6-4a76-b4de-38b9281d8025">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ed48e03e6e4037bf3e89fb85ccd323_I20211231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNS01LTEtMS0xNTQ0NjU_180db40e-f76d-4372-a804-a039d308983d">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1af14e7def84e3590f8cdcf9d63aa32_I20220331" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNS03LTEtMS0xNTQ0NjU_ddf1a078-14a0-47b7-a106-1d8d0b6e1c48">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash per condensed consolidated statement of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108d7bd86abe4e58838391cedbbc7af4_I20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNy0xLTEtMS0xNTQ0NjU_88c936af-a117-48db-9d0a-b449e328adf4">10,512.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184cf5afd6cd4fa685060fb920896ba9_I20230331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNy0zLTEtMS0xNTQ0NjU_feab7007-f868-4b02-806c-acac4e54671c">9,295.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ed48e03e6e4037bf3e89fb85ccd323_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNy01LTEtMS0xNTQ0NjU_b348da65-f26b-4be0-902f-c7d564a2e6b3">6,800.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1af14e7def84e3590f8cdcf9d63aa32_I20220331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMxMDhjZTFhYzYyZTQzYjNiMGZkNjg2OWI5NjI3YjFmL3NlYzpjMTA4Y2UxYWM2MmU0M2IzYjBmZDY4NjliOTYyN2IxZl83My9mcmFnOjY2MmYwOGEwNTI3ZTQwYWNiNDdhMDk5ZGFjNjk3NDg1L3RhYmxlOjc3OTM0YjIxMjczNzQwMTJhMzkxMjRmMzkzMDExM2Y2L3RhYmxlcmFuZ2U6Nzc5MzRiMjEyNzM3NDAxMmEzOTEyNGYzOTMwMTEzZjZfNy03LTEtMS0xNTQ0NjU_b513eb06-164a-4e1d-87f2-bfd308c8904c">7,604.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_76"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. We have four approved medicines that treat the underlying cause of cystic fibrosis (&#8220;CF&#8221;), a life-threatening genetic disease, and we continue to focus on developing additional treatments for CF. Beyond CF, we have a pipeline that includes mid- and late-stage clinical programs in sickle cell disease, beta thalassemia, acute and neuropathic pain, APOL1-mediated kidney disease, type 1 diabetes, and alpha-1 antitrypsin deficiency, and earlier-stage programs in diseases such as muscular dystrophies. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our triple combination regimen, TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), was approved in 2019 in the United States (&#8220;U.S.&#8221;) and in 2020 in the European Union (&#8220;E.U.&#8221;). Collectively, our four medicines are being used to treat more than two-thirds of the approximately 88,000 people with CF in North America, Europe, and Australia. We are evaluating our medicines in additional patient populations, including younger children, with the goal of having small molecule treatments for all people who have at least one mutation in their cystic fibrosis transmembrane conductance regulator (&#8220;CFTR&#8221;) gene that is responsive to our CFTR modulators. We also are pursuing messenger ribonucleic acid (&#8220;mRNA&#8221;) and genetic therapies for people with CF who do not make CFTR protein and, as a result, cannot benefit from our current CF medicines.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are preparing for near-term launches of potential new products in sickle cell disease (&#8220;SCD&#8221;), beta thalassemia, CF and acute pain. We recently completed regulatory submissions in the U.S., E.U. and the United Kingdom (&#8220;U.K.&#8221;) for exagamglogene autotemcel (&#8220;exa-cel&#8221;) for the treatment of SCD and transfusion-dependent beta thalassemia (&#8220;TDT&#8221;). </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Highlights</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, our net product revenues increased to $2.4 billion as compared to $2.1 billion in the first quarter of 2022 primarily due to the strong uptake of TRIKAFTA/KAFTRIO in multiple countries internationally and continued performance of TRIKAFTA in the U.S.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total research and development (&#8220;R&amp;D&#8221;), acquired in-process research and development (&#8220;AIPR&amp;D&#8221;), and selling, general and administrative (&#8220;SG&amp;A&#8221;) expenses increased to $1.3 billion in the first quarter of 2023 as compared to $818.3 million in the first quarter of 2022. The increase was primarily due to increased AIPR&amp;D and the progression of several product candidates in mid- to late-stage clinical development. Cost of sales was 11% and 12% of our net product revenues in the first quarter of 2023 and 2022, respectively.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total cash, cash equivalents and marketable securities increased to $11.5 billion as of March 31, 2023 as compared to $10.9 billion as of December&#160;31, 2022 primarily due to our net product revenues and operating cash flows partially offset by our upfront payments to Entrada Therapeutics, Inc. (&#8220;Entrada&#8221;) and CRISPR Therapeutics AG (&#8220;CRISPR&#8221;), and repurchases of our common stock.</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><img src="vrtx-20230331_g1.gif" alt="MDA chart.gif" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:672px"/></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Updates</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketed Products</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to grow our CF business with (i) continued uptake by patients in countries where we are early in our launch, such as those with recently achieved reimbursement agreements, (ii) label expansions, including into younger patient groups, (iii) the development of mRNA therapies for people with CF who are not eligible for our approved CFTR modulators, and (iv) growth in the number of people living with CF. Recent progress in activities supporting continued uptake and label expansions is included below.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved TRIKAFTA in children with CF 2 to 5 years of age with at least one F508del mutation in the CFTR gene or a mutation in the CFTR gene that is responsive to TRIKAFTA. We have completed regulatory submissions with the European Medicines Agency (&#8220;EMA&#8221;), the Medicines and Healthcare products Regulatory Agency (&#8220;MHRA&#8221;) in the U.K., Health Canada, and the Therapeutic Goods Administration in Australia for the use of KAFTRIO/TRIKAFTA in children with CF 2 to 5 years of age. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We received a positive opinion from the EMA Committee for Medicinal Products for Human Use for the use of ORKAMBI in children with CF 1 year to less than 2 years of age with two copies of the F508del mutation in the CFTR gene.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have submitted a supplemental new drug application to the FDA and marketing authorization applications (&#8220;MAAs&#8221;) to the EMA, MHRA, and Health Canada for the use of KALYDECO in children with CF from 1 month to less than 4 months of age. KALYDECO has been granted Priority Review designation in the U.S. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TRIKAFTA/KAFTRIO is approved and reimbursed or accessible in more than 30 countries outside the U.S.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Potential Near-Term Launch Opportunities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are preparing for the following near-term launches of potential new products: </span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exa-cel in SCD and TDT</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We recently completed rolling submissions of our biologics licensing applications (&#8220;BLAs&#8221;) for exa-cel in the U.S. Exa-cel has been granted Fast Track, Regenerative Medicine Advanced Therapy, Orphan Drug and Rare Pediatric Disease designations in the U.S.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the fourth quarter of 2022, we completed submissions for exa-cel with the EMA and MHRA in the E.U. and U.K., respectively. The EMA and MHRA have validated the MAAs, and exa-cel has been granted Priority Medicines and Orphan Drug designations in the E.U. In the U.K., exa-cel has been granted an Innovation Passport under the Innovative Licensing and Access Pathway from the MHRA.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vanzacaftor/tezacaftor/deutivacaftor in CF</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the fourth quarter of 2022, we completed enrollment in the pivotal SKYLINE 102 and SKYLINE 103 clinical trials, which evaluate the efficacy and safety of our new once-daily investigational triple combination vanzacaftor/tezacaftor/deutivacaftor relative to TRIKAFTA in people with CF 12 years of age and older. We expect to complete these clinical trials by the end of 2023. In parallel, we have initiated a study of vanzacaftor/tezacaftor/deutivacaftor </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in children with CF 6 to 11 years of age, known as the RIDGELINE clinical trial, and we expect to complete this clinical trial by the end of 2023. </span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">VX-548 in Acute Pain</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We continue to enroll the Phase 3 pivotal program for our lead compound, VX-548, for the treatment of moderate to severe acute pain, and we expect to complete the pivotal program in late 2023 or early 2024. VX-548 has been granted Breakthrough Therapy and Fast Track designations in the U.S. for moderate to severe acute pain.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pipeline</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to advance a pipeline of potentially transformative small molecule, mRNA, and cell and genetic therapies aimed at treating serious diseases. Recent and anticipated progress in activities supporting these efforts is included below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cystic Fibrosis</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In collaboration with Moderna, we are developing VX-522, a CFTR mRNA therapeutic for the treatment of people with CF who do not produce any CFTR protein. We have initiated a single-ascending dose clinical trial for VX-522 in people with CF, which is active and enrolling patients. We expect to complete this single-ascending dose clinical trial and initiate a multiple-ascending dose clinical trial in 2023. The FDA has granted Fast Track designation for VX-522.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beta Thalassemia and Sickle Cell Disease</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are evaluating the use of exa-cel, a non-viral </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CRISPR gene-editing therapy, for the treatment of SCD and TDT.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dosing in the Phase 3 CLIMB-111 and CLIMB 121 clinical trials evaluating exa-cel continues, as does the CLIMB 131 long-term follow-up clinical trial in patients 12 years of age and older. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Two additional Phase 3 clinical trials evaluating exa-cel in children with SCD or TDT 5 to 11 years of age are ongoing. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Neuropathic Pain</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have discovered multiple selective small molecule inhibitors of NaV1.8, with the objective of creating a new class of pain medicines that provide effective non-opioid pain relief, without abuse potential.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We continue to enroll and dose patients in a Phase 2 dose-ranging clinical trial evaluating VX-548 in diabetic peripheral neuropathy, a common form of chronic peripheral neuropathic pain. We expect to complete this clinical trial in late 2023 or early 2024.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">APOL1-Mediated Kidney Disease</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inaxaplin is our small molecule for the treatment of APOL1-mediated kidney disease (&#8220;AMKD&#8221;), including APOL1-mediated focal segmental glomerulosclerosis (&#8220;FSGS&#8221;). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to enroll and dose patients in the pivotal program for inaxaplin, a single Phase 2/3 clinical trial, and we expect to complete the Phase 2B dose-ranging portion of the trial in 2023.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The FDA granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inaxaplin Breakthrough Therapy designation for APOL1-mediated FSGS and the EMA granted inaxaplin Orphan Drug and PRIME designations for AMKD. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Type 1 Diabetes</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">VX-880 is a stem cell-derived, fully differentiated, insulin-producing islet cell replacement therapy, using standard immunosuppression to protect the implanted cells. A clinical trial is ongoing to evaluate VX-880 as a potential treatment for type 1 diabetes (&#8220;T1D&#8221;), and proof-of-concept has been achieved. We have completed enrollment and dosing in Part B of the Phase 1/2 clinical trial and we expect to begin Part C of the trial with concurrent dosing. The EMA granted VX-880 PRIME designation. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We continue to advance additional programs in T1D, in which these same stem cell-derived, fully differentiated, insulin-producing islet cells are encapsulated and implanted in an immunoprotective device or are modified to produce hypoimmune cells with the goal of eliminating the need for immunosuppression. The Investigational New Drug Application in the U.S., and the Clinical Trial Application (&#8220;CTA&#8221;) in Canada for VX-264, the cells and device program, have been cleared, and we plan to begin enrollment and dosing in a Phase 1/2 clinical trial in the near term. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our hypoimmune cell research program continues to progress.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A Phase 1/2 clinical trial evaluating VCTX-211, a hypoimmune cell program using ViaCyte cells that originated under the CRISPR and ViaCyte collaboration, is active and enrolling patients.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Alpha-1 Antitrypsin Deficiency</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are working to address the underlying genetic cause of alpha-1 antitrypsin (&#8220;AAT&#8221;) deficiency (&#8220;AATD&#8221;). We are developing novel small molecule correctors of Z-AAT protein folding, with the goal of enabling the secretion of functional AAT into the blood and addressing both the lung and the liver aspects of AATD. We continue to enroll and dose healthy volunteers in a Phase 1 clinical trial for VX-634, which is the first in a series of next-wave investigational molecules with significantly improved potency and drug-like properties as compared to our previous AAT correctors. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We initiated a second Phase 2 clinical trial of VX-864, a first-generation AAT corrector, to assess the impact of longer-term treatment on the liver, as well as the levels of functional AAT in the plasma. This Phase 2 clinical trial continues to enroll and dose patients. </span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Earlier Stage R&amp;D Programs </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with our overall strategy, we are taking a portfolio approach to all of our programs, with additional assets in CF, SCD, TDT, pain, AMKD, T1D and AATD in earlier stages of development. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also advancing preclinical assets in new disease areas, such as DMD and myotonic dystrophy type 1 (&#8220;DM1&#8221;). Additionally, we are working on preclinical molecules with the potential to expand our leadership in existing disease areas, including assets targeting gentler conditioning for exa-cel and NaV1.7 inhibitors in pain.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in External Innovation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent investments in external innovation are included below:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We announced a new licensing agreement for the use of CRISPR&#8217;s gene-editing technology, known as CRISPR/Cas9, to accelerate the development of our hypoimmune cell therapies for T1D. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We closed our previously announced strategic collaboration and licensing agreement with Entrada Therapeutics, Inc. (&#8220;Entrada&#8221;), focused on discovering and developing intracellular Endosomal Escape Vehicle (&#8220;EEV&#8221;) therapeutics for DM1.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Business Environment</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net product revenues come from the sale of our medicines for the treatment of CF. Our CF strategy involves continuing to develop and obtain approval and reimbursement for treatment regimens that will provide benefits to all people with CF and increasing the number of people with CF eligible and able to receive our medicines, including through label expansions, expanded reimbursement, and the development of new medicines. We are advancing our pipeline of product candidates for the treatment of serious diseases outside of CF. Our strategy is to combine transformative advances in the understanding of causal human biology and the science of therapeutics to discover and develop innovative medicines. This approach includes advancing multiple compounds from each program, spanning multiple modalities, into early clinical trials to obtain patient data that can inform selection of the most promising compounds for later-stage development, and to inform discovery and development of additional compounds. We aim to rapidly follow our first-in-class therapies that achieve proof-of-concept with potential best-in-class candidates to provide durable clinical and commercial success.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In pursuit of new product candidates and therapies in specialty markets, we invest in research and development. We believe that pursuing research in diverse areas allows us to balance the risks inherent in product development and may provide product candidates that will form our pipeline in future years. To supplement our internal research programs, we acquire technologies and programs and collaborate with biopharmaceutical and technology companies, leading academic research institutions, government laboratories, foundations and other organizations, as needed, to advance research in our areas of therapeutic interest and to access technologies needed to execute on our strategy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discovery and development of a new pharmaceutical or biological product is a difficult and lengthy process that requires significant financial resources along with extensive technical and regulatory expertise. Across the industry, most potential drug or biological products never progress into development, and most products that do advance into development never </span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receive marketing approval. Our investments in product candidates are subject to considerable risks. We closely monitor the results of our discovery, research, clinical trials and nonclinical studies and frequently evaluate our product development programs in light of new data and scientific, business and commercial insights, with the objective of balancing risk and potential. This process can result in rapid changes in focus and priorities as new information becomes available and as we gain additional understanding of our ongoing programs and potential new programs, as well as those of our competitors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business also requires ensuring appropriate manufacturing and reimbursement of our products. As we advance our product candidates through clinical development toward commercialization and market and sell our approved products, we build and maintain our supply chain and quality assurance resources. We rely on a global network of third parties and our internal capabilities to manufacture and distribute our products for commercial sale and post-approval clinical trials and to manufacture and distribute our product candidates for clinical trials. In addition to establishing supply chains for each new approved product, we adapt our supply chain for existing products to include additional formulations or to increase scale of production for existing products as needed. The processes for cell and genetic therapies can be more complex than those required for small molecule drugs and require additional investments in different systems, equipment, facilities and expertise. We are focused on ensuring the stability of the supply chains for our current products, as well as for our pipeline programs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of our products depend, to a large degree, on the extent to which our products are reimbursed by third-party payors, such as government health programs, commercial insurance and managed health care organizations. Reimbursement for our products, including our potential pipeline therapies, cannot be assured and may take significant periods of time to obtain. We dedicate substantial management and other resources to obtain and maintain appropriate levels of reimbursement for our products from third-party payors, including governmental organizations in the U.S. and ex-U.S. markets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., we have worked successfully with third-party payors to promptly obtain appropriate levels of reimbursement for our CF medicines. We plan to continue to engage in discussions with numerous commercial insurers and managed health care organizations, along with government health programs that are typically managed by authorities in the individual states, to ensure that payors recognize the significant benefits that our medicines provide and provide patients with appropriate levels of access to our medicines now and in the future. We cannot, however, predict how recent changes in the law, including through the Inflation Reduction Act of 2022, will affect our ability to negotiate successfully with third-party payors in the future. In ex-U.S. markets, we seek government reimbursement for our medicines on a country-by-country or region-by-region basis, as required. This is necessary for each new medicine, as well as for label expansions for our current medicines. We expect to continue to focus significant resources to obtain expanded reimbursement for our CF medicines and, ultimately, pipeline therapies, in U.S. and ex-U.S. markets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our business strategy, we seek to acquire technologies, products, product candidates and other businesses that are aligned with our corporate and research and development strategies and complement and advance our ongoing research and development efforts. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, we acquired Catalyst Biosciences, Inc.&#8217;s, or Catalyst&#8217;s, portfolio of protease medicines that target the complement system and related intellectual property for $60.0 million. In the third quarter of 2022, we acquired ViaCyte, a privately held biotechnology company with intellectual property, tools, technologies and assets with potential to accelerate development of our T1D programs, for $315.0 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to identify and evaluate potential acquisitions and may include larger transactions or later-stage assets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaboration and In-Licensing Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into arrangements with third parties, including collaboration and licensing arrangements, for the development, manufacture and commercialization of products, product candidates and other technologies that have the potential to complement our ongoing research and development efforts. Over the last several years, we entered into collaboration agreements with a number of companies, including Arbor Biotechnologies, Inc., CRISPR, Entrada, ImmunoGen, Inc., Kymera Therapeutics, Inc., Mammoth Biosciences, Inc., Moderna, Inc., Obsidian Therapeutics, Inc., and Verve Therapeutics, Inc. Generally, when we in-license a technology or product candidate, we make upfront payments to the collaborator, assume the costs of the program and/or agree to make contingent payments, which could consist of milestone, royalty and option </span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments. Most of these collaboration payments are expensed as AIPR&amp;D; however, depending on many factors, including the structure of the collaboration, the stage of development of the acquired technology, the significance of the in-licensed product candidate to the collaborator&#8217;s operations and the other activities in which our collaborators are engaged, the accounting for these transactions can vary significantly. We expect to continue to identify and evaluate collaboration and licensing opportunities that may be similar to or different from the collaborations and licenses that we have engaged in previously.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, we closed our strategic collaboration and licensing agreement with Entrada. Upon closing, we made an upfront payment of $225.1 million to Entrada, and purchased $24.9 million of Entrada&#8217;s common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, we entered into a non-exclusive license agreement for the use of CRISPR&#8217;s CRISPR-Cas9 gene-editing technology to accelerate the development of our hypoimmune cell therapies for T1D, and made a $100.0 million upfront payment to CRISPR.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquired In-Process Research and Development Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023 and 2022, our AIPR&amp;D included $347.1 million, which primarily related to our upfront payments to Entrada and CRISPR, and $2.0 million, respectively, related to upfront, contingent milestone, or other payments pursuant to our business development transactions, including the collaborations, licenses of third-party technologies, and asset acquisitions described above.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Out-License Agreements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have out-licensed internally developed programs to collaborators who are leading the development of these programs. Pursuant to these out-licensing arrangements, our collaborators are responsible for the research, development, and commercialization costs associated with these programs, and we are entitled to receive contingent milestone and/or royalty payments. As a result, we do not expect to incur significant expenses in connection with these programs and have the potential for future collaborative and royalty revenues resulting from these programs. None of our out-license agreements had a significant impact on our condensed consolidated statement of income during the first quarter of 2023 and 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Equity Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our business development activities, we have periodically made equity investments in our collaborators. As of March 31, 2023, we held strategic equity investments in certain public and private companies, and we expect to make additional strategic equity investments in the future. We invest the majority of our cash, cash equivalents and marketable securities in instruments that meet specific credit quality standards and limit our exposure to any one issue or type of instrument. Our strategic equity investments are maintained and managed separately from our other cash, cash equivalents and marketable securities. As discussed below in &#8220;Other Income (Expense), Net&#8221; in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, any changes in the fair value of equity investments with readily determinable fair values (including publicly traded securities) are recorded to other income (expense), net in our condensed consolidated statement of income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_79"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:47.705%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages and per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenues, net</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,374.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs and expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income (expense), net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per diluted common share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares used in per share calculations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">** Not meaningful</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues, net</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:47.705%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRIKAFTA/KAFTRIO</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,096.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,761.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KALYDECO</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ORKAMBI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SYMDEKO/SYMKEVI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenues, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,374.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, our net product revenues increased by $277.3&#160;million, or 13%, as compared to the first quarter of 2022, primarily due to the strong uptake of TRIKAFTA/KAFTRIO in multiple countries internationally and the continued performance of TRIKAFTA in the U.S. Decreases in revenues for our products other than TRIKAFTA/KAFTRIO were primarily the result of patients switching from these medicines to TRIKAFTA/KAFTRIO.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net product revenues from the U.S. and from ex-U.S. markets were as follows:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:47.629%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ex-U.S.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenues, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,374.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr></table></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs and Expenses</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:47.705%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:1pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">** Not meaningful</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Sales</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cost of sales primarily consists of third-party royalties payable on net sales of our products as well as the cost of producing inventories. Pursuant to our agreement with the Cystic Fibrosis Foundation our tiered third-party royalties on sales of TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI, KALYDECO, and ORKAMBI, calculated as a percentage of net sales, range from the single digits to the sub-teens, with royalties on sales of TRIKAFTA/KAFTRIO lower than for our other products. Over the last several years, our cost of sales has been increasing due to increased net product revenues. Our cost of sales as a percentage of our net product revenues was 11% and 12% in the first quarter of 2023 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:47.705%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses include internal and external costs incurred for research and development of our products and product candidates. We do not assign our internal costs, such as salary and benefits, stock-based compensation expense, laboratory supplies and other direct expenses and infrastructure costs, to individual products or product candidates, because the employees within our research and development groups typically are deployed across multiple research and development programs. We assign external costs of services provided to us by clinical research organizations and other outsourced research by individual program. Our internal costs are significantly greater than our external costs. All research and development costs for our products and product candidates are expensed as incurred.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 2021, we have incurred approximately $6.8 billion in total research and development and AIPR&amp;D expenses associated with product discovery and development. The successful development of our product candidates is highly uncertain and subject to a number of risks. In addition, the duration of clinical trials may vary substantially according to the type, complexity and novelty of the product candidate and the disease indication being targeted. The FDA and comparable agencies in foreign countries impose substantial requirements on the introduction of therapeutic pharmaceutical products, typically requiring lengthy and detailed laboratory and clinical testing procedures, sampling activities and other costly and time-consuming procedures. Data obtained from nonclinical and clinical activities at any step in the testing process may be adverse and lead to discontinuation or redirection of development activities. Data obtained from these activities also are susceptible to varying interpretations, which could delay, limit or prevent regulatory approval. The duration and cost of discovery, nonclinical studies and clinical trials may vary significantly over the life of a project and are difficult to predict. Therefore, accurate and meaningful estimates of the ultimate costs to bring our product candidates to market are not available.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any estimates regarding development and regulatory timelines for our product candidates are highly subjective and subject to change. Until we have data from Phase 3 clinical trials, we cannot make a meaningful estimate regarding when, or if, a clinical development program will generate revenues and cash flows.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research Expenses</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:47.629%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research Expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salary and benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced services and other direct expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infrastructure costs</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:24pt;text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research expenses have been increasing over the last several years as we have invested in our pipeline and expanded our cell and genetic therapy capabilities, resulting in increased headcount, outside services and other direct expenses and infrastructure costs associated with our research facilities. We expect to continue to invest in our research programs with a focus on creating transformative medicines for serious diseases.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Development Expenses</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:47.705%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development Expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salary and benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced services and other direct expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infrastructure costs</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total development expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our development expenses increased by $118.5&#160;million, or 26%, in the first quarter of 2023 as compared to the first quarter of 2022, primarily due to increased costs to support clinical trials associated with our advancing pipeline programs, including pain, our CF triple combination of vanzacaftor/tezacaftor/deutivacaftor, exa-cel and T1D. We are significantly investing in internal headcount, leveraging outsourced services, and investing in infrastructure to support these programs.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquired In-process Research and Development Expenses</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:47.778%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">** Not meaningful</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AIPR&amp;D in the first quarter of 2023 was primarily related to our upfront payments of $225.1 million to Entrada and $100.0 million to CRISPR. Our AIPR&amp;D has historically fluctuated, and is expected to continue to fluctuate, from one period </span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to another due to upfront, contingent milestone, and other payments pursuant to our existing and future business development transactions, including collaborations, licenses of third-party technologies, and asset acquisitions.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:47.705%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased by 12% in the first quarter of 2023 as compared to the first quarter of 2022, primarily due to the continued investment to support the commercialization of our medicines and increased support for our pipeline product candidates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our contingent consideration decreased by $1.9 million and $7.5 million in the first quarter of 2023 and 2022, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Non-Operating Income (Expense), Net </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income increased to $122.6 million in the first quarter of 2023, as compared to $1.6 million in the first quarter of 2022, primarily due to increased market interest rates and increased cash equivalents and available-for-sale debt securities. Our future interest income is dependent on the amount of, and prevailing market interest rates on, our outstanding cash equivalents and available-for-sale debt securities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $11.4 million and $14.9 million in the first quarter of 2023 and 2022, respectively. The majority of our interest expense in these periods was related to imputed interest expense associated with our leased corporate headquarters in Boston.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net was income of $1.3 million and expense of $72.8 million in the first quarter of 2023 and 2022, respectively. The vast majority of these amounts relate to net unrealized gains or losses resulting from changes in the fair value of our strategic equity investments. As of March 31, 2023, the fair value of our investments in publicly traded companies was $148.1 million. To the extent that we continue to hold strategic equity investments in publicly traded companies, we will record other income (expense) related to these investments on a quarterly basis. We expect that due to the volatility of the stock price of biotechnology companies, our other income (expense), net will fluctuate in future periods based on increases or decreases in the fair value of our strategic equity investments. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate fluctuates from period to period due to the global nature of our operations. The factors that most significantly impact our effective tax rate include changes in tax laws, variability in the allocation of our taxable earnings among multiple jurisdictions, the amount and characterization of our research and development expenses, the levels of certain deductions and credits, adjustments to the value of our uncertain tax positions, acquisitions and third-party collaboration and licensing transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded provisions for income taxes of $191.7 million and $192.7 million in the first quarter of 2023 and 2022, respectively. Our effective tax rate of 21.5% in the first quarter of 2023 was higher than the U.S. statutory rate primarily due to an increase in our unrecognized tax benefits partially offset by excess tax benefits related to stock-based compensation. Our effective tax rate of 20.2% in the first quarter of 2022 was lower than the U.S. statutory rate primarily due to excess tax benefits related to stock-based compensation.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_82"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of our financial condition as of March 31, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.958%"><tr><td style="width:1.0%"></td><td style="width:44.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.704%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.003%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.704%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.003%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,495.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,890.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working Capital:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,965.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,234.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,026.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,742.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total working capital</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,939.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,492.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Working Capital</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, total working capital was $9.9 billion, which represented a decrease of $553.2 million from $10.5 billion as of December&#160;31, 2022. The decrease in total working capital in the first quarter of 2023 was primarily related to increased investment in long-term marketable securities and repurchases of our common stock partially offset by $899.9 million of cash provided by operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.559%"><tr><td style="width:1.0%"></td><td style="width:63.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,833.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities were $899.9 million in the first quarter of 2023 as compared to $956.2 million in the first quarter of 2022, primarily due to a $62.3 million decrease in net income resulting from increased AIPR&amp;D partially offset by increased net product revenues.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities were $1.8 billion and $51.0 million in the first quarter of 2023 and 2022, respectively. In the first quarter of 2023, the largest portion of our investing activities were purchases of marketable securities. In the first quarter of 2022, the largest portion of our investing activities were purchases of property and equipment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities were $294.7 million and $95.4 million in the first quarter of 2023 and 2022, respectively. In the first quarter of 2023, the largest portions of our financing activities were payments related to our employee stock benefit plans and repurchases of our common stock pursuant to our Share Repurchase Program. In the first quarter of 2022, the largest portion of our financing activities were payments related to our employee stock benefit plans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Liquidity</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, we had total cash, cash equivalents and marketable securities of $11.5 billion, which represented an increase of $604.9 million from $10.9 billion as of December&#160;31, 2022. We intend to rely on our existing cash, cash equivalents and marketable securities together with cash flows from product sales as our primary source of liquidity.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that cash flows from our product sales together with our current cash, cash equivalents and marketable securities will be sufficient to fund our operations for at least the next twelve months. The adequacy of our available funds to meet our future operating and capital requirements will depend on many factors, including our future product sales, and the potential introduction of one or more of our other product candidates to the market, our business development activities, and the number, breadth, cost and prospects of our research and development programs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities &amp; Financing Strategy</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may borrow up to a total of $500.0 million pursuant to a revolving credit facility that we entered into in July 2022 and could repay and reborrow amounts under this revolving credit agreement without penalty. Subject to certain conditions, we could request that the borrowing capacity be increased by an additional $500.0 million, for a total of $1.0 billion. Negative covenants in our credit agreement could prohibit or limit our ability to access this source of liquidity. As of March 31, 2023, the facility was undrawn, and we were in compliance with these covenants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also raise additional capital by borrowing under credit agreements, through public offerings or private placements of our securities or securing new collaborative agreements or other methods of financing. We will continue to manage our capital structure and will consider all financing opportunities, whenever they may occur, that could strengthen our long-term liquidity profile. There can be no assurance that any such financing opportunities will be available on acceptable terms, if at all.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Capital Requirements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant future capital requirements, including:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected operating expenses to conduct research and development activities, manufacture and commercialize our existing and future products, and to operate our organization.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Facility and finance lease obligations.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Royalties we pay to the Cystic Fibrosis Foundation on sales of our CF products.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cash paid for income taxes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have significant potential future capital requirements including:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have entered into certain business development-related agreements with third parties that include the funding of certain research, development, and commercialization efforts. Certain of our transactions, including collaborations, licensing arrangements, and asset acquisitions, include the potential for future milestone and royalty payments by us upon the achievement of pre-established developmental and regulatory targets and/or commercial targets. Our obligation to fund these research and development and commercialization efforts and to pay these potential milestone and royalties is contingent upon continued involvement in the programs and/or the lack of any adverse events that could cause the discontinuance of the programs associated with our collaborations, licensing arrangements and acquisitions. We may enter into additional business development transactions, including acquisitions, collaborations, licensing arrangements and equity investments, that require additional capital.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">To the extent we borrow amounts under our existing credit agreement, we would be required to repay any outstanding principal amounts in 2027.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of March 31, 2023, we had $2.9 billion remaining authorization available under our Share Repurchase Program.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have not been any material changes to our future capital requirements disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission, or SEC, on February&#160;10, 2023.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_85"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements prepared in accordance with generally accepted accounting principles in the U.S. The </span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preparation of these financial statements requires us to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reported periods. These items are monitored and analyzed by management for changes in facts and circumstances, and material changes in these estimates could occur in the future. Changes in estimates are reflected in reported results for the period in which the change occurs. We base our estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from our estimates if past experience or other assumptions do not turn out to be substantially accurate. During the three months ended March 31, 2023, there were no material changes to our critical accounting policies as reported in our Annual Report on Form 10-K for the year ended December&#160;31, 2022, which was filed with the SEC on February&#160;10, 2023.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_88"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of recent accounting pronouncements, please refer to Note A, &#8220;Basis of Presentation and Accounting Policies.&#8221; </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_91"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item is incorporated by reference from the discussion in Part II, Item 7A, &#8220;Quantitative and Qualitative Disclosures About Market Risk,&#8221; of our Annual Report on Form 10-K for the year ended December&#160;31, 2022, which was filed with the SEC on February&#160;10, 2023.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_94"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management (under the supervision and with the participation of our chief executive officer and chief financial officer), after evaluating the effectiveness of our disclosure controls and procedures (as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this Quarterly Report on Form&#160;10-Q, has concluded that, based on such evaluation, as of March 31, 2023 our disclosure controls and procedures were effective and designed to provide reasonable assurance that the information required to be disclosed is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Controls Over Financial Reporting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No change in our internal control over financial reporting (as defined in Rules&#160;13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended) occurred during the three months ended March 31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_97"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.  Other Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_100"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.  Legal Proceedings</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently subject to any material legal proceedings.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_103"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding risk factors appears in Part I, Item 1A. &#8220;Risk Factors&#8221; of our Annual Report on Form 10-K for the year ended December&#160;31, 2022, which was filed with the SEC on February&#160;10, 2023. There have been no material changes from the risk factors previously disclosed in the Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form&#160;10-Q and, in particular, our Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations set forth in Part I, Item&#160;2, contain a number of forward-looking statements. Forward-looking statements are not purely historical and may be accompanied by words such as &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;forecasts,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;potentially,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; and other words and terms of similar meaning. Such statements may relate to:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the amount of, timing of, and trends with respect to our financial performance, including revenues, costs and expenses, and other gains and losses;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding clinical trials, including expectations for patient enrollment, development timelines, the expected timing of data from our ongoing and planned clinical trials, and regulatory authority filings and other submissions for our therapies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain and obtain adequate reimbursement for our products, our ability to launch, commercialize and market our products or any of our other therapies for which we obtain regulatory approval and our ability to obtain label expansions for existing therapies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to continue to grow our CF business by increasing the number of people with CF eligible and able to receive our medicines, providing improved treatment options for people who are already eligible for one of our medicines, and pursuing genetic therapies for people with CF who cannot currently benefit from our medicines;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the data that will be generated by ongoing and planned clinical trials and the ability to use that data to advance compounds, continue development or support regulatory filings;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our beliefs regarding the support provided by clinical trials and preclinical and nonclinical studies of our therapies for further investigation, clinical trials or potential use as a treatment;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our plans to continue investing in our research and development programs, including anticipated timelines for our programs, and our strategy to develop our pipeline programs, alone or with third party-collaborators;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our beliefs regarding the approximate patient populations for the disease areas on which we focus;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential benefits and therapeutic scope of our acquisitions and collaborations, including the expectation that the use of CRISPR/Cas9 gene editing technology will accelerate the development of our T1D hypoimmune cell therapy program;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the establishment, development and maintenance of collaborative relationships, including potential milestone payments or other obligations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential business development activities, including the identification of potential collaborative partners or acquisition targets;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to expand and protect our intellectual property portfolio and otherwise maintain exclusive rights to products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential fluctuations in foreign currency exchange rates and the effectiveness of our foreign currency management program;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding cash generated by operations, our cash balance and expected generation and interest income;</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our provision for or benefit from income taxes and the utilization of our deferred tax assets;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to use our research programs to identify and develop new product candidates to address serious diseases and significant unmet medical needs;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our plans to expand, strengthen, and invest in our global supply chains and manufacturing infrastructure and capabilities, including for cell and gene therapies; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our liquidity and our expectations regarding the possibility of raising additional capital.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are subject to certain risks, uncertainties, or other factors that are difficult to predict and could cause actual events or results to differ materially from those indicated in any such statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks, uncertainties, and other factors include, but are not limited to, those described in our &#8220;Risk Factors&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Item&#160;1A of our Annual Report on Form 10-K for the year ended December&#160;31, 2022, which was filed with the SEC on February&#160;10, 2023, and those described from time to time in our future reports filed with the Securities and Exchange Commission.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any such forward-looking statements are made on the basis of our views and assumptions as of the date of the filing and are not estimates of future performance. Except as required by law, we undertake no obligation to publicly update any forward-looking statements. The reader is cautioned not to place undue reliance on any such statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_106"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer Repurchases of Equity Securities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, our Board of Directors approved a share repurchase program (our &#8220;Share Repurchase Program&#8221;), pursuant to which we are authorized to repurchase up to&#160;$3.0 billion&#160;of our common stock. Our Share Repurchase Program does not have an expiration date and can be discontinued at any time. The table set forth below shows repurchases of securities by us during the three months ended March 31, 2023 under our Share Repurchase Program.</span></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_109"></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:30.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number <br/>of Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares <br/>Purchased as Part of <br/>Publicly Announced <br/>Plans or Programs (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value<br/>&#160;of Shares that May Yet be <br/>Purchased Under the <br/>Plans or Programs (1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2023 to January 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2023 to February 28, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949,299,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2023 to March 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,864,413,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,864,413,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Under our Share Repurchase Program, we are authorized to purchase shares from time to time through open market or privately negotiated transactions. Such purchases may be pursuant to Rule 10b5-1 plans or other means as determined by our management and in accordance with the requirements of the Securities and Exchange Commission. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_115"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic108ce1ac62e43b3b0fd6869b9627b1f_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.023%"><tr><td style="width:1.0%"></td><td style="width:6.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/875320/000087532023000007/a10k_2022-exhibit1023.htm">Amendment No. 2 to Employment Agreement, between Jeffrey M. Leiden and Vertex Pharmaceuticals Incorporated, dated as of February 8, 2023</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. (incorporated by reference to Exhibit 10.23 to our Annual Report on Form 10-K filed on February 10, 2023).*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="a2023q110-qexhibit311.htm">Certification of the Chief Executive Officer under Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="a2023q110-qexhibit312.htm">Certification of the Chief Financial Officer under Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="a2023q110-qexhibit321.htm">Certification of the Chief Executive Officer and the Chief Financial Officer under Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">XBRL Instance - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Labels</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cover Page Interactive Data File&#8211;&#8211;the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Management contract, compensatory plan or agreement.</span></td></tr></table></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ic108ce1ac62e43b3b0fd6869b9627b1f_118"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:22.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vertex Pharmaceuticals Incorporated</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Charles F. Wagner, Jr. </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles F. Wagner, Jr.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer<br/>(principal financial officer and<br/>duly authorized officer)</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div></body></html>
